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Abstract 
 
Background and Aims 
Despite a growing interest in the use of Cognitive Behavioural Therapy with individuals with 
Autism Spectrum Disorders, there has been little systematic appraisal of effectiveness 
research in this area to date. The primary aim of the current study was to systematically 
appraise the evidence for using CBT in the treatment of either core features of ASD or co-
occurring mental disorder in individuals with ASD across the lifespan. 
Methods 
A systematic search of relevant databases was conducted according to pre-defined criteria, 
followed by a series of random effects meta-analyses to account for the variation in outcome 
report type. 
Results 
Fifty studies met inclusion criteria and 48 studies, involving 2099 participants (1081 CBT, 
1018 control) were included in the meta-analysis. CBT for the treatment of mental disorder 
was associated with a significant “medium” effect size, g = .66, for informant-reported 
measures, and a significant “medium” effect size, g = .73, for clinician-reported measures. 
Similarly, CBT for the treatment of core features of ASD was associated with a significant 
“small” effect size, g = .48, for informant-reported measures, a significant “medium” effect 
size, g = .65, for clinician-reported measures, and a significant “small” effect size, g = .35, for 
task-based measures. CBT was not found to be superior to control when self-reported 
outcome measures were utilised. Sensitivity analyses to exclude outliers and studies deemed 
to be at a high risk of bias generally reduced effect size magnitude. Subgroup analysis was 
severely limited by a lack of definitive studies and the interpretation of results was hampered 
by the poor methodological quality of included studies. 
Conclusions 
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Future larger-scale clinical trials are needed to further explore the effectiveness of CBT in 
this client group, with well characterised samples, clearly defined primary outcome measures 
and adequate randomisation, allocation concealment and blinding.  
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Chapter One: Introduction 
1.1 Introduction to Thesis 
 There is a growing interest in the development of psychotherapeutic interventions for 
use with individuals with Autism Spectrum Disorders (ASD). Cognitive Behavioural Therapy 
(CBT) may be one promising treatment for use with this client group. However, there has 
been little systematic appraisal of effectiveness research in this area to date, particularly 
involving studies with adult participants and those investigating CBT targeting core features 
of ASD. The primary aims of the present research are therefore: (a) to systematically appraise 
the evidence for using CBT in the treatment of either core features of ASD or co-occurring 
mental disorder in individuals with ASD across the lifespan, and (b) to consider whether the 
effectiveness of CBT is moderated by age group or the format of CBT delivery. 
1.1.1 Overview of thesis structure. 
 The thesis consists of four chapters. Chapter One provides an overview of ASD and 
CBT, in addition to briefly summarising intervention research in the area to date and 
highlighting the rationale for the present research. The aims and research questions are then 
presented. 
 Chapter Two provides an overview of the methods used to address the research 
questions, in addition to outlining the rationale for the approaches and techniques selected. A 
summary of the search strategy, study selection and data extraction is provided, alongside 
information on quality appraisal and methodology used to facilitate quantitative synthesis. 
 Chapter Three provides a detailed summary of the outcomes of data collection and 
analysis. An overview of study selection is presented, in addition to a summary of 
characteristics of included studies. The outcomes of the quality appraisal process are 
addressed and a summary of quantitative synthesis is reported in relation to each research 
question. 
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 Chapter Four provides an overall discussion of the findings in relation to the research 
questions and background literature. Clinical and theoretical implications of the study are 
discussed, in addition to limitations and recommendations for future research. 
1.2 Autism Spectrum Disorders 
1.2.1 Diagnostic criteria and core features. 
 The term Autism Spectrum Disorder (ASD) has historically been used as a collective 
term to represent a number of neurodevelopmental conditions, including autism, atypical 
autism, Asperger syndrome, and pervasive developmental disorder not otherwise specified 
(PDD-NOS). However, the use of categories to define ASD has been widely criticised and a 
dimensional assessment examining the core and associated features of ASD has instead been 
recommended (Ousley & Cermak, 2014). The fifth edition of the Diagnostic and Statistical 
Manual of Mental Disorders (American Psychiatric Association, 2013) has adopted this 
approach, abandoning diagnostic subtypes and instead providing criteria to indicate the 
severity level of core ASD features, in addition to the presence of intellectual impairment, 
language impairment and co-occurring medical, neurodevelopmental, mental or behavioural 
disorders. A similar approach is likely to be adopted in the eleventh edition of the 
International Classification of Diseases of the World Health Organisation (ICF-11). Although 
the ICF-11 has not yet been finalised, the proposed revision has also abandoned diagnostic 
subtypes; instead groups are characterised by the presence or absence of intellectual 
impairment and/ or impairment of functional language (ICD-11 Beta Draft; World Health 
Organisation, 2016). 
 Within DSM-5, the “core” features or criteria used to diagnose ASD are: (a) persistent 
deficits in social communication and social interaction across contexts, not accounted for by 
general developmental delays, and (b) restricted, repetitive patterns of behaviour, interests or 
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activities. Table 1 summarises the behavioural symptoms indicated across these core criteria 
or dimensions, in addition to further criteria required for an ASD diagnosis. 
 
Table 1.  
DSM-5 Behavioural Criteria for ASD Diagnosis 
 
 Whilst the move towards dimensional assessment and diagnosis has been generally 
welcomed, there are several limitations of the current system. It could perhaps be argued that 
the merging of Asperger syndrome and PDD-NOS into a general ASD diagnosis may have 
resulted in a loss of sensitivity and identity for individuals who would previously have 
 
A)  Persistent deficits in social communication and social interaction across contexts, not 
accounted for by general developmental delays (3 of 3 symptoms) 
Symptoms A1. Deficits in social-emotional reciprocity 
A2. Deficits in non-verbal communicative behaviours used for social 
interaction 
A3. Deficits in developing and maintaining relationships appropriate to 
developmental level 
B)  Restricted, repetitive patterns of behaviour, interests or activities (at least 2 of 4 
symptoms) 
Symptoms B1.  Stereotyped or repetitive speech, motor movements, or use of objects 
B2.  Excessive adherence to routines, ritualized patterns of verbal or nonverbal 
behaviour, or excessive resistance to change 
B3.  Highly restricted, fixated interests that are abnormal in intensity or focus 
B4.  Hyper-or hypo-reactivity to sensory input or unusual interest in sensory 
aspects of environment 
C)  Symptoms must be present in the early developmental period 
D)  Symptoms cause clinically significant impairment in important areas of current 
functioning 
E) Disturbances are not better explained by intellectual disability or global delay 
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received a more specific diagnosis. Concerns have also been raised regarding the impact upon 
service provision and longitudinal research (Volkmar & Reichow, 2013). However, the actual 
impact of the changes remains to be seen, and whilst the aforementioned concerns remain 
speculative, clinicians and researchers need to move forward with the changes. 
1.2.1 Non-diagnostic features. 
 The phenotype of ASD extends well beyond the aforementioned core features, 
encompassing a range of associated symptoms in the cognitive, behavioural, affective, motor 
and sensory domains (see, for example, Volkmar, Paul, Klin, & Cohen, 2005). Examples of 
common features of ASD not included in current diagnostic criteria include sleeping and 
eating difficulties, anxiety in social situations, a lack of spontaneity or initiative and poor 
planning and organisational skills (Baron-Cohen, 2008). Some individuals with ASD may 
also experience synaesthesia, a condition in which a sensation in one modality triggers a 
perception in another modality (Baron-Cohen et al., 2013) and an estimated ten percent of 
individuals with ASD have savant skills- a skill which is above average for the general 
population (Treffert, 2014). The presentation of ASD across individuals varies widely and the 
term ‘autism spectrum’ (Wing & Gould, 1979) was coined to reflect this heterogeneity in 
symptoms and severity of the condition. However, this notion is no longer defined by any 
sharp separation from “normality” (Wing, 1997), since autistic traits have been shown to be 
normally distributed across the whole population (Baron-Cohen, Hoekstra, Knickmeyer, & 
Wheelwright, 2006; Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001). 
1.2.2 Epidemiology. 
 Whilst prevalence rates remain unclear, it has been estimated that approximately 1.1% 
of the population in the United Kingdom may have ASD (National Autistic Society, 2013). 
This estimate is based on combined epidemiological data reporting a childhood prevalence 
rate of 116.1 per 10000 (Baird et al., 2006) and an adult prevalence rate of 9.8 per 1000 
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(Brugha et al., 2011). These rates are considerably higher than those documented in the past, 
although it is not clear whether this reflects case finding changes or increasing incidence due 
to newly emerging causes (Brugha et al., 2011). Regardless, the current prevalence estimates 
emphasise the need for an enhanced understanding of the aetiology of ASD, in addition to the 
development of effective interventions. 
1.2.3 Aetiology and theoretical perspectives. 
 As already discussed, ASD is associated with a complex spectrum of difficulties and 
is currently diagnosed using only behavioural criteria. Substantial research has been 
conducted to attempt to explain behavioural characteristics of ASD using biological, 
environmental and cognitive theories. Whilst a full review of this research is beyond the 
scope of this thesis, a critical summary of key developments will be presented in this section. 
1.2.3.1 Biological factors. 
 It is now generally accepted that there is a considerable genetic component to ASD, 
with many studies indicating that the condition is highly heritable (Freitag, 2007). Family 
studies have suggested that the rate of recurrence in siblings of individuals with ASD is 2-
8%, considerably higher than the prevalence rate in the general population (Muhle, 
Trentacoste, & Rapin, 2004). Twin studies have also supported the argument for heritability, 
with research indicating a concordance rate of more than 60% in monozygotic (MZ) twins 
(Bailey et al., 1995). In an extension of this study, unaffected twins were re-evaluated for 
broader ASD phenotypes and concordance rose to 90% (Le Couteur et al., 1996). Family 
studies provide similar evidence, with a 6% rate of ASD in siblings of individuals with ASD, 
in contrast to 0.5% in the general population (Rutter, 2005). 
 Despite this compelling evidence for a strong genetic influence, there is a lack of 
clarity regarding the genes involved. Loci on chromosomes 2 and 7 are perhaps the most 
widely implicated to date (Rutter, 2005), although this research is ongoing and remains 
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inconclusive. Further biological research has focused on the role of neurochemistry and 
abnormalities in brain structure in individuals with ASD. A number of transmitter systems 
have been reported to potentially play a role in ASD, including serotonin, dopamine and 
oxytocin (Lam, Aman, & Arnold, 2006). However, many studies in this area can be criticised 
for poor methodology, including small sample sizes and lack of control groups, hindering the 
validity of conclusions drawn. The heterogeneity of ASD also complicates the interpretation 
of research (Polšek, Jagatic, Cepanec, Hof, & Simić, 2011). 
 The literature base for abnormalities in brain structure in individuals with ASD is 
similarly inconclusive. Studies have indicated that there may be an early overgrowth in brain 
volume in children with ASD, followed by a rapid deceleration of growth (Carper, Moses, 
Tigue, & Courchesne, 2002). There is also evidence of abnormalities in the structure of basic 
units of cortical information processing, smaller cerebellar volume, early amygdala 
enlargement and impaired neural connectivity (Polšek et al., 2011). However, again much of 
this research is limited by small sample sizes, clinical heterogeneity and variation in 
methodology. A recent study using the Autism Brain Injury Data Exchange, a database of 
approximately 1000 datasets of participants with ASD, attempted to overcome some of these 
difficulties by conducting a large-scale comparison of volume, thickness and surface area 
measures across the brain (Haar, Berman, Behrmann, & Dinstein, 2014). The study 
concluded that individuals with ASD had significantly larger ventricular volumes, smaller 
corpus callosum volume and several cortical areas with increased thickness, whilst there was 
found to be no difference in intracranial, cerebellar or amygdala volume as previously 
reported. The sharing of data across sites and the publication of this type of study is an 
important step forward for the advancement of our understanding of the neurobiological basis 
of ASD. However, there is a clear need for replication of research in this area and further 
advances in methodology to overcome the current inconsistencies. 
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 Finally, an increase in studies utilising functional magnetic resonance imaging (fMRI) 
has helped to inform our understanding of potential changes in brain function in individuals 
with ASD. A systematic review and meta-analysis in the area (Philip et al., 2012) identified a 
high number of studies in which reductions in neuronal connectivity were reported in 
individuals with ASD compared to controls. Particular difficulties in function were reported 
amongst neuronal areas thought to be involved in social cognition, although this is discussed 
in terms of a lack of preference for social stimuli rather than a primary dysfunction of these 
areas (Philip et al., 2012). Generally, there has been a shift towards the assumption that ASD 
is associated with impairment of specific brain networks rather than particular regions, with 
local “over-connectivity” but long-distance “under-connectivity” between distant brain 
regions (Parellada et al., 2014). 
 fMRI studies have also contributed to the theory that the mirror neurone system may 
be impaired in individuals with ASD. Mirror neurones have been shown in animal studies to 
activate during both the execution and observation of actions (Gallese, Fadiga, Fogassi, & 
Rizzolatti, 1996). Since the understanding of other people’s intentions and mental states 
requires observation of others’ actions, it had been proposed that the mirror neurone system 
may play a direct role in social cognition (Philip et al., 2012). The aforementioned systematic 
review and meta-analysis indicated impaired activation in brain areas thought to be involved 
in the mirror neurone system, including the inferior frontal gyrus, and authors interpreted this 
as evidence for mirror neurone dysfunction in ASD (Philip et al., 2012). 
 Biological and neurological research on the aetiology of ASD has developed 
significantly throughout the last decade, enhanced by advances in methodology. While fMRI 
studies have added a valuable contribution to the understanding of neurophysiology in ASD, 
they tend to merely demonstrate anatomical or functional differences without providing much 
insight into aetiology. Further, studies to date are restricted by small and unrepresentative 
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samples (Philip et al., 2012) and further replication is therefore necessary before firm 
conclusions can be drawn. 
1.2.3.2 Environmental factors. 
 It is now widely accepted that ASD is a multifactorial disorder and it is therefore 
likely that environmental factors play some role in its aetiology. Early theories positing that 
emotional deprivation may play a causal role in the development of ASD (e.g. Bettelheim, 
1967) have now been completely discounted, whilst a range of other factors have since been 
implicated, including intrauterine infections and toxins, obstetric complications, birth order, 
parental social class and postnatal infections (Rutter, 2005). It has also been argued that 
medication prescribing in early life may be an aetiological factor. For example, Niehus & 
Lord (2006) analysed infant medical records and reported that children who went on to 
develop ASD had significantly more ear infections and were prescribed significantly more 
antibiotics than typically developing children. However, much of this research is based on 
isolated case studies and to date there is no conclusive evidence linking any single 
environmental factor with an increased risk of ASD. This is therefore an important area for 
further research, with the study of epigenetic factors in ASD receiving an increasing amount 
of attention in recent years. 
1.2.3.3 Cognitive theories. 
 Given the lack of clarity regarding both biological and environmental factors involved 
in the development of ASD, cognitive theories of ASD are perhaps the most well established 
conceptualisations of ASD to date. In the absence of clear aetiological models, cognitive 
theories have provided firm theoretical foundations for clinical interventions and are 
therefore important to consider in any intervention research in ASD. This section will provide 
a critical summary of the key cognitive models of ASD to date. 
 Theory of mind hypothesis. 
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 One of the earliest and arguably most well discussed explanations of ASD posits that 
individuals with ASD have impaired theory of mind (Baron-Cohen, Leslie, & Frith, 1985). 
First defined in relation to chimpanzees as the ability to impute mental states to oneself and 
others (Premack & Woodruff, 1978), a theory of mind enables humans to predict other 
people’s mental states and to understand that the beliefs and intentions of others may differ 
from one’s own. False belief tasks, for example in which participants watch a sequence of 
events involving dolls and are asked to make judgements that require them to infer that a doll 
has a mistaken belief about the world, have indicated that typically developing children 
develop a theory of mind between the ages of four and six years (Wimmer & Perner, 1983). 
Using the same task, Baron-Cohen et al. (1985) reported that 80 percent of children with 
ASD aged six to sixteen were unable to impute beliefs to others, in contrast to 14 percent of a 
control group consisting of children with Down syndrome who had a higher level of 
intellectual disability. It was concluded that individuals with ASD have a cognitive deficit in 
theory of mind, providing an explanation for social impairment and a lack of imaginative 
play in this client group (Baron-Cohen et al., 1985). 
 This finding has been widely replicated since, and in line with the fact that failure on 
this type of task was not shown to be universal, the theory was modified to propose that 
theory of mind difficulties may develop at a later age in ASD due to developmental 
differences (Baron-Cohen, 1989). This was supported by a meta-analysis indicating that the 
probability of children with ASD passing a false belief task was highly predicted by verbal 
mental age (Happé et al., 1996), a finding which also provided an explanation for why 
individuals with higher functioning ASD were able to pass the task. Consequently, advanced 
tests of theory of mind have since been developed, including the “Reading the Mind in the 
Eyes” and “Reading the Mind in the Voice” tasks, in which individuals with ASD were 
reported to be significantly worse than controls at extracting mental state information from 
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pictures of eyes (Baron-Cohen, Jolliffe, Mortimore, & Robertson, 1997; Baron-Cohen & 
Wheelwright, 2001) and vocalisations (Rutherford, Baron-Cohen, & Wheelwright, 2002).  
 Whilst these later studies provided further support for the theory of mind hypothesis 
at some level, their ecological validity can be questioned since the stimuli were based on 
static images and recordings from scripted audiobooks. Furthermore, it has been argued that 
the development of these advanced tasks could be viewed as a post-hoc response to finding 
data anomalous to the initial theory of mind hypothesis, i.e. that some individuals with ASD 
passed tests of false belief (Rajendran & Mitchell, 2007). However, neuroimaging studies 
have also provided support for the theory by showing less activation in areas of the brain 
assumed to be heavily involved in the perception and understanding of social information, 
including theory of mind. For example, in a study using positron emission tomography 
(PET), Happé et al. (1996) reported that no task-related activity was found in the left medial 
prefrontal cortex of individuals with ASD performing a theory of mind task, an area which 
had previously been associated with task-related activity in a control sample. 
 Taken together, behavioural and biological research does appear to support the theory 
that impaired theory of mind is related to difficulties in social interaction and communication 
and imaginative play in ASD. However, non-social features of ASD, for example restricted 
and repetitive patterns of behaviour and interests, rigidity and difficulties in planning and 
organising, cannot be well explained by this theory. The theory also fails to account for areas 
of strength often seen in this client group. Whilst the model has certainly been influential and 
generated a large amount of research, it cannot account for some core aspects of ASD and 
this is a fundamental limitation. 
 Empathising- systemising theory. 
 Baron-Cohen (2002) revised and extended the theory of mind or ‘mindblindness’ 
hypothesis to account for some of the aforementioned difficulties. The social and 
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communication difficulties in ASD are explained by delays and deficits in empathy, whilst 
areas of strength are attributed to intact or superior skill in systemising. It is proposed that the 
discrepancy between empathising and systemising determines the likelihood of an individual 
developing ASD (Baron-Cohen, 2009). 
 Within this model, empathy is assumed to have two components: a cognitive aspect, 
the identification of mental states in oneself and others, which is discussed as analogous to 
theory of mind; and an affective aspect, responding to another person’s thoughts and feelings 
with an appropriate emotional reaction (Baron-Cohen, 2009). Research has shown that adults 
with high-functioning ASD score lower than comparison groups on the Empathy Quotient 
(EQ), a questionnaire designed to assess both cognitive and affective aspects of empathy 
(Baron-Cohen & Wheelwright, 2004). This was replicated in a study in which parents rated 
their children with ASD using a modified version of the questionnaire (Auyeung, Baron-
Cohen, Wheelwright, & Allison, 2008). Other areas of research have also provided support 
for the notion of delays and deficits in empathy in individuals with ASD. For example, 
Yirmiya, Sigman, Kasari, & Mundy (1992) reported that children with ASD were less able 
than typically developing children to label emotional states, take the perspective of another 
person, and respond with empathy after watching video clips of children experiencing 
different events and emotional responses. 
 Systemising has been defined as “the drive to analyse or construct systems” or trying 
to predict how a system will behave via the identification of rules that govern the system 
(Baron-Cohen, 2009). Within this model, a variety of examples of systems are given, 
including mechanical, abstract systems and social systems, in all of which we are assumed to 
systemise by identifying rules and regularities. Evidence from a variety of sources has 
indicated that individuals with ASD show intact or superior skills in this area. For example, 
adults with high-functioning ASD scored higher than comparison groups on the Systemising 
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Quotient (SQ), a questionnaire designed to capture drive to systemise (Baron-Cohen, Richler, 
Bisarya, Gurunathan, & Wheelwright, 2003). Children with ASD have been shown to be 
above average on a test requiring them to work out how a polaroid camera worked, whilst 
they had difficulties understanding other people’s thoughts and feelings (Perner, Frith, Leslie, 
& Leekam, 1989). This experimental evidence is further supported by clinical descriptions 
and self-reports of individuals with ASD indicating a greater desire to learn about systems 
and to perform system-related behaviours than typically developing individuals (Baron-
Cohen et al., 2003). 
 Baron-Cohen (2002) has extended the empathising-systemising theory to the extreme 
male brain theory of ASD. It is posited that males are naturally better systemisers, whilst 
females are better empathisers, and ASD is described as an extreme of the typically male 
profile. Scores on the EQ and SQ across typically developing men and women and 
individuals with ASD have supported this model (Goldenfeld, Baron-Cohen, & Wheelwright, 
2005), as have other measures of empathising (Baron-Cohen, 2009). It has also been reported 
that brain areas such as the anterior cingulate, prefrontal cortex and thalamus, which are 
generally smaller in males than in females, are smaller still in individuals with ASD. A 
similar pattern of results has been reported for areas of the brain that are typically larger in 
males than in females and it has been suggested that this “hypermasculinisation” may be 
related to higher levels of foetal testosterone in individuals with ASD (Auyeung et al., 2009). 
This is an interesting area of research, although several other studies do not support this 
pattern and further research is necessary before firm conclusions can be drawn. 
 The empathising-systemising theory has several strengths. It is able to account for 
limitations of the theory of mind hypothesis since it can explain both social and non-social 
features of ASD, in addition to strengths often seen in this client group. Furthermore, a 
variety of interventions have been developed as a direct result of this theory, with some 
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promising outcomes. For example, The Transporters is an animation programme in which 
facial expressions of emotion are mapped onto mechanical systems that move in a highly 
predictable way, such as trams and trains. This has been shown to lead to a greater 
improvement in emotion recognition in children with ASD than typically developing children 
(Baron-Cohen, Golan, & Ashwin, 2009) and can perhaps emphasise the utility of using strong 
systemising skills to teach aspects of empathy. Similar results have been demonstrated in 
adults using computer generated emotion regulation teaching (Golan & Baron-Cohen, 2006). 
 However, several limitations should also be acknowledged. The majority of the 
aforementioned studies were conducted with high-functioning individuals and it could 
therefore be questioned whether the E-S theory can account for all individuals with ASD. 
Whilst Baron-Cohen has argued that systemising is evident in lower functioning individuals 
with ASD, for example via repetitive patterns of behaviour (Baron-Cohen, 2006), there is 
minimal experimental evidence to support this. A further limitation is that much of the 
evidence discussed as support for the theory is derived from results on the EQ and SQ, self-
report measures from one particular research group. It is argued that independent evidence is 
needed to verify the E-S and extreme male brain theories, preferably using behavioural 
observations (Andrew, Cooke, & Muncer, 2008). 
 Executive dysfunction theory. 
 Some researchers (for example, Ozonoff, Pennington, & Rogers, 1991) have argued 
that ASD may be explained by an impairment in executive function. Executive function is an 
umbrella term used for cognitive functions including initiation and monitoring, planning, 
impulse control, inhibition, working memory and cognitive flexibility (Stuss & Knight, 
2002). These functions are thought to be mediated by the frontal lobes of the brain, damage to 
which often leads to Dysexecutive Syndrome (Baddeley & Wilson, 1988). Symptoms of 
Dysexecutive Syndrome, including a lack of impulse control, perseveration, difficulty 
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switching attention and a need for sameness, are often seen in individuals with ASD and may 
therefore indicate the involvement of the frontal lobes and impaired executive function (Hill, 
2004). 
 Studies reporting that individuals with ASD are impaired on tasks requiring executive 
function have been interpreted as support for this theory. For example, both children and 
adults with ASD have been shown to be impaired on Tower of Hanoi or Tower of London 
tasks which assess planning (Ozonoff & Jensen, 1999). Tasks of mental flexibility or set 
shifting, for example the Wisconsin card sorting task, have also been shown to be performed 
poorly by individuals with ASD (Hughes, Russell, & Robbins, 1994). Furthermore, 
neuroimaging studies have provided additional support for the theory. For example, in a 
study using functional MRI, Luna et al., (2002) demonstrated that individuals with ASD 
showed significantly less task-related activation in the dorsolateral prefrontal cortex and 
posterior cingulate cortex than healthy controls during a spatial working memory task.  
 Whilst these findings support the hypothesis that some aspects of executive function 
are impaired in individuals with ASD, there are a number of limitations of this theory. 
Research has shown that some individuals with ASD do not score poorly on tests of 
executive function, particularly those with average or above average IQ (Hill & Russell, 
2002), indicating that difficulties with executive function do not appear to be universal in this 
client group. Furthermore, studies have indicated that some areas of executive function, such 
as inhibition measured by a Stroop task, are not impaired in individuals with ASD (Ozonoff 
& Jensen, 1999), although alternative tasks measuring inhibition have demonstrated 
impairments (Hughes & Russell, 1993). This inconsistency is also seen in research into other 
areas of executive function and perhaps undermines the hypothesis that executive dysfunction 
in ASD is comparable to that seen in Dysexecutive Syndrome. A further criticism is that 
executive dysfunction is found in other clinical conditions, including Attention Deficit 
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Hyperactivity Disorder, restricting its use as a diagnostic marker of ASD (Hill, 2004). Whilst 
some research has indicated that there may be a specific pattern of executive dysfunction that 
distinguishes ASD from other neurodevelopmental disorders (Ozonoff & Jensen, 1999; 
Sergeant, Geurts, & Oosterlaan, 2002), this research is certainly far from conclusive. 
 Despite these limitations, the executive dysfunction theory should not be discounted 
completely. Further research is needed to contribute to a clearer understanding of executive 
functioning in individuals with ASD across the lifespan and how executive dysfunction may 
relate to key features of ASD. At present, the theory is not able to account for several key 
features of ASD and is hindered by inconsistent research findings, although it may be useful 
when considered in parallel to other theoretical explanations of ASD. 
 Weak central coherence theory. 
 A final cognitive theory of ASD which warrants discussion relates to weak “central 
coherence”, the ability to bring information together to construct higher level meaning in 
context (Frith, 1989). This account proposes that, whilst typically developing individuals use 
overall meaning to process information, individuals with ASD instead focus on small detail 
and process information using constituent parts rather than the whole picture (Rajendran & 
Mitchell, 2007). 
 Perceptual research involving individuals with ASD has provided support for this 
theory. For example, studies have shown that children with ASD score above average on the 
Children’s Embedded Figure Test, in which participants are required to locate a hidden figure 
within a larger meaningful drawing (Shah & Frith, 1983). Individuals with ASD have also 
consistently shown superior performance on the Block Design subtest of the Wechsler 
Intelligence Scales, in which individual blocks are used to reconstruct a 2-D pattern from 
separate parts (Frith & Happé, 1994). It had previously been suggested that superior 
performance on this task was due to strong general spatial skills in ASD (Prior, 1979), 
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although Shah & Frith (1993) demonstrated that typically developing participants benefitted 
from pre-segmentation of the designs whilst individuals with ASD did not, concluding that 
their superior performance was in fact due to an ability to segment the designs cognitively. 
Performance on these types of task has been related to anecdotal descriptions of some 
features of ASD, for example the ability to quickly notice changes in familiar lay outs and 
patterns (Frith & Happé, 1994). 
 Further evidence for the weak central coherence hypothesis has been provided by 
studies in which individuals with ASD have been shown to perform poorly on tasks requiring 
the use of context or overall meaning to interpret information, for example the 
disambiguation of homographs. Homographs are words that share the same written form as 
another word but have a different meaning. Studies have shown that individuals with ASD 
are less able than typically developing individuals to pronounce homographs correctly when 
the word must be processed as part of the whole sentence meaning (Frith & Snowling, 1983; 
Jolliffe & Baron-Cohen, 1999), suggesting that they may not be making global connections 
between words or ‘reading between the lines’. This finding has been replicated several times 
and has been discussed as an explanation for difficulties understanding communication intent 
often seen in individuals with ASD. 
 A key benefit of this theory is that it is able to account for strengths often seen in 
individuals with ASD, in addition to savant skills, which both the theory of mind and 
executive functioning theories do not. Furthermore, it is able to competently explain aspects 
of social communication difficulty, whilst also accounting for non-social features of ASD. As 
already discussed, this is an area which is often neglected by other cognitive theories which 
instead focus on explanations for social deficits in ASD. 
 However, the theory can also be criticised, particularly as there is evidence that the 
processing of global information is sometimes preserved in individuals with ASD (e.g. 
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Lopez, Donnelly, Hadwin, & Leekam, 2004). This has led to a revision of the theory to 
consider weak central coherence as a cognitive style rather than a deficit; individuals with 
ASD may be able to extract overall meaning with effort, although they are likely to be biased 
to attend to detail (Rajendran & Mitchell, 2007). Whilst this revision makes sense 
theoretically, it fails to account for studies which have found no differences at all in global 
processing between individuals with ASD and typically developing controls (e.g. Mottron & 
Belleville, 1993). There is also evidence that weak central coherence may not be universal 
among individuals with ASD (Jarrold & Russell, 1997) and it may also be seen in individuals 
with schizophrenia (Bellugi, Lichtenberger, Jones, Lai, & St. George, 2000), limiting its 
value as a theoretical account specific to ASD. However, this may not actually be considered 
as problematic by many. 
1.2.4 Summary. 
 ASD is a neurodevelopmental condition diagnosed on the basis of difficulties in social 
interaction and communication across contexts, alongside restricted or repetitive patterns of 
behaviour and interests (American Psychiatric Association, 2013). A wide variety of other 
cognitive and behavioural features are also associated with ASD, including sleeping and 
eating difficulties, some deficits in executive function and synaesthesia. Prevalence rates 
remain unclear, although rates are now higher than previously documented, highlighting the 
need for an enhanced understanding of the aetiology of ASD, in addition to the development 
of effective interventions. 
 Aetiological research in ASD is unfortunately inconsistent, fraught with 
methodological limitations and further complicated by the clinical heterogeneity of ASD. 
Whilst there have been considerable advances in genetic and biological explanations of ASD, 
there is a lack of a comprehensive model of aetiology at present. Cognitive theories of ASD 
are similarly inconsistent, with no one model being able to account for the heterogeneous 
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presentation associated with ASD. Nonetheless, when considered in combination, cognitive 
theories can explain both core and associated features of the condition well. They also 
provide important theoretical foundations, with reference to which interventions can be 
developed and appraised. 
1.3 Psychosocial Interventions to Improve Core Features of Autism Spectrum 
Disorders 
 Treatment strategies to improve core features of ASD are perhaps hindered by the fact 
that the biological causes of ASD remain poorly understood (Granovetter, 2013). However, a 
proliferation of psychosocial interventions have been developed to improve social interaction 
and communication, in addition to restricted or repetitive patterns of behaviour and interests. 
A full review of research focusing on psychosocial interventions to improve core features of 
ASD is beyond the scope of this thesis. However, it is important to acknowledge key 
interventions since the National Institute for Health and Clinical Excellence (NICE) 
guidelines for the diagnosis and management of adults and children with autism (NICE, 
2012a, 2013) specify that individuals with ASD and coexisting mental disorders should be 
offered age-appropriate psychosocial interventions to help address the core features of ASD. 
 A huge number of interventions claiming to be effective in the treatment of core 
features of ASD in children are currently available, although the evidence base for many of 
these is poor (Matson, Adams, Williams, & Rieske, 2013). Interventions with perhaps the 
most solid evidence to date are based upon operant and classical conditioning, as well as 
social learning theory (Matson et al., 2013). Many interventions incorporating principles of 
Applied Behaviour Analysis (ABA; systematic observation and modification of behaviour) 
have been developed with promising results. For example, a recent Cochrane review 
investigating the effectiveness of Early Intensive Behavioural Interventions (EIBI), 
originating from the Lovaas method (Lovaas, 1981), concluded that there is some evidence 
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that EIBI is an effective treatment for some children with ASD, with improvements in 
adaptive behaviours, communication and social skills noted (Reichow, Barton, Boyd, & 
Hume, 2012). However, it was also reported that the strength of this evidence was poor, since 
many of the included studies were non-randomised and subject to a high risk of bias. 
 Unfortunately, this is also a common problem with other types of intervention for 
ASD. There has been some promising research into interventions teaching key skills relating 
to social ability, for example emotion recognition, imitation and joint attention, although 
again much of the research in this area is from case series and quasi-experimental designs 
(Simpson et al., 2004). Interventions focused on the direct teaching of social skills, for 
example via social skills groups, video modelling and social stories are receiving increasing 
attention, but again, further systematic and experimental research is required before firm 
conclusions can be drawn regarding effectiveness.  
 The investigation of psychosocial interventions for adults with ASD is even less 
conclusive. A recent systematic review of peer-reviewed studies in this area found only 13 
relevant studies, the majority of which were case studies or non-randomised controlled trials 
focusing on ABA or social cognition training (Bishop-Fitzpatrick, Minshew, & Eack, 2013). 
Despite the fact that the quantity and quality of studies were limited, the effect sizes of those 
included were largely positive, demonstrating the importance of further research into 
psychosocial interventions for adults with ASD. 
 In summary, there are a wide variety of interventions designed to treat core features of 
ASD, although there is currently little empirical research of a high enough quality to make 
firm conclusions about effectiveness, particularly for interventions designed for adults with 
ASD. The difficulty in synthesising the evidence base is complicated by the heterogeneity in 
the clinical presentation of ASD and individual differences in response to treatment. This is 
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perhaps further complicated by the fact that ASD is associated with high levels of 
comorbidity, an area which will be reviewed in the following section. 
1.4 Psychiatric comorbidity in Autism Spectrum Disorders 
 As acknowledged in diagnostic criteria, ASD commonly co-occurs with intellectual  
and language impairment, in addition to medical, neurodevelopmental, mental and 
behavioural disorders. Intellectual disability and ASD covary at high rates; it has been 
estimated that intellectual disability is present in 24-40% of individuals with ASD (Baird & 
Charman, 2000). Comorbidity with other neurodevelopmental disorders, including Attention 
Deficit Hyperactivity Disorder, is also high (e.g. Simonoff et al., 2008), whilst multiple 
psychiatric comorbidities have been shown to be common in both children and adults with 
ASD. The following section will review research relating to comorbid mental disorder in 
individuals with ASD. 
1.4.1 Comorbid mental disorders.  
1.4.1.1 Children and adolescents. 
 Several studies have indicated that children and adolescents with ASD experience 
high rates of mental disorders. Using an epidemiological, population-derived sample of 12 
year old children, Simonoff et al. (2008) reported that 70% of participants with ASD had at 
least one comorbid disorder and 41% had two or more. The most common psychiatric 
diagnoses in this age group were anxiety disorders, attention-deficit/ hyperactivity disorder 
and oppositional defiant disorder. These results are consistent with other studies involving 
children of varying ages, with studies involving older children also reporting high levels of 
comorbid mood disorders (e.g. Leyfer et al., 2006). Studies of adolescents with ASD have 
reported increased loneliness associated with high levels of affective disorders (Attwood, 
2004a). 
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 Simonoff et al. (2013) extended their earlier study (Simonoff et al., 2008) by 
reassessing participants in their original sample at age 16 years. Results indicated that 
comorbid psychiatric disorders in individuals with ASD are persistent from childhood to 
adolescence. This study can be criticised for the fact that the only measure used to assess 
psychiatric comorbidity was the Strengths and Difficulties Questionnaire (Goodman, 1997), a 
screening measure that does not apply a clinical interpretation, is not validated for use with 
individuals with ASD and does not cover the full range of psychopathology. Additionally, no 
comparison group was utilised, further hindering the interpretation of results. However, the 
study is the first to report persistence of mental disorder in a longitudinal sample of 
individuals with ASD and therefore highlights the importance of targeting comorbid 
psychopathology during intervention with this client group. 
1.4.1.2 Adults.  
 There is a lack of empirical evidence on the prevalence of comorbid psychiatric 
disorders in adults with ASD, particularly when compared to child and adolescent 
populations. Tsakanikos et al. (2006) and Rydén & Bejerot (2008) were the first studies to 
address this issue and reported mixed results, although Tsakanikos et al. (2006) did not use a 
typically developing control group for comparison which was a clear limitation. Both studies 
were further limited by the fact that unstandardised diagnostic assessments were used to 
assess symptoms of mental disorder. 
 Joshi et al. (2013) attempted to address these difficulties in a larger-scale study that 
compared adults with and without ASD referred to a speciality clinic for ASD. The 
prevalence of comorbid psychiatric disorders was assessed using structured diagnostic 
assessments, alongside measures of psychosocial functioning. It was reported that adults with 
ASD had higher levels of both lifetime and current psychiatric comorbidity, including major 
depressive disorder and multiple anxiety disorders. Individuals with ASD were also reported 
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to have a higher level of functional impairment, and were significantly more likely to have 
received both pharmacotherapy and counselling. Whilst further research in this area is clearly 
needed and the generalizability of this data may be questioned due to the fact that all 
participants were recruited from a specialist ASD clinic, the study supports research 
demonstrating high levels of psychiatric comorbidity in children with ASD. This has 
important implications for clinical practice and intervention. 
1.4.2 Theoretical and clinical rationale for psychotherapeutic interventions. 
Gaus (2007) developed a model to conceptualise difficulties commonly reported by 
individuals with ASD seeking psychotherapy based on empirical evidence relating to 
cognitive dysfunction in ASD. Within the model, information processing deficits (e.g. 
impaired theory of mind; dysfunctional internal feedback loops involved in self-perception 
and self-regulation; and weak central coherence) combine, leading to social skills deficits 
(e.g. poor language pragmatics and semantics) and difficulties with activities of daily living, 
resulting in negative social consequences, such as being ignored, rejected or ridiculed (Gaus, 
2007). Difficulties with self-management and activities of daily living (e.g. inefficient task 
management) and a higher than average number of stressful events, increase the frequency 
and intensity of daily “hassles”. Since both poor social support and chronic stress are known 
risk factors for mental health difficulties in the general population (e.g. Cohen & Wills, 
1985), it is hypothesised that individuals with ASD are particularly vulnerable to the 
development of co-morbid mental disorders (Gaus, 2007).  
 Given the high level of coexisting mental disorders in both children and adults with 
ASD, it is unsurprising that there has been a growing interest in the development of 
psychotherapeutic interventions targeting co-occurring mental health difficulties in this client 
group. The development and use of interventions targeting psychiatric comorbidity may 
reduce overall impairment and improve quality of life. Indeed, the NICE guidelines for the 
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diagnosis and management of adults and children with autism (NICE, 2012a, 2013) specify 
that individuals with ASD and coexisting mental disorders should be offered psychosocial 
interventions informed by existing NICE guidance for the specific disorder, with adaptations 
to the method of delivery as appropriate. The Autism Act 2009 also states that mainstream 
services should offer interventions to individuals with ASD, offering reasonable adjustments 
where necessary.  
 From a public health perspective, ASD is associated with high service utilisation due 
to its early onset, high level of associated impairment and high level of psychiatric 
comorbidity (Jarbrink, Fombonne, & Knapp, 2003). The lifelong persistence of ASD adds to 
this picture; research has indicated that support costs for adults with ASD may be more than 
eight times as much as children, with the annual support cost of an adult with ASD in Great 
Britain estimated to be £90,000 (Knapp, Romeo, & Beecham, 2009). There is therefore a 
clear clinical need for research into both the clinical application and effectiveness of 
psychotherapeutic interventions with individuals with ASD across the lifespan. One such 
intervention is Cognitive Behavioural Therapy (CBT) and this will be introduced and 
reviewed in the following section. 
1.5 Cognitive Behavioural Therapy 
 Cognitive Behaviour Therapy (CBT) is a short-term, structured and predominantly 
present-oriented psychotherapy focused on modifying dysfunctional thought patterns and 
behaviour (Beck, 2011). It is currently recommended by the National Institute of Health and 
Clinical Excellence as a first line treatment for many mental disorders, including depression, 
obsessive compulsive disorder, panic disorder, social anxiety disorder, schizophrenia and 
psychosis. There is a growing interest in the use of CBT with individuals with ASD to treat 
both core features of ASD and co-existing mental disorders. This section will provide an 
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overview of the theoretical origins of CBT, in addition to briefly describing research 
literature to date regarding both its effectiveness and clinical practice. 
1.5.1 Theoretical background. 
 As implied by its name, CBT has two main theoretical influences: behavioural 
theories widely endorsed by the behaviourist movement in the 1950’s and 1960’s; and 
cognitive theories which dominated the ‘cognitive revolution’ of the 1970’s (Westbrook, 
Kennerley, & Kirk, 2011). These theories provided the foundations for behavioural therapy 
and cognitive therapy respectively, both of which influenced the development of CBT.  
 Key figures of the behaviourist movement posited that scientific study should 
predominantly focus on observable behaviour rather than unobservable events that take place 
in the mind (Skinner, 1984). Learning theory was particularly influential, providing 
explanations for the learning of new associations between stimuli and responses, and these 
principles were used within behavioural therapy to modify emotional reactions and 
undesirable behaviour. For example, systematic desensitisation (Wolpe, 1958) used principles 
of classical conditioning (implicit learning of a response to a previously neutral stimulus by 
association with an unconditioned stimulus that elicits the response; Pavlov, 1927) to treat 
fear reactions to a stimulus by pairing positive stimuli to the fear inducer during gradual and 
systematic exposure. Other behavioural treatment approaches influenced by learning theories 
include exposure and response prevention (Meyer, 1966) and contingency management 
programmes (see, for example, Petry, 2006). 
 Whilst such approaches had rapid early success and continue to be useful in the 
treatment of anxiety disorders today, the attempt to describe and treat mental disorder in 
purely behavioural terms was widely criticised in the 1970’s (Westbrook et al., 2011). 
Cognitive theorists argued that the omission of cognitive phenomena such as thoughts and 
beliefs in psychotherapies was unjust and their focus was to use experimental investigation to 
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“describe formally the meanings that human beings created out of their encounters with the 
world, and then to propose hypotheses about what meaning-making processes were 
implicated” (Bruner, 1990). Aaron T. Beck and others were influenced by this movement, 
theorising about the role of cognitive processes in emotional disorders. Indeed, Beck’s 
cognitive theory of emotion and emotional disorders (Beck, 1976) provided a firm foundation 
for the development of Cognitive Behavioural Therapy and this cognitive model remains 
central to the practice of modern CBT.  
 Beck (1976) considered that dysfunctional thinking is common to all psychological 
disturbances and directly influenced an individual’s mood, physical symptoms and behaviour. 
A high number of negative automatic thoughts are likely to be generated in situations in 
which dysfunctional assumptions, an intermediate class of beliefs, are activated. The 
development of such assumptions is influenced by an individual’s schemas or core beliefs- 
fundamental, rigid and overgeneralised beliefs that are usually developed as a result of 
childhood or early experiences. A key component of CBT interventions is therefore the 
identification and modification of cognitive structures, i.e. thoughts, beliefs and schemas, to 
facilitate clinical improvement. This is often combined with behaviourally focused 
interventions, for example developing skills in identifying, planning and increasing 
pleasurable activities. In practice, individuals are encouraged to complete structured tasks 
between sessions to consolidate and practice skills and techniques introduced in therapy 
sessions. 
1.5.2 Effectiveness in other populations. 
 Today, CBT is possibly the most extensively researched and widely evidenced 
psychotherapeutic treatment of a range of mental disorders in the general population 
(Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012). Since the body of effectiveness research 
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for CBT is so extensive, the following section will provide an overview of meta-analytical 
literature published in key populations. 
1.5.2.1 Children and adolescents. 
 In a review of meta-analyses of CBT conducted with both children and adults, 
Hofmann et al. (2012) concluded that CBT for children and adolescents showed robust 
support for the treatment of internalising disorders. “Large” effect sizes have been reported 
for the use of CBT in the treatment of anxiety disorders (James, James, Cowdrey, Soler, & 
Choke, 2015; Santacruz et al., 2002), with CBT for obsessive compulsive disorder reported to 
have significantly better outcomes than other psychosocial treatments and medication 
(Guggisberg, 2005). Santacruz et al. (2002) also reported a “medium” effect size for CBT for 
depression in children, whilst Haby, Tonge, Littlefield, Carter, & Vos (2004) concluded that 
CBT was superior to the use of selective serotonin reuptake inhibitors in children and 
adolescents. 
 Hofmann et al. (2012) reported that the evidence for the use of CBT to treat 
externalising disorders in children and adolescents is less conclusive. Meta-analyses have 
indicated that CBT is more effective than no treatment or treatment as usual but no more 
effective than other psychosocial treatments in the reduction of violent behaviours (Ozabacı, 
2011) and the treatment of juvenile sex offenders, childhood sexual abuse survivors, faecal 
incontinence, chronic headaches and childhood obesity (Macdonald et al., 2012; Walker, 
McGovern, Poey, & Otis, 2004). Van der Oord, Prins, Oosterlaan & Emmelkamp (2008) 
reported a moderate mean weighted effect size for ADHD outcomes following CBT, 
although this was deemed less effective than medication. 
  Children and adolescents with intellectual disabilities. 
 The research base for the effectiveness of CBT with children and adolescents with 
intellectual disabilities can certainly be described as in its infancy. To the best of our 
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knowledge no randomised controlled trials or studies adopting an independent group design 
have been conducted with this client group to date. In a recent review of psychological 
therapies in individuals with intellectual disabilities, Vereenooghe & Langdon (2013) 
theorised that the current lack of research may be partially explained by ethical concerns in 
the recruitment of young people with intellectual disabilities. This is disheartening and it is 
hoped that the generation of controlled outcome trials for CBT with children with intellectual 
disabilities will be encouraged by the publication of randomised controlled trials involving 
children with ASD (see Section 1.6.2.1), in addition to the growing clinical interest in the use 
of CBT in children and adolescents with intellectual disabilities.  
1.5.2.2 Adults. 
 The aforementioned review of meta-analyses reporting on the effectiveness of CBT in 
a variety of populations concluded that the strongest support exists for CBT in adults with 
anxiety disorders, somatoform disorders, bulimia nervosa, anger control problems and 
general stress (Hofmann et al., 2012). The evidence base for CBT for anxiety in adults is 
particularly strong (Hofmann & Smits, 2008) and recent research has indicated that guided 
self-help and internet-based CBT can also be effective in the relief of anxiety symptoms 
(Coull & Morris, 2011), although long term maintenance of gains with this modality remains 
unclear. However, it should also be noted that considerable heterogeneity has been reported 
amongst studies reporting on CBT for anxiety disorders and standardised reporting and a 
more uniform approach to study design would be beneficial for future research in this area. 
 Although less consistent, meta-analyses for the effectiveness of CBT in other areas 
have also shown promising results. For example, CBT has been reported to be more effective 
than control conditions in the treatment of smoking cessation, positive symptoms of 
psychosis, depression and insomnia (Hofmann et al., 2012). Evidence for the efficacy of CBT 
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has also been reported in adults with substance dependence (Dutra et al., 2008), although the 
effect size for CBT was small in comparison to other psychosocial interventions in this study. 
 In summary, the evidence for the effectiveness of CBT in adults is generally strong 
across a range of conditions (Hofmann et al., 2012). However, despite the large literature 
base, Hofmann et al. (2012) highlighted that many meta-analytic studies of the effectiveness 
of CBT include studies with inadequate control groups and small sample sizes, emphasising 
the ongoing need for high-quality effectiveness studies and meta-analytic reviews in this area. 
 Older adults. 
 The evidence base for the effectiveness of CBT in older adults remains relatively 
limited compared to studies for working age adults (Whittington & Grey, 2014). However, a 
recent meta-analysis of CBT for late life depression concluded that CBT was more effective 
than waiting list or treatment as usual conditions, although no more effective than 
pharmacotherapy or other psychotherapies (Gould, Coulson, & Howard, 2012). The same 
pattern of results was found for six month follow up and other meta-analyses reporting on the 
effectiveness of CBT for depression in older adults have described similar results (Krishna et 
al., 2011; Wilson, Mottram, & Vassilas, 2008). 
 CBT for anxiety disorders in older adults has been shown to have mixed outcomes. A 
meta-analysis by Thorp et al. (2009) reported that CBT was no more effective than relaxation 
training, although many of the studies included in this review were uncontrolled. In an 
arguably more methodologically sound meta-analysis due to the more stringent inclusion 
criteria (Hendriks, Oude Voshaar, Keijsers, Hoogduin, & van Balkom, 2008), CBT was 
shown to be more effective in reducing anxiety symptoms and accompanying symptoms of 
worry and depression than both a waiting list control and active control conditions. 
 Adults with intellectual disabilities. 
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 The aforementioned systematic review and meta-analysis by Vereenooghe & 
Langdon (2013) investigated the efficacy of psychological therapies of a variety of modalities 
with individuals with intellectual disabilities. Of the 22 trials deemed eligible for review, 18 
reported on cognitive-behavioural interventions, some of which were excluded from the 
meta-analysis if data were included in a later study or if insufficient data were reported. 
Whilst studies involving children and adolescents were included in the systematic review, all 
studies included in the meta-analysis consisted of adult participants. Vereenooghe & Langdon 
(2013) reported that CBT for anger and aggression had an average estimated effect size of g= 
.827, whilst studies evaluating CBT for depression generated an effect size of g= .742. These 
outcomes were interpreted as “large” and “moderate to large” respectively, providing support 
for the use of CBT with individuals with intellectual disabilities. However, the heterogeneity 
of studies included in the review, in addition to the variability of methodological quality 
across studies may limit the validity of this conclusion. Nonetheless, Vereenooghe & 
Langdon (2013) provided a thorough review of research in this area to date, highlighting 
limitations and generating recommendations for future research, including the measurement 
and reporting of level of intellectual functioning to reduce heterogeneity and thorough 
description of methods, interventions and adaptations. Such recommendations are likely to be 
paramount for the development of the literature base for CBT in individuals with intellectual 
disabilities and may also be applicable to studies investigating the use of CBT in individuals 
with ASD. 
1.5.3 Group versus individual Cognitive Behavioural Therapy. 
 There has been an increase in the clinical delivery of CBT using a group format 
throughout the last decade. There are clearly appealing benefits to this, including cost-
effectiveness in an increasingly resource-limited NHS, although it is important to consider 
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itself well to group sessions due to its structured, time-limited and skills-focused approach, 
potential impacts on effectiveness due to the considerable differences in format should be 
explored. 
 CBT delivered in a group format has generally attracted less empirical research than 
individualised CBT, although a number of studies have investigated its effectiveness. 
Jόnsson, Hougaard, & Bennedsen (2011) compared 110 outpatients with OCD randomly 
assigned to sessions of either individual or group CBT and concluded that OCD can be 
treated equally as effectively across both formats, although a meta-analysis of other research 
in this area demonstrated that individual CBT may be slightly superior. Other meta-analyses 
have concluded that group CBT may be an effective treatment for post-traumatic stress 
disorder (Barrera, Mott, Hofstein, & Teng, 2013), depression (Feng et al., 2012) and 
insomnia (Koffel, Koffel, & Gehrman, 2015). These outcomes are promising and emphasise 
the importance of future systematic reviews of the efficacy of CBT to include an exploration 
of effectiveness across both individual and group formats. 
1.5.4 Adaptations. 
 There is an increasing recognition of the need for CBT to be adapted or modified to 
increase its accessibility for some client groups. Perhaps the mostly widely researched groups 
to date in this area are children, older adults and individuals with intellectual disabilities, 
although a wide range of other factors may influence accessibility to CBT, including 
neurodevelopmental disorders, neurological disorders and sensory impairments (Rossiter & 
Holmes, 2013). 
 Common features of adaptive approaches that have been said to be associated with 
effectiveness include the increased use of visual resources, for example drawings, 
photographs and video; simplification of core concepts; the involvement of family members 
and carers; shorter session duration; and increased training of emotional vocabulary and 
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recognition (Rossiter & Holmes, 2013). Such modifications have been associated with 
effectiveness in CBT with children (e.g. Stallard, 2005), individuals with intellectual 
disabilities (e.g. Dodd, Joyce, Nixon, Jennison, & Heneage, 2011) and adults with dementia 
(e.g. Laidlaw, Thompson, & Gallagher-Thompson, 2004), demonstrating the flexibility of the 
intervention. However, very little experimental research has been conducted to systematically 
examine the effectiveness of modifications in individuals with ASD. It is therefore difficult to 
comment on whether particular adaptations to CBT cause improvements in outcome for this 
client group and additional research in this area would therefore be beneficial. 
1.5.5 Summary. 
 CBT is a short-term psychotherapy influenced by cognitive and behavioural theories 
and focused on modifying dysfunctional thought patterns and behaviour (Beck, 2011). It has 
been demonstrated to be effective in the treatment of a large variety of conditions, in both 
individual and group formats. When considering the evidence base for CBT across such a 
wide range of presentations and client groups, it seems logical to explore the use of this 
approach with individuals with ASD. Whilst it is acknowledged that adaptations may need to 
be made to account for social and cognitive difficulties seen in this client group, the fact that 
CBT has already been shown to be successfully adapted for use with a range of client groups 
highlights the flexibility of this approach. 
1.6 Cognitive Behavioural Therapy in Individuals with Autism Spectrum Disorders 
1.6.1 Theoretical rationale. 
The aforementioned model by Gaus (2007; see Section 1.4.2) emphasises the 
interaction between cognitive dysfunction and behavioural outcomes in individuals with ASD 
and may be extended to provide a theoretical rationale for the utility of CBT in this client 
group. Information processing deficits, social skills deficits and difficulties in daily living are 
likely to contribute to the development or reinforcement of negative beliefs and affect. For 
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example, the social consequences of being ignored or ridiculed could influence negative 
schemas about others and the self, subsequently increasing symptoms of low mood and 
anxiety. Difficulties with social cognition and cognitive rigidity can also make it more 
difficult for individuals with ASD to make use of contextual information and to modify 
existing beliefs and affect. Due to the complex nature of ASD, it could therefore be 
hypothesised that a therapy which aims to target behavioural, cognitive and affective skills 
simultaneously would be useful. Whilst many interventions focused specifically on social 
skills deficits have been found to effectively improve social outcomes for individuals with 
ASD (see Section 1.3), CBT may provide a more holistic approach as its conceptual basis 
assumes reciprocity between an individual’s thoughts, feelings and behaviours in social 
situations (Beck, 2011) and interventions are therefore multifaceted. Social skills training 
programmes that are not specific to ASD have reported increased effectiveness in 
interventions incorporating CBT techniques, in contrast to those that focus on either social, 
cognitive or behavioural techniques independently (Bauminger, 2007). Thus, CBT can 
theoretically target both core features of ASD and symptoms of co-occurring mental disorder, 
making it a potentially unique and desirable intervention for use with this client group.  
Given the fact that individuals with ASD have been shown to experience difficulties 
identifying emotions and cognitions in themselves and others, the suitability of CBT for use 
with this client group may logically be questioned. However, recent evidence suggests that 
individuals with ASD are able to accurately report their anxious and depressed cognitions 
(Ozsivadjian, Hibberd, & Hollocks, 2014) and it has also been reported that individuals with 
ASD perform comparably to typically developing individuals on tasks requiring 
discrimination among thoughts, feelings and behaviours and cognitive mediation (Lickel, 
MacLean, Blakeley-Smith, & Hepburn, 2012). Whilst it is acknowledged that this research is 
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currently in its infancy, it is argued that there is currently a lack of evidence to indicate that 
CBT should be contra-indicated in this client group.  
1.6.2 Effectiveness research. 
1.6.2.1 Children and adolescents. 
 There is an emerging literature on the effectiveness of CBT for children and 
adolescents with ASD. To date, the majority of these studies have reported on the use of CBT 
to target symptoms of anxiety (see Shaker-Naeeni, Govender, & Chowdhury, 2014, for a 
review), although there has been a growing interest in alternative uses of CBT with children 
with ASD, for example to treat anger (Sofronoff, Attwood, Hinton, & Levin, 2007), to target 
social and emotional understanding (Beaumont & Sofronoff, 2008) and to improve 
affectionate communication and friendship skills (Andrews, Attwood, & Sofronoff, 2013). 
Many studies have only included participants with at least average intellectual functioning, 
although there have also been some reports of treatment gains with individuals with mild 
intellectual impairment (Ames & Weiss, 2013).  
 Three recent narrative reviews have concluded that CBT may be an effective 
treatment for children and adolescents with ASD, although all have highlighted the need for 
further research in this area in order for firm conclusions to be drawn (Danial & Wood, 2013; 
Ho, Stephenson, & Carter, 2015; Shaker-Naeeni et al., 2014). To date, a further three studies 
have involved quantitative synthesis in the investigation of the effectiveness of CBT in 
children and adolescents with ASD. Sukhodolsky, Bloch, Panza, & Reichow (2013) 
conducted a meta-analysis of randomised controlled trials investigating CBT for anxiety in 
children with high-functioning autism and reported overall effect sizes for clinician- and 
parent-rated outcomes measures as d= 1.19 and d= 1.21 respectively. A sensitivity analysis in 
which outlier studies were removed reduced the magnitude of these effects to d= 0.57 for 
parent ratings and d= 0.89 for clinician ratings, although both remained statistically 
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significant. In contrast, the effect size for self-reported anxiety was considerably lower at 
d=0.17. 
 A similar, more recent study involved a systematic review and meta-analysis 
examining the efficacy of CBT for anxiety among youth with ASD (Ung, Selles, Small, & 
Storch, 2015). An overall treatment effect favouring CBT of d= 0.71 was reported, although 
removal of an outlier study reduced this to d= 0.47. Anxiety informant and treatment 
modality were not found to be statistically significant moderators of treatment response, 
although self-reported outcomes were again found to be significantly lower than informant-
reported and clinician-rated outcomes (Ung et al., 2015). 
 Finally, and most recently, Kreslins, Robertson, & Melville (2015) conducted a 
systematic review and meta-analysis examining the effectiveness of psychosocial 
interventions for anxiety in children and adolescents with ASD. All studies included in the 
meta-analysis utilised both cognitive and behavioural components. In a similar pattern to 
results reported by Sukhodolsky et al. (2013), psychosocial interventions were shown to be 
superior to control conditions on clinician- (d= 1.05) and parent-rated (d= 1.00) outcomes, 
whilst no significant effect was found on examination of self-reported outcomes (Kreslins et 
al., 2015). 
 These are the first systematic reviews incorporating meta-analytic methods to 
quantitatively investigate the use of CBT in individuals with ASD and they report promising 
results. However, they also highlight methodological limitations of the included studies, such 
as a lack of matched active control groups, poor subject characterisation and poor outcome 
assessment. 
1.6.2.2 Adults. 
 Whilst most of the research relating to the effectiveness of CBT in individuals with 
ASD has reported on child and adolescent populations, some studies have included adult 
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS 
 35 
participants. This is important since ASD is a lifelong disorder and difficulties encountered as 
children are likely to continue into adulthood (Seltzer, Shattuck, Abbeduto, & Greenberg, 
2004). A number of case studies have been published reporting clinical gains of modified 
CBT in adults with ASD (see, for example, Cardaciotto & Herbert, 2004; Hare, 1997; Naidu, 
James, Mukaetova-Ladinska, & Briel, 2006), whilst a recent randomised controlled trial 
concluded that CBT was effective in treating comorbid OCD in young people and adults with 
ASD (Russell et al., 2013) based on clinician-rated outcomes. This was the first randomised 
controlled trial to highlight the potential effectiveness of CBT in adults with ASD, although 
CBT was not shown to be any more effective than an anxiety management control group. 
Furthermore, in a similar pattern to studies investigating CBT for anxiety in children and 
adolescents with ASD (see Kreslins et al., 2015; Sukhodolsky et al., 2013; Ung et al., 2015), 
effect sizes for self-rated improvement were small. Several recent narrative reviews of studies 
reporting on the use of CBT in adults with high functioning ASD have concluded that there is 
preliminary evidence that CBT may decrease comorbid psychiatric symptomatology in this 
client group (Binnie & Blainey, 2013; Scattone & Mong, 2013; Spain, Sin, Chalder, Murphy, 
& Happé, 2015), although the need for increased quantitative research in this area was again 
highlighted.  
1.6.3 Rationale for further systematic appraisal of research. 
 Whilst several narrative reviews have highlighted that CBT may be a promising 
treatment for children and adolescents (Danial & Wood, 2013; Ho et al., 2015; Shaker-
Naeeni et al., 2014) and adults (Binnie & Blainey, 2013; Scattone & Mong, 2013; Spain et 
al., 2015) with ASD, there has been little systematic appraisal of research in this area to date 
that has involved quantitative synthesis. In terms of effectiveness, the three meta-analytic 
studies in this area to date (Kreslins et al., 2015; Sukhodolsky et al., 2013; Ung et al., 2015) 
focused exclusively on CBT for anxiety in children, excluding trials that included samples of 
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adults.  Whilst it is acknowledged that there has been considerably more research involving 
children and adolescents with ASD, there is a growing recognition of the need for an 
evidence synthesis of studies involving both child and adult populations. Inclusion and 
consideration of the use and effectiveness of CBT across the lifespan is important since ASD 
is associated with atypical development and the impact of symptoms may fluctuate at 
different life stages, e.g. difficulties in social interaction are likely to become more profound 
during adolescence as social contexts increase in complexity and pose higher social 
expectations (Williams White, Keonig, & Scahill, 2007). 
   By focusing exclusively on the effectiveness of CBT for anxiety for children, 
Sukhodolsky et al. (2013), Ung et al. (2015) and Kreslins et al. (2015) also excluded trials 
investigating CBT for other mental disorders, in addition to trials reporting on the use of CBT 
to target core features of ASD. To the best of our knowledge, no review to date has 
quantitatively reviewed research in either of these areas and it is therefore argued that a meta-
analysis across both areas would be both timely and clinically useful. 
1.7 Aims 
 The aims of this study were twofold:  First, to systematically appraise the evidence for 
using CBT in the treatment of either core features of ASD or co-occurring mental disorder in 
individuals with ASD across the lifespan, and second, to consider whether the effectiveness 
of CBT is moderated by age group or the format of CBT delivery. 
1.8 Research Questions 
 In line with the aims outlined in section 1.7, the following research questions were 
generated: 
 Research Question 1: How effective is Cognitive Behavioural Therapy in reducing 
symptoms of mental disorder in individuals with Autism Spectrum Disorders? 
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 Research Question 2: How effective is Cognitive Behavioural Therapy in the 
treatment of core features of Autism Spectrum Disorders? 
 Research Question 3: Is the effectiveness of Cognitive Behavioural Therapy with 
individuals with Autism Spectrum Disorders moderated by age? 
 Research Question 4: Is individual Cognitive Behavioural Therapy more effective 
than group-based Cognitive Behavioural Therapy in individuals with Autism Spectrum 
Disorders? 
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Chapter Two: Method 
2.1 Introduction 
 This chapter provides an overview of the methods used to address the research 
questions, in addition to outlining the rationale for the approaches and techniques selected. 
The chapter begins with a summary of the search strategy used to identify potentially relevant 
studies, followed by a description of the eligibility criteria and screening method applied to 
select studies for inclusion. A clear account of procedures implemented to extract both 
descriptive and quantitative data from included studies is provided, alongside information on 
the quality assessment framework chosen to facilitate quality appraisal. The chapter 
concludes with a summary of methodology used to facilitate the quantitative synthesis of 
extracted data. 
2.2 Registration of Research 
 The review was prospectively registered with PROSPERO, an international database 
of systematic reviews in health and social care, in order to provide transparency in the review 
process and to avoid duplication of research effort (Weston & Langdon, 2015). 
2.3 Search Strategy 
2.3.1 Database search. 
 Relevant studies were identified by systematic searches of the following electronic 
databases: PsycINFO; MEDLINE; CINAHL Plus and Web of Science, in addition to Google 
Scholar. Initial searches were conducted on 09/12/14 (see Appendix B for output summaries 
from the initial search for each database). Search alerts were set up to repeat the search on a 
weekly basis throughout the data collection period to ensure that relevant articles published 
after the initial search were included. The last date searched was 29/01/16. The Cochrane 
Library was also searched to identify any existing systematic reviews. As search tools and 
assigned subject headings differ across databases, the pooling of tools and terms in a 
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simultaneous search may reduce effectiveness, resulting in the loss of potentially relevant 
articles (Higgins & Green, 2008). Databases were therefore searched individually rather than 
using a host such as EBSCO to search across databases concurrently. 
 Experimental studies that reported on the effectiveness of CBT in children, 
adolescents and/or adults with an ASD were sought by combining key terms describing the 
target population and intervention (see Table 2). Terms related to study design or outcome 
measures were not included to prevent exclusion of studies which may have been relevant. 
Initial search trials resulted in a very high number of clearly irrelevant studies, for example 
medication trials, so exclusion terms were added to narrow the search. Terms were searched 
using US and UK terminology and truncation was used to ensure that all variant word 
endings were identified. A filter was applied to ensure that all articles retrieved were written 
in English. At this stage, titles and abstracts were screened by the primary author to identify 
potentially relevant studies and articles which were clearly not relevant were excluded. 
 
Table 2.  
Search Terms in Title and Abstract 
 
2.3.2 Ancestry method. 
Target 
Population1 
Autism Spectrum Disorder OR ASD OR Autis* OR Asperger* OR Kanner* 
OR Pervasive Developmental Disorder 
Intervention2 Cognitive Behavio* (Therap* OR Treatment OR Intervention) OR Cognitive 
(Therap* OR Treatment OR Intervention) OR Behavio* (Therap* OR 
Treatment OR Intervention) OR CBT OR Psychotherap* OR Problem 
Solving 
Combined 
Terms 
1 AND 2 
Exclusion 
Terms 
(Drug* OR Medication* OR Vitamin* OR Hormon* OR Pharmacotherap*) 
Gene* 
(Applied Behavio* Analysis OR ABA) 
(Education OR Classroom* OR School*) 
Epilepsy 
ADHD 
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 In order to identify further relevant literature, the ancestry method was used to 
examine reference lists of articles retrieved as part of the initial search, including existing 
reviews. Key journals were also identified by examining journal titles of articles meeting 
inclusion criteria; Autism, The Journal of Autism and Developmental Disorders and Research 
in Autism Spectrum Disorders were hand searched from 2000 to present. The World Health 
Organisation (WHO) International Clinical Trials registry was searched for relevant ongoing 
studies. 
2.3.3 Grey literature search. 
 A key source of potential bias in meta-analytic research is publication bias or the 
“file-drawer” problem (Rosenthal, 1979); the fact that significant findings are more likely to 
be published than non-significant findings. It has been reported that studies with positive 
outcomes are approximately seven times more likely to be published than studies supporting 
the null hypothesis (Coursol & Wagner, 1986). This can lead to the overestimation of 
population effects in meta-analytic reviews that do not include unpublished studies, since 
effect sizes in comparable unpublished studies are likely to be smaller (McLeod & Weisz, 
2004).  
 Various strategies were therefore used to identify unpublished or “grey” literature and 
to minimise publication bias. An initial search was conducted via http://www.opengrey.eu/, a 
database including research reports, doctoral dissertations and conference papers. This was 
supplemented with searches of Dissertation Abstracts International and the British Library e-
theses Online Service, in addition to the scanning of relevant conference programs online and 
searching trial registers for completed and ongoing studies. Authors of potentially relevant 
trial protocols were contacted to request a progress update and any relevant data. First authors 
of included studies were contacted by email to request support in identifying unpublished or 
ongoing research which may have been relevant (see Appendix C). 
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2.4 Eligibility Screening 
2.4.1 Eligibility criteria. 
2.4.1.1 Inclusion criteria. 
 Studies meeting the following criteria were included in the meta-analysis: 
1. Inclusion of participants with a diagnosis of ASD (or autistic disorder, Asperger 
disorder, childhood disintegrative disorder or pervasive developmental disorder not otherwise 
specified prior to the publication of DSM-V). Diagnosis made by a qualified clinician or by 
the use of a standardised diagnostic assessment 
2. Use of a control or comparison group design, for example waiting list or treatment as 
usual (TAU), with or without randomisation 
3. Inclusion of a clinician-led CBT intervention, either individual or group-based, 
incorporating both cognitive and behavioural components and based on well-established and 
theoretically driven principles and techniques. Articles describing interventions in which 
CBT theory and principles were utilised to teach or improve behavioural patterns, for 
example social skills, were included providing that this was explicitly stated 
4. Use of at least one validated/ standardised outcome measure of either core ASD 
features, i.e. difficulties in social interaction, impaired social communication or restricted or 
repetitive patterns of behaviour and interests, or co-occurring symptoms of mental disorder, 
for example anxiety, depression or psychosis 
5. Written in English 
2.4.1.2 Exclusion criteria. 
The following exclusion criteria were applied: 
1. Single case studies, case series, single case designs, qualitative studies, meta-analysis and 
review articles 
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2. Studies in which the effect of the CBT intervention could not be isolated from other 
treatment methods, for example psychotropic medication 
3. Studies which reported on applied behavioural analysis or behaviour modification only, 
including behavioural activation as a stand-alone treatment 
4. Studies which used the same dataset as an already included study, to avoid double 
counting of data, which could introduce significant bias (Senn, 2009) 
 No limits were applied on date of publication or completion of research due to the 
novelty of this review. No limits were applied on age of participants due to the nature of 
Research Question 3. Both published and non-published studies were included to avoid 
publication bias. 
2.4.2 Screening method. 
 Literature deemed to be potentially relevant from the title or abstract was screened for 
eligibility by both the primary researcher and a research supervisor. Inter-rater reliability was 
assessed using a Kappa statistic (Altman, 1991) and final decisions on inclusion were made 
via discussion. Reasons for the exclusion of articles at full-text stage are reported in section 
3.2. 
2.5 Data Extraction 
2.5.1 Data extraction method. 
 Information was extracted and coded from each study meeting eligibility for the meta-
analysis using a predesigned data extraction form (see Appendix D). Data extraction was 
conducted by the primary researcher and independently checked by a research supervisor for 
accuracy and completeness. Any disagreements were resolved via discussion. In the event of 
missing or unclear information, authors of included studies were contacted via email in an 
attempt to obtain or clarify the data (see Appendix E for email correspondence). A summary 
table was completed detailing the key data extracted from each included study. 
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2.5.2 Non effect size data. 
 A unique identification number was assigned to each study and a range of descriptive 
data were extracted to facilitate data synthesis and quality appraisal. Excluding effect size 
data, the following data were extracted: full reference; year of publication and country of 
origin; type of report; group descriptors, for example CBT format, number and format of 
control group/s, duration of treatment and reported baseline differences; sample descriptors, 
including number and basic characteristics of participants across groups, for example mean 
age and age range; and design descriptors, for example randomisation, method of allocation, 
CBT target, outcome measures used and length of follow up. 
2.5.3 Effect size data. 
 Calculation of effect sizes was based on data reported in research papers, in addition 
to responses from authors to requests for further information. If means and standard 
deviations were not directly reported but were possible to calculate from data included in the 
study, the primary author of the current research calculated these independently. The 
Cochrane Collaboration Review Manager software (RevMan Version 5.3; The Cochrane 
Collaboration, 2014) was used for effect size calculations. This software was chosen as it was 
freely available and had the capability to conduct all planned analytic procedures, in addition 
to having extensive features for collaborative management of the review (Bax, Yu, Ikeda, & 
Moons, 2007). 
 The standardised mean difference (SMD) was calculated for outcomes assessed 
immediately post-intervention to estimate the difference between treatment and control 
conditions for each study. The SMD was used rather than the weighted mean difference since 
outcome measures were not consistent across studies (Lipsey & Wilson, 2001). The 
standardized mean difference expresses the size of the intervention effect in each study 
relative to the variability observed in that study. Cohen’s d (Cohen, 1988) was calculated by 
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subtracting the mean post-test score of the control group from the mean post-test score of the 
experimental group and dividing the result by the pooled standard deviation. Cohen’s d was 
then transformed into Hedge’s g (Hedges, 1981) using correction factor J to correct for 
possible positive bias due to small sample size. The magnitude of Hedges g was interpreted 
using Cohen’s (1988) convention as “small” (0.2), “medium” (0.5), and “large” (0.8). The 
variance and standard error of g was also calculated for each study. 
 The SMD does not correct for differences in the direction of the scale. The majority of 
continuous outcome measures included in analysis were based on scales in which an increase 
in score indicated greater symptom severity. Where this was not the case, i.e. when an 
increase in score indicated a positive outcome, the mean values were multiplied by -1 to 
ensure that all scales pointed in the same direction (Deeks, Higgins, & Altman, 2011). 
 Data from various intervention arms were pooled when there was only one control 
arm to avoid double counting of data (Senn, 2009). The following formulae were used to pool 
means and standard deviations across intervention arms, as recommended by Higgins and 
Deeks (2011). This method was chosen as it produces outcomes as if the combined groups 
have never been divided into two, giving a more accurate estimate than standard pooling 
techniques. 
 Mean: 
 
 Standard Deviation: 
 
 In instances where data pertaining to a comparable outcome were presented in some 
studies as dichotomous data and in other studies as continuous data, the SMD was calculated 
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS 
 45 
for continuous data and Odds Ratios (OR) were calculated for dichotomous data. The ORs 
were re-expressed as SMDs, allowing the data to be pooled together, using the following 
formula (Chinn, 2000): 
 
 The standard error (SE) of SMDs and log ORs was calculated from 95% confidence 
intervals using the following formula (Higgins & Deeks, 2011): 
 
SE = Upper	limit − Lower	limit3.92  
 
 The SE of log ORs was converted to the SE of SMDs by multiplying by the same 
constant; 67 = 0.5513 (Deeks et al., 2011). All SMDs and SEs were then combined using the 
Generic Inverse-Variance method in RevMan (The Cochrane Collaboration, 2014). 
2.5.3.1 Outcome measures 
 Outcome measures were validated or standardised measures of either core ASD 
features, for example The Social Skills Rating System (SSRS; Gresham & Elliott, 1990), or 
co-occurring symptoms of mental disorder, for example the Spence Children’s Anxiety Scale 
(Spence, 1998). Outcome measures which were not appropriately validated or standardised 
were not included. 
 Measures taking the form of self-, clinician- or informant-report were included, in 
addition to task-based measures. Since evidence indicates that ASD may impair an 
individual’s ability to judge their own social or communicative behaviour, due to subtle 
mind-reading difficulties (Baron-Cohen, 1995; Baron-Cohen et al., 1997), effect sizes were 
calculated individually for all report types, in the event that more than one type of measure 
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS 
 46 
was reported for the same construct. This enabled comparison of effect size estimates across 
outcome report type. As effect sizes were calculated individually for all report types included 
in each study, the level of effect size data extracted varied across studies. 
 In instances in which more than one outcome measure was included for the same 
report-type, the primary outcome measure was used in analysis where this was specified.  If 
primary outcome measures were not specified, the most commonly used measure across 
similar studies was selected. Where no commonalities across studies were noted, and authors 
failed to specify their primary outcome measure for a report-type, this was picked at random. 
 In instances in which the construct being measured varied considerably across report-
types/s, the measures/s pertaining to the primary construct being targeted were included. 
Measures not pertaining to the primary construct being targeted were not included to avoid 
inappropriate comparisons during analysis. Outcome measures selected for each study for 
each report-type are documented in Table 3. 
2.6 Quality Assessment Framework 
 Careful consideration was given to the evaluation of the validity of included studies to 
ensure that conclusions drawn regarding the effectiveness of the intervention were as accurate 
as possible. A large number of scales have been developed to quantify the quality or risk of 
bias in clinical trials. However, few have been validated using established criteria and the 
conclusions of different scales when assessing the same data have been shown to vary 
considerably (Juni, Witschi, Bloch, & Egger, 1999). The use of such scales is therefore 
discouraged in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidance (Liberati et al., 2009) and the use of a checklist or component approach 
to provide a framework for critical appraisal is recommended.  
 The NICE Quality Appraisal Checklist for Quantitative Intervention Studies (NICE, 
2012b; see Appendix F) was used in the present study as it enables appraisal of internal and 
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external validity of both randomised and non-randomised trials. The checklist was completed 
for each included study by both the primary researcher and a research supervisor and inter-
rater reliability was assessed using a Kappa statistic (Altman, 1991). The second rater was an 
expert in the content area which was felt to be important as increased knowledge of the area 
may result in a more consistent assessment of study validity (Jadad et al., 1996). The quality 
appraisal process was not blinded as it has been suggested to add little benefit (Berlin & 
Cirigliano, 1997; Kjaergard, Villumsen, & Gluud, 2001) and practical aspects were also a 
factor, i.e. most of the included studies were by this point well known to the researchers. A 
decision was made not to contact study authors to collect missing information in relation to 
quality assessment due to resource constraints, and because it has been reported that answers 
to these types of request are likely to be positively biased (Haahr & Hróbjartsson, 2006). 
 Outcomes of quality assessment are presented in section 3.4. Potential risks of bias 
and threats to study validity both within and across studies are narratively summarised. A 
decision was made not to weight studies according to their validity or risk of bias as formal 
statistical methods are not sufficiently well developed to allow for this (Higgins, Altman, & 
Sterne, 2011), and are therefore not currently recommended (Greenland & O'Rourke, 2001). 
Sensitivity analyses were conducted to demonstrate how conclusions may be affected if 
studies deemed to be at a high risk of bias were excluded from the analysis. 
2.7 Data Synthesis 
 Meta-analysis was employed to analyse intervention effects and moderating variables 
using the Cochrane Collaboration Review Manager software (RevMan, Version 5.3; The 
Cochrane Collaboration, 2014). 
2.7.1 Model. 
 A random-effects model was used for the following reasons: 1) heterogeneity was 
anticipated since the project was accumulating data from a wide variety of sources and we 
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could therefore not assume a common effect size, and 2) inferences made from random-
effects models are unconditional and may be applied to a population of studies larger than the 
sample (Ellis, 2010), enabling the research questions to be addressed. Inverse variance 
methods were used to calculate study weight, assigning greater value to more precise studies 
with large samples or smaller variances. 
 Separate random-effects meta-analyses were conducted to account for the variation in 
outcome report type: self-report, informant-report, clinician-rated and task-based. 
Heterogeneity assessment, subgroup analysis, sensitivity analysis and exploration of 
publication bias were conducted for each report type. 
2.7.2 Heterogeneity assessment. 
 It was anticipated that there may be considerable heterogeneity within the studies 
included in the analysis. Potential sources of heterogeneity included the method of CBT used 
(individual or group), the age range of participants, symptom severity at baseline and 
outcome measures used. Heterogeneity was explored using the I2 statistic, which describes 
the percentage of variation across studies that is due to heterogeneity rather than chance 
(Higgins & Thompson, 2002). The I2 statistic was chosen rather than Cochran’s Q since it 
enabled quantification of the effect of heterogeneity, providing a measure of the degree of 
inconsistency in the studies’ results (Higgins & Thompson, 2002) and it does not inherently 
depend on the number of studies included in the meta-analysis (Higgins, Thompson, Deeks, 
& Altman, 2003). The degree and impact of heterogeneity was assessed using the 
categorisation of “low” (25%), “medium” (50%) and “high” (75%) (Higgins et al., 2003), in 
addition to a qualitative assessment of diversity within methodology. 
2.7.3 Subgroup analysis. 
 Subgroup analysis was conducted to evaluate the impact of potentially moderating 
variables and to address the research questions directly. The following planned subgroup 
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analyses were conducted for each of the outcome report types provided at least two studies 
fulfilled the requirements for meta-analysis. All subgroup analysis was conducted using 
RevMan. 
 A random-effects meta-analysis was conducted to assess potential variations of 
treatment effects across outcome constructs (co-occurring symptoms of mental disorder and 
“core” symptomatology), in line with Research Questions 1 and 2. 
 A second analysis was conducted to assess potential variations of treatment effects 
across common age groups, addressing Research Question 3. Studies were assigned to an age 
group on the basis of the age range of participants (children and adolescents: 4-18; adults: 
>18; mixed: samples including both children/ adolescents and adults).  
 A third analysis was conducted to assess variation of treatment effects by type of CBT 
(individual and group), in order to address Research Question 4. 
 Additional planned subgroup analysis included publication (published and non-
published). However, the subgroup analysis for publication was not conducted due to the lack 
of unpublished trials sourced that met inclusion criteria for the study. 
 In addition to the planned subgroup analyses, an additional unplanned analysis was 
conducted. Due to the high number of studies included which specifically assessed co-
occurring symptoms of anxiety, a subgroup analysis was conducted to assess potential 
variations of treatment effects across age groups (children and adolescents: 4-18; adults: >18; 
mixed: samples including both children/ adolescents and adults) within this subset of studies. 
2.7.4 Sensitivity analysis. 
 Sensitivity analyses were undertaken to consider whether the findings were robust to 
the decisions made in the process of obtaining them (Higgins & Thompson, 2002). As several 
outlier studies with a considerably larger effect size estimate than the other studies were 
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identified, sensitivity analyses were conducted by removing outliers and recalculating the 
estimated weighted mean effect size and heterogeneity statistic.  
 Several pilot or feasibility studies also met inclusion criteria for the current research. 
Efficacy analyses in pilot trials have been shown to be vulnerable to false positive and false 
negative findings and can potentially be misleading (Kraemer & Kupfer, 2006). This is likely 
to be directly related to sample size, with smaller sample sizes in pilot trials contributing to 
unstable effect sizes (Leon, Davis, & Kraemer, 2011). A plan was therefore made to conduct 
sensitivity analysis using the above method to examine the effect of the inclusion of pilot or 
feasibility trials. However, during the analysis it was felt that a number of other included 
studies which were not defined by the authors as pilot or feasibility trials were in fact lower 
in quality and/or had smaller sample sizes than many pilot or feasibility trials. Quality 
appraisal and risk of bias was therefore considered on a study by study basis and sensitivity 
analysis was conducted by removing studies deemed to be at a high risk of bias rather than 
those defined by authors as pilot or feasibility trials. 
2.7.5 Exploration of publication bias. 
 Publication bias was assessed graphically using funnel plots plotting effect size 
against sample size (Light & Pillemer, 1984) since a skewed and asymmetrical plot may 
indicate a publication bias (Greenhouse & Iyengar, 2009). However, funnel plots were 
supplemented by further analysis due to their recognised limitations; they require a large 
number of studies of varying sizes and their inter-rater reliability is low (Song, Hooper, & 
Loke, 2013), whilst publication bias is not the only source of asymmetry in funnel plots 
(Egger, Smith, Schneider, & Minder, 1997). For example, true heterogeneity of effect sizes, 
English language bias and data irregularities can also lead to asymmetry (Egger et al., 1997). 
 Where publication bias was detected, the fail-safe N (Rosenthal, 1979) was used to 
assess the impact of bias by calculating an estimate of the number of new studies averaging a 
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null result that would be required to bring the overall treatment effect to non-significance. 
Fail-safe N was calculated using an online calculator (see Rosenberg, 2005, for further 
details). 
It is recognised that there are several limitations of this approach. The calculation of 
the fail-safe N has been criticised as different formulas for fail-safe N can lead to widely 
varying estimates and do not take information on heterogeneity or sample size into account 
(Becker, 2005). Results were therefore interpreted with caution. 
 A decision was made not to correct for detected publication bias, for example, by 
using the trim and fill method (Duval & Tweedie, 2000) which involves the removal of 
smaller studies presumed to be causing asymmetry, the estimation of the true “centre” of the 
funnel, and the replacement of the studies alongside artificial studies to correct the 
asymmetry (Sterne, Egger, & Moher, 2011). This approach has been criticised as it relies on 
the assumption that the ‘missing’ studies are those with the smallest effect sizes (Vevea & 
Woods, 2005) which can lead to overcorrection. In addition, it does not take into account 
reasons for funnel plot asymmetry other than publication bias (Sterne et al., 2011). More 
sophisticated methods have been devised (see Field & Gillett, 2010) but as they have only 
been shown to be effective in meta-analyses including a very large number of studies, they 
were not considered for the current research. 
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Chapter Three: Results 
3.1 Introduction 
In order to address the research questions, this chapter provides a detailed summary of 
the data collection and analysis. The chapter begins with an overview of the identification, 
screening and inclusion or exclusion of articles, supported by a PRISMA flow diagram 
(Moher, Liberati, Tetzlaff, & Altman, 2009).  A clear summary of included studies is 
provided, alongside a table detailing key characteristics of all studies included in the 
quantitative synthesis. The outcomes of the quality appraisal process are addressed and a 
summary of the quantitative synthesis is reported with reference to each research question. 
The chapter ends with a brief discussion of the key findings.  
3.2 Study Selection 
 Following the removal of duplicate studies by both electronic and manual screening, 
the systematic search of electronic databases identified 2332 potentially eligible studies, and 
of these, 2263 were excluded by the primary author as it was clear from the screening of titles 
and abstracts that they did not meet inclusion criteria. The remaining 69 studies were 
supplemented by 102 studies identified by the ancestry method and two studies identified 
during the grey literature search, giving a total of 173 studies which were retrieved and 
assessed for eligibility by both the primary researcher and a research supervisor. One hundred 
and twenty-three studies were excluded at this stage for a variety of reasons, including a lack 
of a control or comparison group design (107 studies), use of a dataset that had already been 
utilised in an included study (five studies) and a lack of both cognitive and behavioural 
techniques within the intervention (four studies); see Figure 1 for full list of reasons for 
exclusion.  
Six relevant protocols were identified during the search process and authors were 
contacted to request a progress update and any relevant data. Two authors replied with an 
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update that their studies had just been accepted for publication and forwarded the manuscripts 
(Begeer et al., 2015; Langdon et al., 2016). These studies were included, whilst the remaining 
four authors did not reply and the protocols were therefore excluded. 
 Fifty studies met inclusion criteria for the study. However, it was not possible to 
include two of these studies (DeRosier, Swick, Davis, McMillen, & Matthews, 2011; 
Provencal, 2003) in the meta-analysis as requests to authors for data required to calculate 
effect sizes were unsuccessful. Forty-eight studies, involving 2099 participants (1081 CBT, 
1018 control) were therefore included in the quantitative synthesis. There was very good 
agreement between the researchers regarding study inclusion (96.5%; Kappa 0.92; 95% CI 
[0.85, 0.98; see Appendix G for calculation]. Figure 1 depicts a PRISMA flow diagram 
(Moher et al., 2009), outlining the identification, screening and inclusion or exclusion of 
articles throughout the process. Reasons for article rejection are clearly indicated. 
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Figure 1. PRISMA flow diagram of study selection 
 
3.3 Study Characteristics 
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 Key characteristics of the 50 studies meeting the inclusion criteria are detailed in 
Table 3. Two of the included studies were unpublished; both were academic theses sourced 
via the grey literature search (Clarke, 2012; Provencal, 2003). The quality of these studies 
was assessed using the same framework as all published studies.  
 As indicated in Table 3, 24 of the included studies assessed the effectiveness of CBT 
for co-occurring symptoms of mental disorder, whilst 24 studies targeted core features of 
ASD. One study (White et al., 2013) investigated both social skills and anxiety. Since 
outcomes for both could not be included due to the high risk of bias associated with double 
counting of data (Senn, 2009), the data pertaining to outcomes for social skills were included 
as this increased the data available to evaluate the effectiveness of CBT in the treatment of 
core features of ASD. One study (Wood, Fujii, Renno, & Van Dyke, 2014) described the use 
of a CBT intervention to target both social communication and anxiety, although anxiety 
outcomes were reported in a separate paper (Fujii et al., 2013). The Fujii et al. (2013) study 
was excluded during screening of full-text articles since it used the same participants as 
Wood et al. (2014), again to avoid double counting of data (Senn, 2009). 
3.3.1 Studies investigating the effectiveness of CBT for symptoms of mental 
disorder. 
 All 24 studies investigating the effectiveness of CBT for co-occurring symptoms of 
mental disorder were included in quantitative synthesis. Seventeen of the studies involved 
children and adolescents, whilst four included adult participants. Three studies (McGillivray 
& Evert, 2014; Pahnke, Lundgren, Hursti, & Hirvikoski, 2014; Russell et al., 2013) included 
both adolescent and adult participants and were therefore assigned to a ‘Mixed Age’ 
subgroup for analysis.  
 Fifteen of the 24 studies in the co-occurring symptoms of mental disorder group 
examined group-based CBT, whilst eight reported on individual CBT. The remaining study 
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(Langdon et al., 2016) involved 21 group sessions, in addition to 3 individual sessions prior 
to group entry to support socialisation to the CBT model. Since this study was predominantly 
group-based, the decision was made to include it in the ‘group-based’ subgroup when 
analysing mode of CBT delivery. 
 Fourteen of the studies targeting symptoms of mental disorder were defined by 
authors as randomised controlled trials, seven of which compared a CBT intervention with a 
waiting list control group and three of which compared CBT to treatment as usual. Three 
randomised controlled trials compared CBT to a non-CBT group-based treatment: either a 
social recreational program (Hesselmark, Plenty, & Bejerot, 2014; Sung et al., 2011) or an 
anxiety management group (Russell et al., 2013). The final randomised controlled trial 
(Cortesi, Giannotti, Sebastiani, Panunzi, & Valente, 2012) compared a CBT group to a group 
which received a placebo drug. This study also included a condition in which participants 
received melatonin and a condition in which participants received both melatonin and CBT. 
Participants from these intervention arms were not included as the use of a drug-based 
comparison group was not utilised in any other included study. Three of the 24 studies 
investigating the effectiveness of CBT for co-occurring symptoms of mental disorder were 
quasi-experimental or non-randomised (Clarke, 2012; McGillivray & Evert, 2014; van 
Steensel, Dirksen, & Bögels, 2014), whilst seven were defined by the authors as pilot studies. 
These studies were included in initial analysis but treated with caution (see Section 3.4 for 
further details). Three of the seven pilot studies within this group were randomised, whilst 
four were not, and six compared a CBT intervention to a waiting list control group, whilst 
one compared CBT to treatment as usual. 
 The majority of studies investigating the effectiveness of CBT for co-occurring 
symptoms of mental disorder were targeting anxiety symptoms (15 of the 24 studies). As this 
was such a large group, a subgroup analysis was conducted to assess potential variations of 
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treatment effects across age groups within this subset of studies, enabling comparison to 
recent meta-analytic studies which have looked specifically at the effectiveness of CBT for 
anxiety in individuals with ASD (Kreslins et al., 2015; Sukhodolsky et al., 2013; Ung et al., 
2015). Two studies targeting symptoms of Obsessive Compulsive Disorder (Russell et al., 
2013; Russell, Mataix-Cols, Anson, & Murphy, 2009) were also included within this subset, 
as was a study investigating depression, anxiety and rumination (Spek, van Ham, & 
Nyklicek, 2013) and a study investigating depression, anxiety and stress (McGillivray & 
Evert, 2014). In the latter two studies, only outcomes pertaining specifically to anxiety were 
used to reduce heterogeneity within the quantitative synthesis as much as possible. In total, 
19 studies were included within the anxiety subset. Of the remaining five studies, one 
targeted anger (Sofronoff et al., 2007), one targeted general emotional regulation skills 
(Scarpa & Reyes, 2011), one targeted insomnia (Cortesi et al., 2012), one targeted self-
esteem, quality of life and sense of coherence (Hesselmark et al., 2014) and one targeted 
stress and emotional distress (Pahnke et al., 2014). 
 As anticipated, there was extensive variation in the outcome measures used across 
studies. Many studies included outcome measures from various sources, with the most 
common report type being self-report within studies targeting co-occurring symptoms of 
mental disorder, followed closely by informant-report (usually parent) outcomes and 
clinician-rated outcomes. Only one study within this group used a task-based outcome 
measure (Cortesi et al., 2012). 
 There was also considerable variation in the intensity and content of intervention. The 
number of sessions ranged from four to 50, whilst the length of each session ranged from 40 
to 180 minutes. The majority of studies investigating the effectiveness of CBT for co-
occurring symptoms of mental disorder used a structured protocol (22 out of 24). In terms of 
content, 21 of the studies utilised “traditional” CBT methods, with common components 
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including role play, exposure and teaching/ rehearsal of emotional regulation skills. Common 
adaptations for the use of CBT in individuals with ASD included an increased emphasis on 
behavioural rather than cognitive components, the use of social stories and vignettes and 
increased involvement of family members. One of the studies (Hepburn, Blakeley-Smith, 
Wolff, & Reaven, 2016) piloted a videoconferencing CBT intervention designed for delivery 
in a small, multi-family group format, whilst another study (Spek et al., 2013) used a 
modified version of Mindfulness Based Therapy (Segal, Williams, & Teasdale, 2002) with 
cognitive elements omitted. The final study within this group (Pahnke et al., 2014) utilised a 
modified Acceptance and Commitment Therapy protocol (Hayes, Strosahl, & Wilson, 2003) 
and participants in the CBT group engaged in daily mindfulness exercises in addition to 
structured intervention sessions. 
3.3.2 Studies investigating core features of ASD. 
 Of the 26 studies investigating the effectiveness of CBT for core features of ASD, 24 
were included within quantitative synthesis; as previously mentioned, Provencal (2003) and 
De Rosier et al. (2011) were excluded as attempts to obtain data required to calculate effect 
sizes were unsuccessful. In a similar pattern to the above, of the 24 studies included in 
quantitative synthesis, 22 included children and adolescents whilst only two involved adult 
participants. This highlights the fact that the research base investigating the effectiveness of 
CBT in individuals with ASD is considerably more established within child and adolescent 
populations than with adults.  
 Twenty-one of the 24 studies in the core features group examined group-based CBT, 
as may be expected since the majority of studies targeted social skills. One study (Wood et 
al., 2014) reported on the effectiveness of individual CBT. As previously mentioned, this 
study examined CBT targeting both social interaction and anxiety, although anxiety outcomes 
are reported elsewhere (Fujii et al., 2013) and are not included in the present research to 
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prevent double counting of data. The remaining two studies (Beaumont & Sofronoff, 2008; 
White et al., 2013) involved both individual and group sessions. In both of these studies each 
component was reported with equal importance and they were therefore excluded from the 
‘CBT type’ subgroup analysis. 
 Fourteen of the studies targeting core features were defined by authors as randomised 
controlled trials, one of which is the only Phase III trial in this area to date (Freitag et al., 
2016). Thirteen of the RCT’s compared a CBT intervention with a waiting list control group, 
whilst Freitag et al. (2016) compared CBT to treatment as usual. The final RCT (Soorya et 
al., 2015) compared CBT to an active control group structured around facilitated play. Of the 
remaining ten studies investigating the effectiveness of CBT for core features of ASD, three 
were quasi-experimental or non-randomised and seven were defined by the authors as pilot 
studies. Again, these studies were included in initial analysis but treated with caution (see 
Section 3.4 for further details). The quasi-experimental studies involved a variety of control 
groups: Ozonoff & Miller (1995) compared CBT to no treatment, Laugeson et al. (2012) used 
a waiting list control group and Laugeson et al. (2014) reported the use of an active control 
group based on a non-CBT social skills curriculum (‘Super Skills’; Coucouvanis, 2005). Of 
the studies defined as pilot studies by the authors, three used a waiting list control group, two 
compared CBT to treatment as usual and one (Koning, Magill-Evans, Volden, & Dick, 2013) 
compared CBT to “no intervention”. The remaining study (Baghdadli et al., 2013) reported 
the use of an active control group with sessions consisting predominantly of leisure activities. 
Six of the seven pilot studies within this group were randomised, whilst the remaining study 
(Turner-Brown, Perry, Dichter, Bodfish, & Penn, 2008) was quasi-experimental. 
 The majority of studies investigating the effectiveness of CBT for core features of 
ASD were targeting social skills (18 of the 24 studies included in quantitative synthesis), 
while of the remaining six studies, four targeted Theory of Mind (Begeer et al., 2011; Begeer 
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et al., 2015; Ozonoff & Miller, 1995; Solomon, Goodlin-Jones, & Anders, 2004), one 
targeted affectionate communication (Andrews et al., 2013) and one targeted the perception 
of facial emotions (Baghdadli et al., 2013). A number of studies targeted both social skills 
and aspects of social cognition. In these circumstances, the primary outcome measure was 
included. In situations in which the primary outcome measure was not specified, only 
outcome measures pertaining to social skills were included to avoid comparisons of different 
constructs across report types. 
 As reported in Section 3.3.1, there was also extensive variation in the outcome 
measures used across studies investigating the effectiveness of CBT for core features of ASD. 
Again, many studies included outcome measures from various sources, with the most 
common report type within this group being informant-report, followed by self-report. In 
contrast to studies investigating the effectiveness of CBT for co-occurring mental disorder, 
seven studies within this group utilised task-based measures, for example Theory of Mind 
tasks. 
 As in studies targeting co-occurring symptoms of mental disorder, there was again 
considerable variation in the intensity and content of the intervention. The number of sessions 
ranged from five (Andrews et al., 2013) to 70, with Laugeson et al. (2014) reporting on an 
intervention in which children received 30 minute sessions five days per week over a period 
of 14 weeks. The length of each session ranged from 30 minutes to whole day sessions. The 
majority of studies investigating the effectiveness of CBT for core features of ASD used a 
structured protocol (22 out of 24).  
 In terms of content, studies within this group less commonly reported “traditional” 
CBT methods. Some studies did not directly refer to cognitive behavioural therapy per se but 
they explicitly mentioned the inclusion of both cognitive and behavioural techniques in the 
intervention and therefore met inclusion criteria for the current study. Content commonly 
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included direct social skills teaching and role play, emotional identification work and 
problem-solving exercises or discussions. Common adaptations for the use of CBT in 
individuals with ASD included increased use of social stories and vignettes, increased use of 
role play and the involvement of family members in intervention sessions and homework 
activities. 
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Table 3.  
Characteristics of Included Studies 
Source CBT Target Methods Participants Intervention Outcome Measures 
used in Meta-
Analysis  
(Effect Size) 
Follow Up 
Studies targeting symptoms of mental disorder: Children and Adolescents 
(Sofronoff, 
Attwood, & 
Hinton, 
2005) 
Anxiety - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 48; Mean 
Age, 10.55; Age 
Range, 9-12 
- CG: N= 23; Mean 
Age, 10.75; Age 
Range, 9-12 
 
- Country: Australia 
- Group-based 
- Child only or Child + Parent 
sessions (intervention arms 
pooled to prevent double 
counting of data) 
- 6 x 120 minute sessions 
- Original, manualised program 
 
- Self-Report: None 
- Informant-Report: 
Spence Children’s 
Anxiety Scale- 
Parent Report (0.10) 
- Clinician-Rated: 
None 
- Task-Based: None 
- 6 week 
follow up 
(Chalfant, 
Rapee, & 
Carroll, 
2007) 
Anxiety - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 28 
- CG: N= 19 
- TS: Mean Age, 
10.8; Age Range, 8-
13 
 
- Country: Australia 
- Group-based 
- 12 x 120 minute sessions 
- Adapted ‘Cool Kids’ program 
(Lyneham, Abbott, Wignall, & 
Rapee, 2003) 
- Self-Report: 
Spence Children’s 
Anxiety Scale (2.64) 
- Informant-Report: 
Spence Children’s 
Anxiety Scale- 
Parent Report (4.27) 
- Clinician-Rated: 
Anxiety Disorders 
Interview Schedule- 
Child & Parent: 
Diagnostic Status 
(2.51) 
- Task- Based: None 
- None 
(Sofronoff et 
al., 2007) 
Anger - Randomised 
Controlled Trial 
- IG: N= 24; Mean 
Age, 10.79; Age 
- Group-based (pairs) 
- Parallel parent group 
- Self-Report: None 
- Informant-Report: 
- 6 week 
follow up 
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- CG: WL Range, 9-13 
- CG: N= 21; Mean 
Age, 10.77; Age 
Range, 10-13 
 
- Country: Australia 
- 6 x 120 minute sessions 
- Original, manualised program 
(built on Sofronoff et al., 2005) 
Children’s Inventory 
of Anger- parent 
Report (0.40) 
- Clinician-Rated: 
None 
- Task-Based: None 
(CBT group 
only) 
(Reaven et 
al., 2009) 
Anxiety - Pilot study 
- Quasi-
experimental 
- CG:WL 
- IG: N= 10 
- CG: N= 23 
- TS: Mean Age, 
11.8; Age Range, 8-
14 
 
- Country: USA 
- Group-based 
- Multi-family sessions  
- 12 x 90 minute sessions 
- Original, manualised program 
(‘Face your Fears’) 
 
- Self-Report: 
Screen for Child 
Anxiety and Related 
Emotional 
Disorders- Child 
Report (0.28) 
- Informant-Report: 
Screen for Child 
Anxiety and Related 
Emotional 
Disorders- Parent 
Report (0.86) 
- Clinician-Rated: 
None 
- Task-Based: None 
- None 
(Wood et al., 
2009) 
Anxiety - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 17; Mean 
Age, 9.18; Age 
Range not reported 
- CG: N= 23; Mean 
Age, 9.22; Age 
Range not reported 
- TS: Age Range, 7-
11 
 
- Country: USA 
- Individual 
- Parental involvement in all 
sessions 
- 16 x 90 minute sessions 
(approximately 30 minutes with 
child and 60 minutes with 
parents/ family) 
- Modified ‘Building 
Confidence’ program (Wood & 
McLeod, 2008) 
- Self-Report: 
Multidimensional 
Anxiety Scale for 
Children (-0.03) 
- Informant-Report: 
Multidimensional 
Anxiety Scale for 
Children- Parent 
Report (1.21) 
- Clinician-Rated: 
Anxiety Disorders 
- Three month 
follow up 
(CBT group 
only) 
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Interview Schedule- 
Child & Parent: 
Clinical Severity 
Rating (2.47) 
- Task-Based: None 
(Scarpa & 
Reyes, 2011) 
Emotional 
regulation: 
Anxiety and 
Anger  
- Pilot study 
- Randomised 
- CG: WL 
- IG: N= 5; Mean 
Age, 5.84; Age 
Range not reported 
- CG: N= 6; Mean 
Age, 5.47; Age 
Range not reported 
- TS: Age Range, 
4.5-7 
 
-Country: USA 
- Group-based 
- Simultaneous psycho-
educational parent group 
- 9 x 60 minute sessions 
- Modified manualised program 
used by Sofronoff et al. (2005; 
Sofronoff et al., 2007) to be 
developmentally appropriate for 
younger children 
- Self-Report: None 
- Informant-Report: 
Emotion Regulation 
Checklist- Emotion 
Regulation subscale 
(-0.09) 
- Clinician-Rated: 
None 
- Task-Based: None 
- None 
(Sung et al., 
2011) 
Anxiety - Randomised 
Controlled Trial 
- CG: AP 
(Manualised 
Social 
Recreational 
Program) 
- IG: N= 36; Mean 
Age, 11.33; Age 
Range not reported 
- CG: N= 34; Mean 
Age, 11.09; Age 
Range not reported 
- TS: Age Range, 9-
16 
 
- Country: 
Singapore 
- Group-based 
- 16 x 90 minute sessions 
- Original, manualised program 
- Self-Report: 
Spence Children’s 
Anxiety Scale (0.07) 
- Informant-Report: 
None 
- Clinician-Rated: 
Clinical Global 
Impression- Severity 
(0.46) 
- Task-Based: None 
 
- Three month 
follow up 
- Six month 
follow up 
(Clarke, 
2012) 
Anxiety - Cluster 
randomisation 
- CG: TAU 
- IG: N= 14; Mean 
Age, 12.64; Age 
Range not reported 
- CG: N= 14; Mean 
Age, 12.86; Age 
Range not reported 
- Group-based 
- No parental involvement in 
intervention 
- 6 x 60 minute sessions 
- Adapted ‘Exploring Feelings’ 
program (Attwood, 2004b) 
- Self-Report: 
Spence Children’s 
Anxiety Scale (0.70) 
- Informant-Report: 
Spence Children’s 
Anxiety Scale- 
- Six-eight 
week follow 
up 
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- TS: Age Range 
not reported 
 
- Country: UK 
Parent Report (0.67) 
- Clinician-Rated: 
None 
- Task-Based: None 
(Cortesi et 
al., 2012) 
Insomnia - Randomised 
Controlled Trial 
- CG: Placebo 
drug 
(Trial also 
included 
‘melatonin’ 
condition & 
‘melatonin + 
CBT’ condition) 
- IG: N= 40; Mean 
Age, 7.1; Age 
Range not reported 
- CG: N= 40; Mean 
Age, 6.3; Age 
Range not reported 
- TS: Age Range, 4-
10 
 
- Country: Italy 
- Individual 
- Family sessions (child and 
parents) + maintenance sessions 
for parents 
- 4 x 50 minute sessions 
- Original program. Unclear 
whether program was 
manualised. 
- Self-Report: None 
- Informant-Report: 
Children’s Sleep 
Habits 
Questionnaire- Total 
Score (completed by 
parents; 1.01) 
- Clinician-Rated: 
None 
- Task-Based: 
Actigraph data- 
Total sleep time 
(0.62) 
- None 
(Reaven, 
Blakeley-
Smith, 
Culhane-
Shelburne, & 
Hepburn, 
2012) 
Anxiety - Randomised 
Controlled Trial 
- CG: TAU 
- IG: N= 24; Mean 
Age, 10.5; Age 
Range, 7-13 
- CG: N= 26; Mean 
Age, 10.4; Age 
Range, 7-14 
 
- Country: USA 
- Group-based 
- Multi-family sessions  
- 12 x 90 minute sessions 
- Original, manualised program 
(‘Face your Fears’- based on 
2009 pilot study) 
 
- Self-Report: 
Screen for Child 
Anxiety and Related 
Emotional 
Disorders- Child 
Report (0.28) 
- Informant- Report: 
Screen for Child 
Anxiety and Related 
Emotional 
Disorders- Parent 
Report (0.45) 
- Clinician-Rated: 
Anxiety Disorders 
Interview Schedule- 
- Three month 
follow up 
- Six month 
follow up 
(CBT group 
only) 
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Parent: No. of 
Principal Anxiety 
Diagnoses (0.60) 
- Task-Based: None 
(McNally 
Keehn, 
Lincoln, 
Brown, & 
Chavira, 
2013) 
Anxiety - Pilot study 
- Randomised 
- CG: WL 
- IG: N= 12; Mean 
Age, 11.65; Age 
Range not reported 
- CG: N= 10; Mean 
Age, 11.02; Age 
Range not reported 
- TS: Age Range, 8-
14 
 
- Country: USA 
- Group-based 
- 16 x 75 minute sess                                                                                                                     
ions 
- Adapted ‘Coping Cat’ 
Program (Kendall, 1994) 
- Self-Report: 
Spence Children’s
Anxiety Scale (0.47) 
- Informant-Report: 
Spence Children’s 
Anxiety Scale- 
Parent Report (0.91) 
- Clinician-Rated: 
Anxiety Disorders 
Interview Schedule- 
Parent: Interference 
Rating (1.35) 
- Task-Based: None 
- Two month 
follow up
(CBT group 
only) 
(Storch et al., 
2013) 
Anxiety - Randomised 
Controlled Trial 
- CG: TAU 
- IG: N= 24; Mean 
Age, 8.83; Age 
Range not reported 
- CG: N= 21; Mean 
Age, 8.95; Age 
Range not reported 
- TS: Age Range, 7-
11 
 
- Country: USA 
- Individual 
- Parallel parent sessions + 
parental involvement in some 
child sessions 
- 16 x 60-90 minute sessions 
- Manualised, modular 
treatment approach 
(Behavioural Interventions for 
Anxiety in Children with 
Autism program-BIACA; 
Wood & Drahota, 2005) 
- Self-Report: 
Revised Children’s 
Manifest Anxiety 
Scale- Total 
Anxiety: Not 
included in 
quantitative 
synthesis as request 
for data required to 
calculate effect size 
was unsuccessful 
- Informant-Report: 
Multidimensional 
Anxiety Scale for 
Children- Parent 
- Three month 
follow up 
(CBT 
treatment-
responders 
group only) 
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Report (0.48) 
- Clinician-Rated: 
Anxiety Disorders 
Interview Schedule- 
Child & Parent: 
Highest Clinical 
Severity Rating 
(0.89) 
- Task-Based: None 
(McConachie 
et al., 2014) 
Anxiety - Pilot study 
- Randomised 
- CG: WL 
- IG: N= 17; Mean 
Age, 11.7; Age 
Range not reported 
- CG: N= 15; Mean 
Age, 11.8; Age 
Range not reported 
- TS: Age Range 
not reported 
 
- Country: UK 
- Group-based 
- Parallel parent group 
- 7 x 120 minute sessions 
- Slightly adapted ‘Exploring 
Feelings’ program (Attwood, 
2004b) for UK use 
- Self-Report: 
Spence Children’s 
Anxiety Scale (0.04) 
- Informant-Report: 
Spence Children’s 
Anxiety Scale- 
Parent Report (0.20) 
- Clinician-Rated: 
Anxiety Disorders 
Interview Schedule- 
Parent: Primary 
diagnosis Clinical 
Severity Rating 
(0.43) 
- Task-Based: None 
- Three month 
follow up 
- Six month 
follow up 
(van Steensel 
et al., 2014) 
Anxiety - Quasi-
experimental 
- CG: TAU 
- IG: N= 24; Mean 
Age, 11.0; Age 
Range not reported 
- CG: N= 25; Mean 
Age, 10.72; Age 
Range not reported 
- TS: Age Range, 8-
18 
- Individual 
- Parental attendance at all 
sessions 
- 15 sessions (length not 
reported) 
- Modified, combined version 
of individual and family CBT 
intervention (Bodden, Dirksen, 
- Self-Report: None 
- Informant-Report: 
None 
- Clinician-Rated: 
Clinician-Rated: 
Anxiety Disorders 
Interview Schedule- 
Child & Parent: 
- Three month 
follow up 
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- Country: The 
Netherlands 
& Bögels, 2008) Diagnostic Status 
(0.44) 
- Task-Based: None 
(Hepburn et 
al., 2016) 
Anxiety - Pilot study 
- Quasi-
experimental 
- CG: WL (not 
recruited 
simultaneously 
with CBT 
group) 
- IG: N= 17; Mean 
Age, 11.53; Age 
Range not reported 
- CG: N= 16; Mean 
Age, 12.12; Age 
Range not reported 
- TS: Age Range 
not reported 
 
- Country: USA 
- Group-based 
- ‘Telehealth’/ 
videoconferencing intervention 
designed for delivery in a small, 
multi-family group format 
- Parental involvement in all 
sessions + parent-only time at 
end of sessions (20-30 minutes) 
- 10 x 60 minute sessions + 1 
‘booster’ session 
- Modified version of ‘Face 
Your Fears’ program (Reaven, 
2011; Reaven et al., 2012; 
Reaven et al., 2009) 
- Self-Report: None 
- Informant-Report: 
Screen for Child 
Anxiety and Related 
Emotional Disorders 
(0.48) 
- Clinician-Rated: 
None 
- Task-Based: None 
- None 
(Storch et al., 
2015) 
Anxiety - Randomised 
Controlled Trial 
- CG: TAU 
- IG: N= 16; Mean 
Age, 12.75; Age 
Range not reported 
- CG: N= 15; Mean 
Age, 12.73; Age 
Range not reported 
- TS: Age Range, 
11-16 
 
- Country: USA 
- Individual 
- Parallel parent sessions + 
parental involvement in 
majority of adolescent sessions 
- 16 x 60-90 minute sessions 
- Manualised, modular 
treatment approach 
(Developmentally modified 
version of Behavioural 
Interventions for Anxiety in 
Children with Autism program-
BIACA; Wood & Drahota, 
2005) 
- Self-Report: 
Revised Child’s 
Anxiety and 
Depression Scales (-
0.12) 
- Informant-Report: 
Multidimensional 
Anxiety Scale for 
Children- Parent 
Report (0.09) 
- Clinician-Rated: 
Clinician-Rated: 
Anxiety Disorders 
Interview Schedule- 
Child & Parent: 
- One month 
follow up 
(CBT 
treatment-
responders 
group only) 
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Primary diagnosis 
Clinical Severity 
Rating (1.38) 
- Task-Based: None 
(Wood et al., 
2015) 
Anxiety - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 19; Mean 
Age, 12.4; Age 
Range not reported 
- CG: N= 14; Mean 
Age, 12.2; Age 
Range not reported 
- TS: Age Range, 
11-15 
 
- Country: USA 
- Individual 
- Parallel parent sessions + 
parental involvement in all 
adolescent sessions 
- 16 x 60-90 minute sessions 
- Manualised, modular 
treatment approach 
(Developmentally modified 
version of Behavioural 
Interventions for Anxiety in 
Children with Autism program-
BIACA; Wood & Drahota, 
2005) 
- Self-Report: 
Revised Child’s 
Anxiety and 
Depression Scales (-
0.09) 
- Informant-Report: 
Multidimensional 
Anxiety Scale for 
Children- Parent 
Report (0.71) 
- Clinician-Rated: 
Anxiety Disorders 
Interview Schedule- 
Child & Parent: 
Primary diagnosis 
Clinical Severity 
Rating (0.39) 
- Task-Based: None 
- One month 
follow up 
(CBT 
treatment-
responders 
group only) 
Studies targeting symptoms of mental disorder: Adults 
(Russell et 
al., 2009) 
Obsessive 
Compulsive 
Disorder 
- Pilot study 
- Quasi-
experimental 
- CG: TAU 
- IG: N= 12; Mean 
Age, 23.8; Age 
Range not reported 
- CG: N= 12; Mean 
Age, 32.1; Age 
Range not reported 
- TS: Age range not 
reported 
 
- Individual sessions 
- Mean number of sessions: 
27.5; Range: 10-50 
- Treatment not manual or 
protocol driven 
- Self-Report: Beck 
Anxiety Inventory (- 
0.39; secondary 
measure) 
- Informant-Report: 
None 
- Clinician-Report: 
Yale-Brown 
Obsessive 
- None 
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- Country: UK Compulsive Scale 
(primary measure;  
-0.31) 
- Task-Based: None 
(Spek et al., 
2013) 
Depression, 
anxiety and 
rumination 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 20; Mean 
Age, 44.4; Age 
Range not reported 
- CG: N= 21; Mean 
Age, 40.1; Age 
Range not reported 
- TS: Age range not 
reported 
 
- Country: The 
Netherlands 
- Group-based 
- 9 x 150 minute sessions 
- Modified version of 
Mindfulness Based Therapy 
(Segal et al., 2002)- cognitive 
elements omitted 
- Self-Report: 
Symptom Checklist-
90-Revised: Anxiety 
scale (0.85) 
- Informant-Report: 
None 
- Clinician-Rated: 
None 
- Task-Based: None  
- None 
(Hesselmark 
et al., 2014) 
Self-esteem, 
quality of life 
and sense of 
coherence 
- Randomised 
Controlled Trial 
- CG: AP 
(Recreational 
Activity) 
- IG: N= 34; Mean 
Age, 31.9; Age 
Range not reported 
- CG: N= 34; Mean 
Age, 31.8; Age 
Range not reported 
- TS: Age Range, 
19-53 
 
- Country: Sweden 
- Group-based 
- 36 x 180 minute sessions 
- Original, manualised, modular 
program 
- Self-Report: 
Rosenberg Self-
Esteem Scale (0.07; 
primary measure) 
- Informant-Report: 
None 
- Clinician-Rated: 
None 
- Task-Based: None  
8-57 months 
after treatment 
termination 
(Langdon et 
al., 2016) 
Anxiety - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 26; Mean 
Age, 33.1; Age 
Range, 20-64 
- CG: N= 26; Mean 
Age, 38.7; Age 
Range, 17-65 
 
- Predominantly group-based 
- 21 x 60 minute group sessions 
+ 3 x 60 minute individual 
sessions prior to group entry for 
socialisation to model  
- Original manualised program 
- Self-Report: 
Liebowitz Social 
Anxiety Scale  
(-0.37; secondary 
measure) 
- Informant-Report: 
None 
- Six month 
follow (CBT 
group only) 
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- Country: UK - Clinician-Rated: 
Hamilton Rating 
Scale for Anxiety 
(0.10) 
- Task-Based: None 
Studies targeting symptoms of mental disorder: Mixed (Adolescents and Adults) 
(Russell et 
al., 2013) 
Obsessive 
Compulsive 
Disorder 
- Randomised 
Controlled Trial 
- CG: AP 
(Anxiety 
Management) 
- IG: N= 23; Mean 
Age, 28.6; Age 
Range, 14-49 
- CG: N= 23; Mean 
Age, 25.2; Age 
Range, 14-65 
 
- Country: UK 
- Individual sessions 
- Up to 20 x 60 minute 
sessions. Mean number of 
sessions: 17.4 
- Original manualised treatment  
- Self-Report: 
Obsessive 
Compulsory 
Inventory-Revised 
(0.28; secondary 
measure) 
- Informant-Report: 
Children’s 
Obsessive 
Compulsive 
Inventory- Parent 
Version (-0.39) 
- Clinician-Rated: 
Yale-Brown 
Obsessive 
Compulsive Scale 
(0.36) 
- Task-Based: None 
- One month 
follow up 
- Three month 
follow up 
- Six month 
follow up 
- Twelve 
month follow 
up 
(CBT group 
only) 
(McGillivray 
& Evert, 
2014) 
Depression, 
anxiety and 
stress 
- Quasi-
experimental 
- CG: WL 
- IG: N= 26; Mean 
Age, 20.27; Age 
Range not reported 
- CG: N= 16; Mean 
Age, 20.5; Age 
Range not reported 
- TS: Age Range, 
15-25 
- Group-based 
- 9 x 120 minute sessions 
- Original, manualised program 
(‘Think well, Feel well and Be 
well’) 
- Self-Report: 
Depression Anxiety 
Stress Scales- 
Anxiety Score 
(0.06) 
- Informant-Report: 
None 
- Clinician-Rated: 
- Three month 
follow up 
- Nine month 
follow up 
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- Country: Australia 
None 
- Task-Based: None 
(Pahnke et 
al., 2014) 
Stress and 
emotional 
distress 
- Pilot study 
- Cluster 
randomisation 
- CG: WL 
- IG: N= 15; Mean 
Age, 16.2; Age 
Range not reported 
- CG: N= 13; Mean 
Age, 16.8; Age 
Range not reported 
- TS: Age Range, 
13-21 
 
- Country: Sweden 
- Group-based 
- School-based. No parental 
involvement in sessions 
- 12 x 40 minute sessions + 
daily 6-12 minute mindfulness 
exercises in classroom 
- Modified an Acceptance and 
Commitment Therapy protocol 
(Hayes et al., 2003) 
- Self-Report: 
Strengths and 
Difficulties 
Questionnaire (-
0.38) 
- Informant-Report: 
Strengths and 
Difficulties 
Questionnaire- 
Teacher Report: Not 
included in 
quantitative 
synthesis as request 
for data required to 
calculate effect size 
was unsuccessful 
- Clinician-Rated: 
None 
- Task-Based: None 
- Two month 
follow up 
Studies targeting core features of ASD: Children and Adolescents 
(Ozonoff & 
Miller, 1995) 
Theory of Mind 
and social skills 
- Quasi-
experimental 
- CG: No 
treatment 
- IG: N= 5; Mean 
Age, 13.8; Age 
Range, 13-14 
- CG: N= 4; Mean 
Age, 13.6; Age 
Range, 11-16 
 
- Country: USA 
- Group-based 
- 14 x 90 minute sessions 
- Original program. Unclear 
whether program was 
manualised 
- Self-Report: None 
- Informant-Report: 
None 
- Clinician-Rated: 
None 
- Task-Based: 
Theory of Mind 
Composite (0.64) 
- None 
(Provencal, 
2003) 
Social skills and 
peer 
- Quasi-
experimental 
- IG: N= 10; Mean 
Age, 14.5; Age 
- Group-based 
- Concurrent parent sessions 
Not included in 
quantitative 
- None 
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relationships - CG: TAU Range, 12-16 
- CG: N= 9; Mean 
Age, 14.2; Age 
Range, 12-16 
 
- Country: USA 
- 25  x 75 minute sessions 
(weekly for eight months) 
- Original program. Unclear 
whether program was 
manualised 
synthesis as request 
for data required to 
calculate effect sizes 
was unsuccessful 
(Solomon et 
al., 2004) 
Emotion 
recognition, 
theory of mind 
and problem 
solving 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 9; Mean 
Age, 9.7; Age 
Range, 7-12 
- CG: N= 9; Mean 
Age, 9.2; Age 
Range, 7-11 
 
- Country: USA 
- Group-based 
- Concurrent parent training 
- 20 x 75 minute sessions 
- Original, modularised 
program. Unclear whether 
program was manualised 
- Self-Report: None 
- Informant-Report: 
None 
- Clinician-Rated: 
None 
- Task-Based: 
Strange Stories Task 
(ToM; 0.24) 
- None 
(Beaumont & 
Sofronoff, 
2008) 
Social skills and 
emotion 
recognition 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 26; Mean 
Age, 9.64; Age 
Range, 7-11 
- CG: N= 23; Mean 
Age, 9.81; Age 
Range, 8-11 
 
- Country: Australia 
- Individual sessions 
(computer-game based) + group 
sessions 
- Simultaneous parent training 
sessions + teacher handouts 
- 8 x 120 minute sessions 
- Original, manualised program 
(‘The Junior Detective Training 
Program’) 
- Self-Report: None 
- Informant-Report: 
Social Skills 
Questionnaire- 
Parent report (1.42) 
- Clinician-Rated: 
None 
- Task-Based: 
Assessment of 
Perception of 
Emotion from Facial 
Expression (0.07) 
- Six week 
follow up 
- Five month 
follow up 
(Laugeson, 
Frankel, 
Mogil, & 
Dillon, 2009) 
Social skills and 
friendship 
quality 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 17; Mean 
Age, 14.6; Age 
Range not reported 
- CG: N= 16; Mean 
Age, 14.6; Age 
Range not reported 
- Group-based 
- Concurrent parent sessions 
- 12 x 90 minute sessions 
- Manualised program 
(‘Program for the Education 
and Enrichment of Relational 
- Self-Report: 
Friendship Qualities 
Scale (0.14) 
- Informant-Report: 
Social Skills Rating 
System: Social 
- None 
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- TS: Age range, 13-
17 
 
- Country: USA 
Skills’; PEERS). Adapted from 
‘Children’s Friendship 
Training’ (Frankel & Myatt, 
2003) 
Skills Scale (0.81) 
- Clinician-Rated: 
None 
- Task-Based: None 
(Frankel et 
al., 2010) 
Social skills - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 35; Mean 
Age, 8.6; Age 
Range not reported 
- CG: N= 33; Mean 
Age, 8.5; Age 
Range not reported 
- TS: Age range not 
reported 
 
- Country: USA 
- Group-based 
- Concurrent parent sessions 
- 12 x  60 minute sessions 
- Manualised program: 
‘Children’s Friendship 
Training’ (Frankel & Myatt, 
2003) 
- Self-Report: The 
Loneliness Scale 
(0.67) 
- Informant-Report: 
Social Skills Rating 
System- Assertion 
Scale (0.40) 
- Clinician-Rated: 
None 
- Task-Based: None 
- Twelve week 
follow up 
(CBT group 
only) 
(Koenig et 
al., 2010) 
Social skills - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 25; Mean 
Age, 9.2; Age 
Range not reported 
- CG: N= 19; Mean 
Age, 9.3; Age 
Range not reported 
- TS: Age range, 8-
11 
 
- Country: USA 
- Group-based 
- 16 x  75 minute sessions 
- Original, manualised program 
- Inclusion of peer mentors 
- Self-Report: None 
- Informant-Report: 
Social Competence 
Inventory (0.11) 
- Clinician-Rated: 
Clinical Global 
Impressions Scale- 
Improvement (2.43) 
- Task-Based: None 
- None 
(Lopata et al., 
2010) 
Social skills, 
face-emotion 
recognition, 
interest 
expansion and 
interpretation of 
non-literal 
language 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 18; Mean 
Age, 9.39; Age 
Range not reported 
- CG: N= 18; Mean 
Age, 9.56; Age 
Range not reported 
- TS: Age range, 7-
12 
- Group-based 
- Weekly parent training groups 
- Summer program: 25 whole 
day sessions (over 5 weeks) 
- Manualised program (Lopata, 
Thomeer, Volker, & Nida, 
2006; Lopata, Thomeer, 
Volker, Nida, & Lee, 2008) 
- Self-Report: None 
- Informant-Report: 
Social 
Responsiveness 
Scale (0.69) 
- Clinician-Rated: 
None 
- Task-Based: None 
- None 
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- Country: USA 
(Begeer et 
al., 2011) 
Theory of Mind - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 19; Mean 
Age, 10.3; Age 
Range, 8-13 
- CG: N= 17; Mean 
Age, 10.3; Age 
Range, 8-12 
 
- Country: The 
Netherlands 
- Group-based 
- Parental involvement at end of 
sessions + monthly training for 
parents 
- 16 x 90 minute sessions 
- Manualised program  
(‘Theory of Mind Training’; 
Gevers, Clifford, Mager, & 
Boer, 2006; Steerneman, 
Jackson, Pelzer, & Muris, 
1996)  
- Self-Report: Index 
of Empathy for 
Children and 
Adolescents (-0.17) 
- Informant-Report: 
None 
- Clinician-Rated: 
None 
- Task-Based: 
Theory of Mind test 
(0.04) 
- None 
(DeRosier et 
al., 2011) 
Social skills - Randomised 
Controlled Trial 
- CG: ‘Social 
Skills Group 
Intervention’- 
not adapted for 
ASD  
(S.S.GRIN; 
DeRosier, 2002, 
2007) 
- IG: N= 27; Mean 
Age, 10.2; Age 
Range not reported 
- CG: N= 28; Mean 
Age, 9.9; Age 
Range not reported 
- TS: Age Range, 8-
12 
 
- Country: USA 
- Group-based 
- 15 x 60 minute sessions, 
including 4 joint parent-child 
sessions 
- Manualised program (‘Social 
Skills Group Intervention- High 
Functioning Autism’; 
S.S.GRIN-HFA). Adapted from 
‘Social Skills Group 
Intervention’ (S.S.GRIN; 
DeRosier, 2002, 2007) 
Not included in 
quantitative 
synthesis as request 
for data required to 
calculate effect sizes 
was unsuccessful 
- None 
(Laugeson et 
al., 2012) 
Social skills - Quasi-
experimental 
- CG: WL 
- IG: N= 14; Mean 
Age, 15.0; Age 
Range not reported 
- CG: N= 14; Mean 
Age, 14.3; Age 
Range not reported 
- TS: Age range, 12-
17 
- Group-based 
- Concurrent parent sessions 
- 14 x 90 minute sessions 
- Modified version of ‘Program 
for the Education and 
Enrichment of Relational 
Skills’ (PEERS; Laugeson et 
al., 2009) 
- Self-Report: 
Quality of Play 
Questionnaire: Host 
Score (1.07) 
- Informant-Report: 
Social Skills Rating 
System- Parent 
Report: Social Skills 
- Fourteen 
week follow 
up (CBT 
group only) 
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- Country: USA 
Scale (0.94) 
- Clinician-Rated: 
None 
- Task-Based: None 
(Thomeer et 
al., 2012) 
Social skills, 
face-emotion 
recognition, 
interest 
expansion and 
interpretation of 
non-literal 
language 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 17; Mean 
Age, 9.24; Age 
Range not reported 
- CG: N= 18; Mean 
Age, 9.39; Age 
Range not reported 
- TS: Age range, 7-
12 
 
- Country: USA 
- Group-based 
- Weekly parent training groups 
- Summer program: 25 whole 
day sessions (over 5 weeks) 
- Manualised program (Lopata 
et al., 2006; Lopata et al., 2008; 
Lopata et al., 2010) 
- Self-Report: None 
- Informant-Report: 
Social 
Responsiveness 
Scale (0.65) 
- Clinician-Rated: 
None 
- Task-Based: None 
- Two-three 
month follow 
up 
(Andrews et 
al., 2013) 
Affectionate 
communication 
and friendship 
skills 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 29, Mean  
Age and Age Range 
not reported 
- CG: N= 29, Mean  
Age and Age Range 
not reported 
- TS: Mean Age, 
9.02; Age Range, 7-
12 
 
- Country: Australia 
- Group-based 
- 5 x 120 minute sessions 
- Original, manualised program 
- Self-Report: None 
- Informant-Report: 
Affection for Others 
Questionnaire for 
children with 
Asperger's 
syndrome (0.43) 
- Clinician-Rated: 
None 
- Task-Based: None 
- Three month 
follow up 
(CBT group 
only) 
(Baghdadli et 
al., 2013) 
Perception of 
facial emotions 
and quality of 
life 
- Pilot study 
- Randomised 
- AP: Leisure 
Activities 
- IG: N= 7; Mean 
Age, 10.7; Age 
Range not reported 
- CG: N= 7; Mean 
Age, 11.5; Age 
Range not reported 
- TS: Age range, 8-
- Group-based 
- 20 x 90 minute sessions 
- Original, manualised program 
(‘Social Skills Training Group-
based program; SST-GP) 
- Self-Report: None 
- Informant-Report: 
None 
- Clinician-Rated: 
None 
- Task-Based: 
Diagnostic Analysis 
- None 
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- Country: France 
of Non Verbal 
Accuracy 2 
(DANVA2)- Adult 
facial expressions (-
0.05) 
(Ichikawa et 
al., 2013) 
Social 
reciprocity 
- Pilot study 
- Randomised 
- CG: WL 
- IG: N= 5; Mean 
Age, 5.3; Age 
Range, 5-5 
- CG: N= 6; Mean 
Age, 5.2; Age 
Range, 5-5 
 
Country- Japan 
- Group-based 
- Concurrent parental sesssions 
- 20 x 120 minute sessions 
- Original, manualised program 
- Self-Report: None 
- Informant-Report: 
Strengths and 
Difficulties 
Questionnaire  
(-0.44) 
- Clinician-Rated: 
Interaction Rating 
Scale (0.08) 
- Task-Based: None 
- None 
(Koning et 
al., 2013) 
Social skills - Pilot study 
- Randomised 
- CG: No 
intervention. 
Nature of 
control group 
unclear 
 
- IG: N= 7; Mean 
Age, 10.99; Age 
Range not reported 
- CG: N= 8; Mean 
Age, 11.15; Age 
Range not reported 
- TS: Age range, 10-
12 
 
Country- Canada 
- Group-based 
- 15 x 120 minute sessions 
- Original, manualised program, 
incorporating both structured 
skills building and loosely 
structured natural situations 
with fun activities 
- Self-Report: None 
- Informant-Report: 
Social 
Responsiveness 
Scale (0.43) 
- Clinician-Rated: 
None 
- Task-Based: Child 
and Adolescent 
Social Perception 
Measure- Emotion  
score (0.61) 
- None 
(White et al., 
2013) 
Social skills and 
anxiety 
(included within 
core features 
analysis only to 
- Pilot study 
- Randomised 
- CG: WL 
- IG: N= 15; Mean 
Age, 14.2; Age 
Range not reported 
- CG: N= 15; Mean 
Age, 15.0; Age 
- Individual therapy (up to 13 x 
60-70 minute sessions) + group 
therapy (7 x 75 minute 
sessions) 
- Parent education and coaching 
- Self-Report: None 
- Informant-Report: 
Social 
Responsiveness 
Scale (0.82) 
- None 
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prevent double 
counting of 
data) 
Range not reported 
- TS: Age range not 
reported 
 
- Country: USA 
at the end of each individual 
session 
- Original, manualised, modular 
program 
- Clinician-Rated: 
Developmental 
Disabled Children’s 
Global Assessment 
Scale (0.17) 
- Task-Based: None 
(Laugeson et 
al., 2014) 
Social skills - Quasi-
experimental 
- CG: AP: 
Social skills 
curriculum 
based on ‘Super 
Skills’ 
(Coucouvanis, 
2005) 
- IG: N= 40; Mean 
Age, 12.68; Age 
Range not reported 
- CG: N= 33; Mean 
Age, 12.74; Age 
Range not reported 
- TS: Age range, 12-
14 
 
- Country: USA 
- Group-based 
- Teacher-led 
- Daily 30 minute sessions x 5 
days per week x 14 weeks 
- Manualised program (‘PEERS 
Curriculum for School-Based 
Professionals’), adapted from 
‘Program for the Education and 
Enrichment of Relational 
Skills’ (PEERS; Laugeson & 
Frankel, 2010) 
- Self-Report: 
Friendship Qualities 
Scale (0.38) 
- Informant-Report: 
Social 
Responsiveness 
Scale- Teacher 
Report (-0.07) 
- Clinician-Rated: 
None 
- Task-Based: None 
- None 
(Schohl et al., 
2014) 
Social skills and 
friendship 
quality 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 29; Mean 
Age, 14.00; Age 
Range not reported 
- CG: N= 29; Mean 
Age, 13.31; Age 
Range not reported 
- TS: Age range, 11-
16 
 
- Country: USA 
- Group-based 
- Concurrent parent sessions 
- 14 x 90 minute sessions 
- Manualised program 
(‘Program for the Education 
and Enrichment of Relational 
Skills’: PEERS; Laugeson & 
Frankel, 2010) 
- Self-Report: 
Friendship Qualities 
Scale (-0.01) 
- Informant-Report: 
Social Skills Rating 
System: Social 
Skills Scale (0.44) 
- Clinician-Rated: 
None 
- Task-Based: None 
- None 
(Wood et al., 
2014) 
Social 
communication 
and anxiety 
(anxiety 
outcomes 
- Pilot study 
- Randomised 
- CG: TAU 
- IG: N= 7; Mean 
Age, 8.7; Age 
Range not reported 
- CG: N= 6; Mean 
Age, 8.8; Age 
- Individual 
- Parental involvement in all 
sessions 
- 32 x 90 minute sessions 
(approximately 30 minutes with 
- Self-Report: None 
- Informant-Report: 
None 
- Clinician-Rated: 
Bauminger’s 
- None 
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reported in Fujii 
et al., 2013) 
Range not reported 
- TS: Age Range, 7-
11 
 
Country- USA 
child, and 60 minutes with 
parents/ family) 
- Modified ‘Building 
Confidence’ program (Wood & 
McLeod, 2008) 
Observational 
Measure of Social 
Communication 
Behaviour- Positive 
or Appropriate 
Interaction with 
Peers (1.51) 
- Task-Based: None 
 
(Yoo et al., 
2014) 
Social skills - Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 23; Mean 
Age, 14.04; Age 
Range not reported 
- CG: N= 24; Mean 
Age, 13.54; Age 
Range not reported 
- TS: Age Range, 
12-18 
 
- Country: South 
Korea 
- Group-based 
- Concurrent parent sessions 
- 14 x 90 minute sessions 
- Modified version of ‘Program 
for the Education and 
Enrichment of Relational 
Skills’ (PEERS; Laugeson & 
Frankel, 2010) 
- Self-Report: 
Korean Version of 
Social Skills Rating 
System (-0.23) 
- Informant-Report: 
Social 
Responsiveness 
Scale (0.16) 
- Clinician-Rated: 
Autism Diagnostic 
Observation 
Schedule- 
Reciprocal Social 
Interaction score 
(0.62) 
- Task-Based: None 
- Three month 
follow up 
(Begeer et 
al., 2015) 
Theory of Mind 
and social skills 
- Randomised 
Controlled Trial 
- CG: WL 
- IG: N= 52; Mean 
Age, 9.7; Age 
Range, 7-12 
- CG: N= 45; Mean 
Age, 9.5; Age 
Range, 7-12 
 
- Group-based 
- 8 x 60 minutes sessions 
- Shortened version of ToM 
training program used in 
Begeer et al. (2011) 
- Self-Report: None 
- Informant-Report: 
Theory of Mind 
Behaviour Checklist 
(0.74)  
- Clinician-Rated: 
None 
- Six month 
follow up 
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- Country: The 
Netherlands 
- Task-Based: 
Theory of Mind test 
(0.64) 
(Freitag et 
al., 2016) 
Social skills - Randomised 
Controlled Trial 
- Multicentre 
phase-III trial 
- CG: TAU 
- IG: N= 101; Mean 
Age, 12.7; Age 
Range not reported 
- CG: N= 108; 
Mean Age, 12.9; 
Age Range not 
reported 
- TS: Age Range, 8-
19 
 
- Country: Germany 
- Group-based 
- 12 x 90 minutes sessions 
- 3 additional parent training 
sessions 
- Original, manualised program 
(‘Social Skills Training 
Autism- Frankfurt’; SOSTA-
FRA) 
- Self-Report: None 
- Informant-Report: 
Social 
Responsiveness 
Scale (0.22) 
- Clinician-Rated: 
None 
- Task-Based: None 
- Three month 
follow up 
(Soorya et 
al., 2015) 
Social 
behavioural 
impairments and 
social cognition 
- Randomised 
Controlled Trial 
- CG: AP 
(Facilitated 
play) 
- IG: N= 35; Mean 
Age, 10.05; Age 
Range not reported 
- CG: N= 34; Mean 
Age, 9.87; Age 
Range not reported 
- TS: Age Range, 8-
11 
 
- Country: USA 
- Group-based 
- Concurrent parent sessions 
- 12 x 90 minutes sessions 
- Original, manualised program 
(‘Seaver Nonverbal 
communication, Emotion 
recognition, and Theory of 
mind Training’; Seaver-NETT)  
- Self-Report: None 
- Informant-Report: 
Social Behaviour 
Composite (0.48) 
- Clinician-Rated: 
None 
- Task-Based: None 
- Three month 
follow up 
(only began 
part way 
through trial 
so follow up 
data not 
available for 
all 
participants) 
Studies targeting core features of ASD: Adults 
(Turner-
Brown et al., 
2008) 
Social 
interaction and 
social cognition 
- Pilot study 
- Quasi-
experimental 
- CG: TAU 
- IG: N= 6; Mean 
Age, 42.5; Age 
Range, 25-55 
- CG: N= 5; Mean 
Age, 28.8; Age 
Range, 27-29 
 
- Group-based 
- 18 x 50 minute sessions 
- Modified version of Social 
Cognition & Interaction 
Training (SCIT; Roberts, Penn, 
& Combs, 2004) 
- Self-Report: Social 
Communication 
Skills Questionnaire 
(-0.11) 
- Informant-Report: 
None 
- Clinician-Rated: 
- None 
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- Country: USA Social Skills 
Performance 
Assessment (0.19) 
- None 
(Gantman, 
Kapp, 
Orenski, & 
Laugeson, 
2012) 
Social skills - Pilot study 
- Randomised 
- CG: WL 
- IG: N= 9; Mean 
Age, 19.9; Age 
Range not reported 
- CG: N= 8; Mean 
Age, 20.9; Age 
Range not reported 
- TS: Age Range, 
18-23 
 
- Country: USA 
- Group-based 
- Concurrent caregiver sessions 
- 14 x 90 minute sessions 
- Modified version of ‘Program 
for the Education and 
Enrichment of Relational 
Skills’ (PEERS; Laugeson & 
Frankel, 2010) 
- Self-Report: Social 
and Emotional 
Loneliness Scale for 
Adults (0.63) 
- Informant-Report: 
Social 
Responsiveness 
Scale (0.60) 
- Clinician-Rated: 
None 
- Task-Based: None 
- None 
IG, intervention group; CG, control group; TS, total sample (where group demographics are not reported); WL, waiting list; TAU, treatment as usual; 
AP, Attention Placebo 
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3.4 Quality Appraisal 
 As detailed in Chapter 2 (section 2.6), the NICE Quality Appraisal Checklist for 
Quantitative Intervention Studies (NICE, 2012b) was completed for each included study by 
both the primary researcher and a research supervisor to assess internal and external validity 
and identify potential sources of bias. There was ‘moderate’ agreement between the 
researchers regarding ratings for internal validity (72.0%; Kappa 0.48; 95% CI, 0.26 to 0.71; 
see Appendix G for calculation) and ‘good’ agreement regarding ratings for external validity 
(84.0%; Kappa 0.66; 95% CI, 0.45 to 0.86; see Appendix G for calculation). Disagreements 
were resolved via discussion. Table 4 summarises the final ratings given to each study, 
alongside key sources of bias identified. 
 A persistent problem across all studies was small sample size, contributing to reduced 
power. Freitag et al. (2016) included the highest number of participants (101 CBT, 108 
control), whilst eight of the studies included in the quantitative synthesis involved less than 
ten participants per group. Several of these studies were defined by the authors as pilot or 
feasibility trials. However, it was felt that a number of other included studies which were not 
defined by the authors as pilot or feasibility trials were in fact lower in quality and/or had 
smaller sample sizes than many pilot or feasibility trials. Quality appraisal and risk of bias 
was therefore considered on a study by study basis and sensitivity analysis was conducted by 
removing studies deemed to be at a high risk of bias rather than those defined by authors as 
pilot or feasibility trials. 
 Other common problems included the lack of reporting on compliance with 
intervention sessions, poor reporting on missing data and minimal information on fidelity 
checks. Very few studies reported adequate allocation concealment and ten of the 48 studies 
included in quantitative analysis were non-randomised, contributing to a high risk of 
allocation bias. Due to the nature of the interventions involved, it was obviously not possible 
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for investigators to blind participants (and often informants) to intervention allocation. 
However, blinding of outcome assessors was possible but was not conducted in the majority 
of studies, contributing to detection bias. 
 A final common difficulty across studies was failure to specify a primary outcome 
measure or measures. This complicated the quantitative synthesis process, particularly in 
studies where a high number of outcome measures were utilised and/or in studies using 
different measures to assess a range of constructs. In addition, the lack of measures that are 
validated or norm-referenced for use with individuals with ASD was noted, although this is 
clearly a wider issue that needs attention. These factors will be discussed in more depth in 
Chapter 4, in addition to a more thorough discussion of quality issues within the included 
studies and implications for future research.
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Table 4.  
Summary of Quality Assessment 
Study External 
Validity 
Internal 
Validity 
Key Sources of Bias 
Studies targeting symptoms of mental disorder: Children and Adolescents 
Sofronoff et al. (2005) + + Small sample; No allocation concealment; Lack of blinding 
Chalfant et al. (2007) + + Small sample; No allocation concealment; Lack of blinding 
Sofronoff et al. (2007) + + Small sample; No allocation concealment; Lack of blinding; Drop outs prior to 
intervention not included in analysis 
Reaven et al. (2009): Pilot study - + Small sample; Non-randomised; No allocation concealment; Participants 
entered in order of expressed interest- possible confound; Lack of blinding 
Wood et al. (2009) + + Small sample; Lack of blinding 
Scarpa & Reyes (2011): Pilot study - - Very small sample; No allocation concealment; Limited information on 
randomisation procedure; Lack of blinding; Did not adjust for baseline 
differences between groups 
Sung et al. (2011) + + Small sample; No allocation concealment; Lack of blinding; Did not adjust for 
baseline differences between groups 
Clarke (2012) - - Small sample; Lack of individual randomisation (cluster); No allocation 
concealment; Lack of blinding; No formal assessment of anxiety prior to 
allocation 
Cortesi et al. (2012) + + Recruitment method unclear; Limited information on randomisation procedure 
Reaven et al. (2012) ++ + Small sample 
McNally Keehn et al. (2013): Pilot 
study 
+ + Small sample; No allocation concealment; Lack of blinding 
Storch et al. (2013) + + Small sample; Simple randomisation procedure 
McConachie et al. (2014): Pilot 
study 
+ + Small sample 
Van Steensel et al. (2014) - + Small sample; Non-randomised; No allocation concealment; Lack of blinding; 
Did not adjust for baseline differences between groups 
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Hepburn et al. (2016): Pilot study - - Small sample; Non-randomised; No allocation concealment; Control group not 
recruited simultaneously with CBT group; Lack of blinding; Did not adjust for 
baseline differences between groups 
Storch et al. (2015) + + Small sample; Simple randomisation procedure 
Wood et al. (2015) + + Small sample  
Studies targeting symptoms of mental disorder: Adults 
Russell et al. (2009): Pilot study - - Small sample; Non-randomised; No allocation concealment; CBT group had 
more severe OCD at baseline- not adjusted for in analysis; Treatment not 
manualised 
Spek et al. (2013) + + Small sample; Lack of blinding 
Hesselmark et al. (2014) - - Small sample; Two participants not randomised; No allocation concealment; 
Lack of blinding; High amount of drop outs/ missing data; Did not adjust for 
baseline differences between groups 
Langdon et al. (2016) + + Small sample; Lack of fidelity checks 
Studies targeting symptoms of mental disorder: Mixed (Adolescents and Adults) 
Russell et al. (2013) + + Small sample; Possible contamination as crossover between groups and 
unclear when post-assessments were completed;  
McGillivray & Evert (2014) - - Small sample; Non-randomised;  No allocation concealment; Lack of blinding; 
Asymptomatic participants included 
Pahnke et al. (2014): Pilot study + + Small sample; Lack of individual randomisation (cluster); No allocation 
concealment; Lack of blinding; Potential for contamination between groups as 
all conducted within same school 
Studies targeting core features of ASD: Children and Adolescents 
Ozonoff & Miller (1995) - - Very small sample; Non-randomised; No allocation concealment; Recruitment 
poorly described; Inappropriate analysis 
Provencal (2003) - - Very small sample; Non-randomised; No allocation concealment; Partial 
blinding; Inappropriate analysis; Did not adjust for baseline differences 
between groups 
Solomon et al. (2004) - - Very small sample; Limited information on randomisation procedure; No 
allocation concealment; Lack of blinding; Inappropriate analysis;  
Beaumont & Sofronoff (2008) + + Small sample; Lack of information on randomisation; Lack of blinding 
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS 
 86 
Laugeson et al. (2009) + + Small sample; No allocation concealment; Lack of blinding 
Frankel et al. (2010) + + Small sample; Simple randomisation; No allocation concealment; Lack of 
blinding 
Koenig et al. (2010) + + Small sample; Simple randomisation; No allocation concealment 
Lopata et al. (2010) + + Small sample; No allocation concealment; Lack of blinding 
Begeer et al. (2011) + + Small sample; Lack of information on randomisation; Lack of blinding 
DeRosier et al. (2011) + + Small sample; Lack of information on randomisation; No allocation 
concealment; Lack of blinding 
Laugeson et al. (2012) - + Small sample; Non-randomised; No allocation concealment; Lack of blinding 
Thomeer et al. (2012) + + Small sample; No allocation concealment; Lack of blinding 
Andrews et al. (2013) + + Small sample; No allocation concealment; Lack of blinding 
Baghdadli et al. (2013): Pilot study - - Very small sample 
Ichikawa et al. (2013): Pilot study - - Very small sample; Lack of blinding 
Koning et al. (2013): Pilot study - - Small sample; No allocation concealment; Lack of blinding; Lack of normed 
outcome measures 
White et al. (2013): Pilot study + + Small sample; No allocation concealment; Lack of blinding 
Laugeson et al. (2014) - - Small sample; Non-randomised; No allocation concealment; Lack of blinding;  
Schohl et al. (2014) + + Small sample; Lack of information on randomisation procedure; No allocation 
concealment; Partial blinding; High number of drop outs 
Wood et al. (2014): Pilot study - - Very small sample; Inappropriate analysis 
Yoo et al. (2014) + + Small sample; Lack of information on randomisation procedure; No allocation 
concealment; Partial blinding;  
Begeer et al. (2015) + + Lack of blinding 
Freitag et al. (2016) ++ ++  
Soorya et al. (2015) ++ + Small sample; Use of Social Behaviour Composite as primary outcome 
measure- not validated 
Studies targeting core features of ASD: Adults 
Turner-Brown et al. (2008): Pilot 
study 
- - Very small sample; Non-randomised; No allocation concealment; Two 
participants changed groups; Inappropriate analysis 
Gantman et al. (2012): Pilot study - - Very small sample; Simple randomisation; No allocation concealment; Lack of 
blinding; Inappropriate analysis 
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++, All or most of the checklist criteria have been fulfilled; where they have not been fulfilled the conclusions are very unlikely to alter; +, Some 
of the checklist criteria have been fulfilled; where they have not been fulfilled, or not adequately described, the conclusions are unlikely to alter; 
- , Few or no checklist criteria have been fulfilled and the conclusions are likely or very likely to alter 
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3.5 Meta-analysis 
 Data were analysed in a series of meta-analyses. Outcomes relating to each research 
question will be presented in turn, organised by report-type. Data collected from all outcome 
measures deemed appropriate were included unless otherwise specified (see Section 2.5.3.1 
for further information on the selection of outcome measures to include). 
3.5.1 Research question 1: How effective is CBT in reducing symptoms of 
mental disorder in individuals with ASD? 
3.5.1.1 Self-reported outcomes. 
 Seventeen studies, including 645 participants (329 CBT, 316 control), that 
investigated the effectiveness of CBT in reducing symptoms of mental disorder included 
appropriate self-reported outcome measures. One study (Storch et al., 2013) utilised a 
relevant self-reported outcome measure but it was not possible to include this in the analysis 
as an attempt to obtain the data necessary to calculate the effect size was unsuccessful. The 
outcome measures used varied considerably across studies. 
 As indicated in Figure 2, a random-effects meta-analysis of these trials indicated a 
“small” but non-significant effect favouring CBT over waiting-list, treatment as usual or 
active control as reported by participants (g = 0.24; 95% CI [-0.05, 0.53], z = 1.60, p = .11). 
The analysis indicated a significant amount of heterogeneity, with I2 indicating that 69% of 
the variability in estimated treatment effect was due to heterogeneity rather than chance (p < 
.001). 
 As one study (Chalfant et al., 2007) had a SMD (g = 2.64) considerably higher than 
the other included studies (g ranged from -0.39 to 0.85), a sensitivity analysis was conducted 
to remove this outlier. Exclusion of this study resulted in no significant treatment effect (g = 
0.10; 95% CI [-0.06, 0.27], z = 1.21, p = .23) and I2 reduced markedly to 4% (p = .41), 
indicating the considerable impact that the inclusion of this study had on the pooled SMD. A 
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS   
 
 89 
further sensitivity analysis to remove studies deemed to be at a high risk of bias (Clarke, 
2012; Hesselmark et al., 2014; McGillivray & Evert, 2014; Reaven et al., 2009; Russell et al., 
2009) resulted in a very similar effect (g = 0.09; 95% CI [-0.12, 0.30], z = 0.84, p = .40). 
Figure 2. Forest plot showing estimated treatment effect of CBT for symptoms of mental 
disorder in ASD based on self-reported outcomes 
3.5.1.2 Informant-reported outcomes. 
 Sixteen studies, including 620 participants (325 CBT, 295 control), that investigated 
the effectiveness of CBT in reducing symptoms of mental disorder included appropriate 
informant-reported outcome measures. One study (Pahnke et al., 2014) utilised a relevant 
informant-reported outcome measure but it was not possible to include this in the analysis as 
an attempt to obtain the data necessary to calculate the effect size was unsuccessful. The 
outcome measures used varied considerably across studies. 
 As indicated in Figure 3, a random-effects meta-analysis of these trials indicated a 
significant “medium” effect favouring CBT over waiting-list, treatment as usual or active 
control as reported by informants (g = 0.66; 95% CI [0.29, 1.03], z = 3.49, p < .001). The 
analysis indicated a significant amount of heterogeneity, with I2 indicating that 78% of the 
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variability in estimated treatment effect was due to heterogeneity rather than chance (p < 
.001). 
 Chalfant et al. (2007) again had a SMD (g = 4.27) considerably higher than the other 
included studies (g ranged from -0.39 to 1.21) and a sensitivity analysis was therefore 
conducted to remove this outlier. Exclusion of this study resulted in a lower treatment effect 
(g = 0.47; 95% CI [0.25, 0.69], z = 4.17, p < .001), although it remained statistically 
significant. I2 reduced to 38% (p = .07), again indicating the impact that the inclusion of this 
study had on the pooled SMD. A further sensitivity analysis to remove studies deemed to be 
at a high risk of bias (Clarke, 2012; Hepburn et al., 2016; Reaven et al., 2009; Scarpa & 
Reyes, 2011) resulted in a very similar effect (g = 0.45; 95% CI, 0.18 to 0.72, z = 3.24, p = 
.001). 
Figure 3. Forest plot showing estimated treatment effect of CBT for symptoms of mental 
disorder in ASD based on informant-reported outcomes 
3.5.1.3 Clinician-rated outcomes. 
 Thirteen studies, including 514 participants (262 CBT, 252 control), that investigated 
the effectiveness of CBT in reducing symptoms of mental disorder included appropriate 
clinician-rated outcome measures. Two of these studies (Chalfant et al., 2007; van Steensel et 
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al., 2014) presented the outcomes as dichotomous data. In order to include these studies in a 
random-effects meta-analysis, the Odds Ratio was calculated and re-expressed as a SMD 
(Chinn, 2000; see Section 2.5.3 for further information). The outcome measures used varied 
considerably across studies. 
 A random-effects meta-analysis using the Generic Inverse Variance method was 
conducted as estimates of effect were calculated for the two aforementioned studies. As 
shown in Figure 4, analysis indicated a significant “medium” effect favouring CBT over 
waiting-list, treatment as usual or active control as rated by clinicians (g = 0.73; 95% CI 
[0.38, 1.08], z = 4.05, p < .001). The analysis again indicated a significant amount of 
heterogeneity, with I2 indicating that 69% of the variability in estimated treatment effect was 
due to heterogeneity rather than chance (p < .001). 
 Two studies (Chalfant et al., 2007; Wood et al., 2009) had a SMD (g = 2.51 and g = 
2.47 respectively) considerably higher than the other included studies (g ranged from -0.31 to 
1.38) and a sensitivity analysis was conducted to remove these outliers. Exclusion of these 
studies resulted in a lower treatment effect (g = 0.52; 95% CI [0.27, 0.77], z = 4.06, p < .001), 
although it remained statistically significant. I2 reduced to 36% (p = .11), again indicating the 
impact that the inclusion of these studies had on the pooled SMD. A further sensitivity 
analysis to remove studies deemed to be at a high risk of bias (Russell et al., 2009; van 
Steensel et al., 2014) resulted in a very similar effect (g = 0.59; 95% CI [0.33, 0.85], z = 4.48, 
p = <.001). 
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Figure 4. Forest plot showing estimated treatment effect of CBT for symptoms of mental 
disorder in ASD based on clinician-rated outcomes 
3.5.1.4 Task-based outcomes. 
 Only one study that investigated the effectiveness of CBT in reducing symptoms of 
mental disorder included an appropriate task-based outcome measure (Cortesi et al., 2012). It 
was therefore not possible to calculate a pooled SMD in this area. 
3.5.1.5 Summary. 
Twenty-four studies that investigated the effectiveness of CBT in reducing 
symptoms of mental disorder in children, adolescents and adults with ASD were 
included within this analysis. Overall effect sizes on informant- reported and 
clinician-rated outcomes were g= 0.66 and g= 0.73 respectively, both of which may 
be interpreted as “medium”. When outlying studies were removed, the magnitude of 
these effects reduced to g= 0.47 and g= 0.52 respectively, although they remained 
statistically significant. In contrast, the overall effect size on self-reported outcomes 
was g= 0.24, which may be interpreted as a “small” but non-significant effect. When 
an outlying study was removed, the magnitude of the effect reduced to g= 0.10, 
indicating no superiority of CBT over control on self-reported outcome measures. 
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Further sensitivity analysis to remove studies deemed to be at a high risk of bias did 
not significantly affect the results for any outcome report type. 
3.5.2 Research question 2: How effective is CBT in the treatment of core 
features of ASD? 
3.5.2.1 Self-reported outcomes. 
 Nine studies, including 370 participants (192 CBT, 178 control), that investigated the 
effectiveness of CBT in the treatment of core features of ASD included appropriate self-
reported outcome measures. The outcome measures used varied considerably across studies. 
 As indicated in Figure 5, a random-effects meta-analysis of these trials indicated a 
“small” but non-significant effect favouring CBT over waiting-list, treatment as usual or 
active control as reported by participants (g = 0.25; 95% CI, [-0.03, 0.53], z = 1.77, p = .08). 
Heterogeneity was not found to be significant, although I2 indicated that 40% of the 
variability in estimated treatment effect was due to heterogeneity rather than chance (p = .10). 
 A sensitivity analysis to remove studies deemed to be at a high risk of bias (Gantman 
et al., 2012; Laugeson et al., 2014; Laugeson et al., 2012; Turner-Brown et al., 2008) resulted 
in no significant treatment effect (g = 0.10; 95% CI [-0.24, 0.45], z = 0.58, p = .56). 
 
Figure 5. Forest plot showing estimated treatment effect of CBT for core features of ASD 
based on self-reported outcomes  
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3.5.2.2 Informant-reported outcomes. 
 Eighteen studies, including 950 participants (480 CBT, 470 control), that investigated 
the effectiveness of CBT in the treatment of core features of ASD included appropriate 
informant-reported outcome measures. The outcome measures used varied considerably 
across studies. 
 As indicated in Figure 6, a random-effects meta-analysis of these trials indicated a 
significant “small” effect favouring CBT over waiting-list, treatment as usual or active 
control as reported by informants (g = 0.48; 95% CI [0.30, 0.65], z = 5.39, p < .001). 
Heterogeneity was again not found to be significant, although I2 indicated that 36% of the 
variability in estimated treatment effect was due to heterogeneity rather than chance (p = .06). 
 A sensitivity analysis to remove studies deemed to be at a high risk of bias (Gantman 
et al., 2012; Ichikawa et al., 2013; Koning et al., 2013; Laugeson et al., 2014; Laugeson et al., 
2012) resulted in a slightly larger “medium” treatment effect (g = 0.52; 95% CI [0.34, 0.70], z 
= 5.63, p < .001), with a small reduction in heterogeneity (I2 = 33%, p = .12). 
 
Figure 6. Forest plot showing estimated treatment effect of CBT for core features of ASD 
based on informant-reported outcomes 
3.5.2.3 Clinician-rated outcomes. 
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 Six studies, including 153 participants (79 CBT, 74 control), that investigated the 
effectiveness of CBT in the treatment of core features of ASD included appropriate clinician-
rated outcome measures. One of these studies (Koenig et al., 2010) presented the outcome as 
dichotomous data. In order to include this study in a random-effects meta-analysis, the Odds 
Ratio was calculated and re-expressed as a SMD (Chinn, 2000; see Section 2.5.3 for further 
information). The outcome measures used varied across studies. 
 A random-effects meta-analysis using the Generic Inverse Variance method was 
conducted as an estimate of effect was calculated for Koenig et al. (2010). As shown in 
Figure 7, analysis indicated a significant “medium” effect favouring CBT over waiting-list, 
treatment as usual or active control as rated by clinicians (g = 0.65; 95% CI [0.10, 1.21], z = 
2.30, p = .02). Heterogeneity was again found to be non-significant, although I2 indicated that 
47% of the variability in estimated treatment effect was due to heterogeneity rather than 
chance (p = .10). 
 One study (Koenig et al., 2010) had a SMD (g = 2.43) considerably higher than the 
other included studies (g ranged from 0.08 to 1.51) and a sensitivity analysis was conducted 
to remove this outlier. Exclusion of Koenig et al. (2010) resulted in a lower treatment effect 
(g = 0.47; 95% CI [0.09, 0.85], z = 2.40, p = .02), although it remained statistically 
significant. I2 reduced to 1% (p = .40), indicating the considerable impact that the inclusion 
of this study had on the pooled SMD. A further sensitivity analysis to remove studies deemed 
to be at a high risk of bias (Ichikawa et al., 2013; Turner-Brown et al., 2008; Wood et al., 
2014) resulted in a very similar treatment effect (g = 0.44; 95% CI [-0.01, 0.89], z = 1.90, p = 
.06), although this was no longer statistically significant. It is highly likely that this is because 
the exclusion of the above studies left only two studies in the analysis; as such, this analysis 
should be interpreted with marked caution, considering that it is based upon a small number 
of participants (N = 77).  
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Figure 7. Forest plot showing estimated treatment effect of CBT for core features of ASD 
based on clinician-rated outcomes 
3.5.2.4 Task-based outcomes. 
 Seven studies, including 237 participants (117 CBT, 120 control), that investigated 
the effectiveness of CBT in the treatment of core features of ASD included appropriate task-
based outcome measures. The outcome measures used varied considerably across studies. 
 As indicated in Figure 8, a random-effects meta-analysis of these trials indicated a 
significant “small” effect favouring CBT over waiting-list, treatment as usual or active 
control on task-based measures (g = 0.35; 95% CI [0.09, 0.61], z = 2.67, p = .008). 
Heterogeneity was not an issue, with I2 indicating that 0% of the variability in estimated 
treatment effect was due to heterogeneity rather than chance (p = .58). 
 A sensitivity analysis to remove studies deemed to be at a high risk of bias (Baghdadli 
et al., 2013; Koning et al., 2013; Ozonoff & Miller, 1995; Solomon et al., 2004) resulted in a 
very similar treatment effect (g = 0.30; 95% CI [-0.12, 0.72], z = 1.42, p = .16), although this 
was no longer statistically significant. Again, it is highly likely that this is because the 
exclusion of the above studies left only three studies in the analysis and this result should 
therefore be interpreted with marked caution, being based on studies that included N = 182 
participants. 
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Figure 8. Forest plot showing estimated treatment effect of CBT for core features of ASD 
based on task-based outcomes 
3.5.2.5 Summary. 
Twenty-six studies that investigated the effectiveness of CBT in the treatment of 
core features of ASD in children, adolescents and adults with ASD were identified for 
potential inclusion, with twenty-four of these studies being included in the quantitative 
synthesis. The overall effect size on self-reported outcomes was g= 0.25, a “small” but non-
significant effect which was reduced further when a sensitivity analysis was conducted to 
remove studies deemed to be at a high risk of bias. In contrast, the overall effect size on 
informant- reported outcomes was g= 0.48, a “small” but significant effect. Sensitivity 
analysis to remove studies deemed to be at a high risk of bias resulted in a slightly larger 
“medium” treatment effect (g= 0.52). 
The overall effect size on clinician-rated outcomes was g= 0.65, which may be 
interpreted as a “medium” effect. When an outlying study was removed, the magnitude of 
this effect reduced to g= 0.47, although it remained statistically significant. However, once a 
further sensitivity analysis to remove studies deemed to be at a high risk of bias was 
completed, the magnitude of effect was no longer significant.  Similarly, the overall effect 
size on task-based outcomes indicated a significant “small” effect favouring CBT over 
control (g= 0.35), although this was no longer statistically significant when studies deemed to 
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be a high risk of bias were removed. The fact that there were very few studies within the 
analysis for clinician-rated and task-based measures is likely to have been influential and data 
for these outcome types should therefore be interpreted with marked caution. 
3.5.3 Research question 3: Is the effectiveness of CBT with individuals with 
ASD moderated by age? 
3.5.3.1 Self-reported outcomes. 
 As reported in Sections 3.5.1.1 and 3.5.2.1, CBT was not superior to control groups 
on self-reported outcome measures for both studies investigating the effectiveness of CBT for 
co-occurring symptoms of mental disorder and studies investigating CBT targeting core 
features of ASD. However, subgroup analysis was conducted as planned to compare 
effectiveness across age groups in order to ensure that a significant effect had not become 
masked by the inclusion of studies from other age groups. 
 Studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD 
 Subgroup meta-analysis of studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD indicated no significant difference between age groups on 
self-reported outcomes, with I2 indicating that 0% of the variability in effect estimates was 
due to genuine subgroup differences rather than sampling error (p = .43). No significant 
effect of CBT was found in adult studies (g = 0.05; 95% CI [-0.50, 0.60], z = 0.18, p = .86) or 
mixed age group studies (g = 0.03; 95% CI [-0.35, 0.41], z = 0.16, p = .87) on self-rated 
outcomes (see Figure 9). A “small” combined effect size favouring CBT in child and 
adolescent studies was found (g = 0.40; 95% CI [-0.05, 0.85], z = 1.75, p = .08), although this 
was non-significant and exclusion of an outlier (Chalfant et al., 2007) eliminated this effect (g 
= 0.15; 95% CI [-0.07, 0.38], z = 1.34, p = .18). 
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Figure 9.  Forest plot showing estimated treatment effect of CBT for co-occurring mental 
disorders based on self-rated outcomes: age subgroup analysis 
 Studies investigating CBT targeting core features of ASD 
 Subgroup meta-analysis of studies investigating CBT targeting core features of ASD 
again indicated no significant difference between age groups on self-reported outcomes, with 
I2 indicating that 0% of the variability in effect estimates was due to genuine subgroup 
differences rather than sampling error (p = .84). A “small” combined effect size favouring 
CBT was found in both child and adolescent (g = 0.25; 95% CI [-0.07, 0.56], z = 1.52, p = 
.13) and adult (g = 0.33; 95% CI [-0.43, 1.09], z = 0.85, p = .39) studies, although these were 
non-significant (see Figure 10). 
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Figure 10.  Forest plot showing estimated treatment effect of CBT for core features of ASD 
based on self-rated outcomes: age subgroup analysis 
3.5.3.2 Informant-reported outcomes. 
 Of the 16 studies that included appropriate informant-reported outcome measures in 
the investigation of the effectiveness of CBT in reducing symptoms of mental disorder, 15 
involved children and adolescents. One study included both adolescents and adults, whilst 
none included adults only. Similarly, of the 18 studies that included appropriate informant-
reported outcome measures in the investigation of the effectiveness of CBT for core features 
of ASD, 17 involved children and adolescents, whilst one included adults only. Planned 
subgroup analysis of age group across informant-report type was therefore not possible. 
3.5.3.3 Clinician-rated outcomes. 
 Studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD 
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 Subgroup meta-analysis of studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD indicated a significant difference between age groups on 
clinician-rated outcomes, with I2 indicating that 80.2% of the variability in effect estimates 
was due to genuine subgroup differences rather than sampling error (p = .006). Analysis 
indicated a “large” combined effect size favouring CBT in child and adolescent studies (g = 
0.95; 95% CI [0.55, 1.35], z = 4.64, p < .001), whilst no significant effect of CBT was found 
in adult studies (g = -0.04; 95% CI [-0.50, 0.43], z = 0.15, p = .88) on clinician-rated 
outcomes (see Figure 11). Exclusion of outliers (Chalfant et al., 2007; Wood et al., 2009) 
resulted in a lower treatment effect for child and adolescent studies (g = 0.67; 95% CI [0.42, 
0.91], z = 5.28, p < .001), although it remained statistically significant. However, this 
comparison should be treated with extreme caution since there were only two adult trials 
available for the analysis involving only N = 72 participants, in contrast to the trials involving 
N = 402 children and adolescents. 
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Figure 11.  Forest plot showing estimated treatment effect of CBT for co-occurring mental 
disorders based on clinician-rated outcomes: age subgroup analysis 
 Studies investigating CBT targeting core features of ASD 
 Of the six studies that included appropriate clinician-rated outcome measures in the 
investigation of the effectiveness of CBT for core features of ASD, five involved children 
and adolescents, whilst only one included adults. Planned subgroup analysis of age group 
across clinician-rated outcomes was therefore not possible in studies investigating CBT 
targeting core features of ASD. 
3.5.3.4 Task-based outcomes. 
 Only one study investigating the effectiveness of CBT for co-occurring symptoms of 
mental disorder included a task-based measure. All seven of the studies that included an 
appropriate task-based measure in the investigation of the effectiveness of CBT for core 
features of ASD involved children and adolescents. Planned subgroup analysis of age group 
across task-based measures was therefore not possible. 
3.5.3.5 Summary. 
 Planned subgroup analysis to investigate whether the effectiveness of CBT with 
individuals with ASD is moderated by age was severely limited by the small number of 
studies involving adult participants. It was not possible to conduct subgroup analysis by age 
for informant-report or task-based outcomes for this reason. 
 Subgroup analysis of studies investigating CBT targeting both core features of ASD 
and co-occurring mental disorder indicated no significant differences between age groups on 
self-reported outcomes. Subgroup analysis of clinician-rated outcome measures in studies 
investigating CBT targeting symptoms of mental disorder in individuals with ASD indicated 
a significantly larger effect for child and adolescent studies than adult studies. However, this 
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS   
 
 103 
comparison was limited by the fact that only two adult trials were available for the analysis 
and the outcome should therefore be interpreted with extreme caution. 
3.5.4 Research question 4: Is individual CBT more effective than group-based 
CBT in individuals with ASD? 
3.5.4.1 Self-reported outcomes. 
 As reported in Sections 3.5.1.1 and 3.5.2.1, no significant effect of CBT over control 
on self-reported outcome measures was found, both in studies investigating the effectiveness 
of CBT for co-occurring symptoms of mental disorder and studies investigating CBT 
targeting core features of ASD. However, subgroup analysis was conducted as planned to 
compare effectiveness across CBT type in order to ensure that a significant effect had not 
become masked by the inclusion of studies from the opposing group. 
 Studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD 
 Subgroup meta-analysis of studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD indicated no significant difference between CBT type on 
self-reported outcomes. I2 indicated that 59.2% of the variability in effect estimates was due 
to genuine subgroup differences rather than sampling error, although this was non-significant 
(p = .12) and the removal of an outlier (Chalfant et al., 2007) reduced I2 to 2.6%. No 
significant effect of individual CBT was found (g = -0.03; 95% CI [-0.34, 0.28], z = 0.22, p = 
.83) on self-rated outcomes (see Figure 12). A “small” combined effect size favouring group-
based CBT was found (g = 0.37; 95% CI [-0.03, 0.76], z = 1.82, p = .07), although this was 
non-significant and exclusion of an outlier (Chalfant et al., 2007) eliminated this effect (g = 
0.16; 95% CI [-0.06, 0.38], z = 1.45, p = .15). 
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Figure 12.  Forest plot showing estimated treatment effect of CBT for co-occurring mental 
disorders based on self-rated outcomes: CBT type subgroup analysis 
 Studies investigating CBT targeting core features of ASD 
 Of the 9 studies that included appropriate self-reported outcome measures in the 
investigation of the effectiveness of CBT for core features of ASD, none investigated 
individual CBT. Planned subgroup analysis of CBT type across informant-report outcomes 
was therefore not possible in this pool of studies. 
3.5.4.2 Informant-reported outcomes. 
 Studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD 
 Subgroup meta-analysis of studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD indicated no significant difference between CBT type on 
informant-reported outcomes (see Figure 13), with I2 indicating that 0% of the variability in 
effect estimates was due to genuine subgroup differences rather than sampling error (p = .50). 
Exclusion of one key outlier (Chalfant et al., 2007) indicated that individual-based CBT (g = 
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0.52; 95% CI [0.04, 1.00], z = 2.13, p = .03) was slightly more effective than group-based 
CBT (g = 0.41; 95% CI [0.18, 0.64] z = 3.54, p < .001), although again this difference was 
not significant (p = .50). It should be noted that heterogeneity for studies investigating 
individual CBT was particularly high (I2 = 70%). 
 
Figure 13. Forest plot showing estimated treatment effect of CBT for co-occurring mental 
disorders based on informant-reported outcomes: CBT type subgroup analysis 
 Studies investigating CBT targeting core features of ASD 
 Of the 18 studies that included appropriate informant-reported outcome measures in 
the investigation of the effectiveness of CBT for core features of ASD, none investigated 
individual CBT. Planned subgroup analysis of CBT type across informant-report outcomes 
was therefore not possible in this pool of studies. 
3.5.4.3 Clinician-rated outcomes. 
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 Studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD 
 Subgroup meta-analysis of studies investigating CBT targeting symptoms of mental 
disorder in individuals with ASD indicated no significant difference between CBT type on 
clinician-rated outcomes (see Figure 14), with I2 indicating that 0% of the variability in effect 
estimates was due to genuine subgroup differences rather than sampling error (p = .72). 
Exclusion of two outliers (Chalfant et al., 2007; Wood et al., 2009) resulted in the same 
outcome, with no significant difference between individual-based CBT (g = 0.53; 95% CI 
[0.12, 0.94], z = 2.55, p = .01) and group-based CBT (g = 0.49; 95% CI [0.17, 0.81], z = 2.99, 
p = .003).  
 
Figure 14. Forest plot showing estimated treatment effect of CBT for co-occurring mental 
disorders based on clinician-rated outcomes: CBT type subgroup analysis 
 Studies investigating CBT targeting core features of ASD 
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 Of the six studies that included appropriate clinician-rated outcome measures in the 
investigation of the effectiveness of CBT for core features of ASD, four investigated group-
based CBT, whilst only one reported on individual CBT. White et al. (2013) utilised both 
group and individual sessions. Planned subgroup analysis of CBT type across clinician-rated 
outcomes was therefore not possible in studies investigating CBT targeting core features of 
ASD. 
3.5.4.4 Task-based outcomes. 
 Only one study investigating the effectiveness of CBT for co-occurring symptoms of 
mental disorder included a task-based measure. Six of the seven studies that included an 
appropriate task-based measure in the investigation of the effectiveness of CBT for core 
features of ASD investigated group-based CBT. One study utilised both group and individual 
CBT, whilst none investigated individual CBT only. Planned subgroup analysis of age group 
across informant-report type was therefore not possible. 
3.5.4.5 Summary. 
 Planned subgroup analysis to investigate whether the effectiveness of CBT with 
individuals with ASD is moderated by CBT type was restricted. For studies investigating 
CBT for core features of ASD, subgroup analysis by CBT type was not possible for any 
outcome type due to the lack of studies investigating individual CBT.  
 In terms of studies investigating CBT for mental disorder, it was not possible to 
conduct subgroup analysis on task-based outcomes as only one study investigating the 
effectiveness of CBT for co-occurring symptoms of mental disorder included a task-based 
measure. Subgroup analysis of self-reported, informant-reported and clinician-rated outcome 
measures in studies investigating CBT targeting symptoms of mental disorder in individuals 
with ASD indicated no significant difference in effect between individual and group-based 
CBT. 
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3.5.5 Additional analysis: Sub group analysis by age within studies targeting 
anxiety  
 Nineteen studies were included within the anxiety subset. A subgroup analysis was 
conducted to assess potential variations of treatment effects across age groups within this 
subset of studies, enabling comparison to recent meta-analytic studies which have looked 
specifically at the effectiveness of CBT for anxiety in children and adolescents with ASD 
(Kreslins et al., 2015; Sukhodolsky et al., 2013; Ung et al., 2015). 
3.5.5.1 Self-reported outcomes. 
 Fifteen studies, including 558 participants (280 CBT, 278 control), that investigated 
the effectiveness of CBT in reducing symptoms of anxiety included appropriate self-reported 
outcome measures. One study (Storch et al., 2013) utilised a relevant self-reported outcome 
measure but it was not possible to include this in the analysis as an attempt to obtain the data 
necessary to calculate the effect size was unsuccessful. The outcome measures used varied 
considerably across studies. 
 A random-effects meta-analysis indicated no significant difference between age 
groups on self-reported outcomes, with I2 indicating that 0% of the variability in effect 
estimates was due to genuine subgroup differences rather than sampling error (p = .66). 
Analysis indicated a “small” but non-significant combined effect size favouring CBT in child 
and adolescent studies (g = .40; 95% CI [-0.05, 0.85], z = 1.75, p = .08) on self-reported 
outcomes. No effect was found when a key outlier (Chalfant et al., 2007) was removed (g = 
.15; 95% CI [-0.07, 0.38], z = 1.35, p = .18). Similarly, no significant effect of CBT was 
found in adult studies (g = .04; 95% CI [-0.79, 0.86], z = 0.09, p = .93) or studies involving 
both adolescents and adults (g = .16; 95% CI [-0.30, 0.62], z = 0.69, p = .49) based on self-
reported outcomes (see Figure 15). 
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Figure 15. Forest plot showing estimated treatment effect of CBT for anxiety symptoms 
based on self-reported outcomes: age subgroup analysis 
3.5.5.2 Informant-reported outcomes. 
 Of the 13 studies that included appropriate informant-reported outcome measures in 
the investigation of the effectiveness of CBT in reducing symptoms of anxiety, 12 involved 
children and adolescents. One study included both adolescents and adults, whilst none 
included adults only. Planned subgroup analysis of age group across informant-report type 
was therefore not possible. 
 A random-effects meta-analysis of the child and adolescent studies indicated a “large” 
effect favouring CBT over waiting-list, treatment as usual or active control as reported by 
informants (g = .80; 95% CI [0.34, 1.25], z = 3.42, p < .001). The analysis indicated a 
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significant amount of heterogeneity, with I2 indicating that 80% of the variability in estimated 
treatment effect was due to heterogeneity rather than chance (p < .001). 
 Chalfant et al., (2007) again had a SMD (g = 4.27) considerably higher than the other 
included studies and a sensitivity analysis was therefore conducted to remove this outlier. 
Exclusion of this study resulted in a lower treatment effect (g = 0.49; 95% CI [0.29, 0.70], z = 
4.74, p < .001), although it remained statistically significant. I2 reduced to 2% (p = .42), 
indicating the high impact that the inclusion of this study had on the pooled SMD. 
3.5.5.3 Clinician-rated outcomes. 
 Subgroup meta-analysis of studies investigating CBT targeting symptoms of anxiety 
in individuals with ASD indicated a significant difference between age groups on clinician-
rated outcomes, with I2 indicating that 80.2% of the variability in effect estimates was due to 
genuine subgroup differences rather than sampling error (p = .006). Analysis indicated a 
“large” combined effect size favouring CBT in child and adolescent studies (g = 0.95; 95% 
CI [0.55, 1.35], z = 4.64, p < .001), whilst no significant effect of CBT was found in adult 
studies (g = -0.04; 95% CI [-0.50, 0.43], z = 0.15, p = .88) on clinician-rated outcomes (see 
Figure 16). Exclusion of outliers (Chalfant et al., 2007; Wood et al., 2009) resulted in a lower 
treatment effect for child and adolescent studies (g = 0.67; 95% CI [0.42, 0.91], z = 5.28, p < 
.001), although it remained statistically significant. However, this comparison should be 
treated with caution since there were only two adult trials available for the analysis, again 
including only N = 72 participants. 
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Figure 16. Forest plot showing estimated treatment effect of CBT for anxiety symptoms 
based on clinician-rated outcomes: age subgroup analysis 
3.5.5.4 Task-based outcomes. 
 None of the 19 studies within the anxiety subset included a task-based outcome 
measure. It was therefore not possible to calculate a pooled SMD or conduct subgroup 
analysis in this area. 
3.5.5.5 Summary. 
 Nineteen studies that investigated the effectiveness of CBT in reducing symptoms of 
anxiety in children, adolescents and adults with ASD were included, and within this subset, 
no significant difference between age groups was found on self-reported outcomes. In 
contrast, a significant difference between age groups on clinician-rated outcomes was found, 
with a “large” combined effect size favouring CBT in child and adolescent studies but no 
significant effect of CBT in adult studies.  It was not possible to conduct subgroup analysis 
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by age for informant-reported and task-based outcomes due to a lack of adult studies and 
studies using task-based measures respectively. 
 The majority of studies investigating CBT for anxiety involved children and 
adolescents. Within this subgroup, overall effect sizes on informant- reported and clinician-
rated outcomes were g= 0.80 and g= 0.95 respectively, both of which may be interpreted as 
“large” effects. When outlying studies were removed, the magnitude of these effects reduced 
to g= 0.49 and g= 0.67 respectively, although they remained statistically significant. In 
contrast, the overall effect size on self-reported outcomes was g= 0.40, which may be 
interpreted as a “small” but non-significant effect. When an outlying study was removed, the 
magnitude of the effect reduced to g= 0.15, indicating no superiority of CBT over control on 
self-reported outcome measures. 
3.5.6 Exploration of publication bias. 
 Publication bias was assessed graphically using funnel plots plotting summary effect 
size against standard error (Light & Pillemer, 1984). Fail-safe N (Rosenthal, 1979) was used 
to assess the impact of bias by calculating an estimate of the number of new studies averaging 
a null result that would be required to bring the overall treatment effect to non-significance. 
3.5.6.1 Self-reported outcomes. 
 Visual inspection of a funnel plot of studies including self-reported outcomes in the 
investigation of CBT for mental disorder did not indicate significant asymmetry (see Figure 
17). As the combined effect size within this outcome type was not found to be significant, 
Fail-safe N was not calculated. 
 Exploration of publication bias within studies including self-reported outcomes in the 
investigation of CBT for core features was not conducted, both because the number of 
included studies was less than ten (Sterne et al., 2011) and because the combined effect size 
within this outcome type was found to be non-significant. 
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Figure 17. Funnel plot of standard error by Hedge’s g: Studies including self-reported 
outcomes in the investigation of CBT for mental disorder 
3.5.6.2 Informant-reported outcomes. 
 Visual inspection of funnel plots of studies including informant-reported outcomes in 
the investigation of both CBT for mental disorder and CBT for core features of ASD did not 
indicate significant asymmetry (see Figures 18 and 19).  
 The calculation of Fail-safe N (Rosenthal, 1979) indicated that 281 new studies 
averaging a null result would be required to bring the overall treatment effect for studies 
investigating CBT for mental disorder to non-significance (based on informant-reported 
outcomes), whilst 287 new studies averaging a null result would be required to bring the 
overall treatment effect for studies investigating CBT for core features of ASD to non-
significance. As these figures exceed 5n+ 10, this indicates that the findings observed in the 
present study are likely to be robust to the effects of publication bias (Rosenberg, 2005). 
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS   
 
 114 
 
Figure 18. Funnel plot of standard error by Hedge’s g: Studies including informant-reported 
outcomes in the investigation of CBT for mental disorder 
 
Figure 19. Funnel plot of standard error by Hedge’s g: Studies including informant-reported 
outcomes in the investigation of CBT for core features of ASD 
3.5.6.3 Clinician-rated outcomes. 
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 Visual inspection of a funnel plot of studies including clinician-rated outcomes in the 
investigation of CBT for mental disorder did not indicate significant asymmetry (see Figure 
20). A funnel plot of studies including clinician-rated outcomes in the investigation of CBT 
for core features was not conducted as the number of included studies was less than ten 
(Sterne et al., 2011). 
 The calculation of Fail-safe N (Rosenthal, 1979) indicated that 227 new studies 
averaging a null result would be required to bring the overall treatment effect for studies 
investigating CBT for mental disorder to non-significance (based on clinician-rated 
outcomes). As this figure exceeds 5n+ 10, this indicates that the findings are likely to be 
robust to the effects of publication bias (Rosenberg, 2005). 
 The calculation of Fail-safe N (Rosenthal, 1979) for studies investigating CBT for 
core features of ASD indicated that only 18 new studies averaging a null result would be 
required to bring the overall treatment effect to non-significance. This may indicate that the 
findings in this area may be subject to publication bias and the finding is likely to be heavily 
influenced by the reduced number of studies within this analysis. 
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Figure 20. Funnel plot of standard error by Hedge’s g: Studies including clinician-rated 
outcomes in the investigation of CBT for mental disorders 
3.5.6.4 Task-based outcomes. 
 Exploration of publication bias within studies including task-based outcomes in the 
investigation of CBT for mental disorder was not conducted as it was not possible to 
calculate a pooled effect size in this area due to a lack of studies. 
 A funnel plot of studies including task-based outcomes in the investigation of CBT 
for core features of ASD was not conducted as the number of included studies was less than 
ten (Sterne et al., 2011). The calculation of Fail-safe N (Rosenthal, 1979) for studies 
investigating CBT for core features of ASD (based on task-based outcome measures) 
indicated that only 5 new studies averaging a null result would be required to bring the 
overall treatment effect to non-significance. Again, this may indicate that the findings in this 
area are subject to publication bias and the finding is likely to be heavily influenced by the 
reduced number of studies within this analysis. 
3.5.6.5 Summary. 
 A brief exploration of possible publication bias was conducted for outcome types in 
which the pooled effect size was found to be significant. Based on the visual inspection of 
funnel plots (Light & Pillemer, 1984) and the calculation of fail-safe N (Rosenthal, 1979), 
results of studies based on informant-report outcomes appear to be robust to the effects of 
publication bias. A similar conclusion may be drawn from studies investigating CBT for 
mental disorder based on clinician-rated outcomes. In contrast, the findings for studies 
including clinician-rated and task-based outcomes in the investigation of CBT for core 
features of ASD were found to be more vulnerable to the threat of publication bias, i.e. less 
tolerant to the possible exclusion of null results. However, as discussed in Section 2.7.5, this 
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approach is not without its limitations and results should therefore be interpreted with 
caution.  
3.6 Chapter Summary 
 Fifty studies met inclusion criteria for the present research and 48 studies, involving 
2099 participants (1081 CBT, 1018 control) were included in the quantitative synthesis. 
There was very good agreement between the researchers regarding study inclusion. Twenty-
four of the included studies assessed the effectiveness of CBT for co-occurring symptoms of 
mental disorder, whilst 24 studies targeted core features of ASD. The majority of studies 
involved children and adolescents. There was considerable variation amongst studies in terms 
of trial design, outcome measures utilised and CBT type, content and intensity. 
 Regarding quality appraisal, there was ‘moderate’ agreement between the researchers 
regarding ratings for internal validity and ‘good’ agreement regarding ratings for external 
validity. Key sources of potential bias identified included small sample size, non-
randomisation and a lack of blinding. A lack of reporting on compliance to intervention 
sessions, poor reporting on missing data and minimal information on fidelity checks were 
also commonly identified issues, as was the lack of specification of a primary outcome 
measure. However, the exclusion of studies in which a high risk of bias was identified during 
sensitivity analysis did not have a significant impact on results in most areas. 
 Quantitative synthesis indicated “small” to “medium” effect sizes for the effectiveness 
of CBT in reducing symptoms of mental disorder in children, adolescents and adults with 
ASD, based on informant-reported and clinician-rated outcomes. CBT was not superior to 
control on self-reported outcome measures. A similar pattern was found in studies 
specifically investigating the effectiveness of CBT for anxiety, in addition to studies targeting 
core features of ASD. Planned subgroup analysis to investigate whether the effectiveness of 
CBT with individuals with ASD is moderated by age was severely limited by the small 
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number of studies involving adult participants. Planned subgroup analysis to investigate 
whether the effectiveness of CBT with individuals with ASD is moderated by CBT type was 
again restricted. However, preliminary analysis of both informant-reported and clinician-
rated outcome measures in studies investigating CBT targeting symptoms of mental disorder 
in individuals with ASD indicated no significant difference in effect between individual and 
group-based CBT. 
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Chapter Four: Discussion 
4.1 Introduction 
 There is a growing interest in the development of psychotherapeutic interventions for 
use with individuals with Autism Spectrum Disorders. Cognitive Behavioural Therapy may 
be one promising treatment for use with this client group. However, there has been little 
systematic appraisal of effectiveness research in this area to date, particularly involving 
studies with adult participants and those investigating CBT targeting core features of ASD. 
The primary aim of the current study was therefore to systematically appraise the evidence 
for using CBT in the treatment of either core features of ASD or co-occurring mental disorder 
in individuals with ASD across the lifespan. This chapter provides an overall discussion of 
the findings in relation to the research questions and background literature. Clinical and 
theoretical implications of the study are discussed, in addition to strengths and limitations of 
the current research. Finally, recommendations regarding how future research can be 
extended and improved are outlined. 
4.2 Summary of Findings in Relation to Research Questions 
4.2.1 Research Question 1: How effective is Cognitive Behavioural Therapy in 
reducing symptoms of mental disorder in individuals with Autism Spectrum 
Disorders? 
 To the best of my knowledge there are currently three reviews involving quantitative 
synthesis of studies investigating CBT for ASD published to date (Kreslins et al., 2015; 
Sukhodolsky et al., 2013; Ung et al., 2015), all of which focus on the treatment of anxiety 
symptoms in children. The current study built on these previous meta-analytic reviews by 
extending search criteria to include studies investigating the treatment of any mental disorder 
across the lifespan. A total of 24 studies were identified that investigated the effectiveness of 
CBT in reducing symptoms of mental disorder in children, adolescents or adults with ASD. 
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Results indicated that CBT is associated with a “small” to “medium” effect size when used to 
treat co-morbid mental health problems, although this varied according to whether outcome 
data were taken from self-report, informant-report, clinician-report, or task-based measures. 
“Medium” effect sizes of g= 0.66 and g= 0.73 were found on informant- reported and 
clinician-rated outcomes respectively. However, the removal of outlying studies and studies 
deemed to be at a high risk of bias resulted in a reduction in the magnitude of these effects to 
g= 0.45 and g= 0.59. When assessing informant-reported and clinician-rated outcomes, CBT 
was therefore found to be superior to control conditions in the treatment of mental disorder 
across the lifespan, with a “small” to “medium” treatment effect. In contrast, a “small” but 
non-significant effect of g= 0.24 was found for self-reported outcomes. The removal of an 
outlying study and studies at risk of bias reduced the magnitude of the effect to g= 0.09, 
indicating no superiority of CBT over control on self-reported outcome measures.  
 Additional subgroup analysis of the subset of studies investigating the effectiveness of 
CBT for anxiety in children and adolescents enabled a more direct comparison to the anxiety-
specific meta-analytic reviews of Sukhodolsky et al. (2013), Ung et al. (2015) and Kreslins et 
al. (2015). Consistent with these studies, the present research found overall effect sizes on 
informant- reported and clinician-rated outcomes of g= 0.80 and g= 0.95 respectively, both of 
which may be interpreted as “large” effects. When outlying studies were removed, the 
magnitude of these effects reduced to g= 0.49 and g= 0.67 respectively, although they 
remained statistically significant. In contrast, the overall effect size on self-reported outcomes 
was g= 0.40, which may be interpreted as a “small” but non-significant effect. When an 
outlying study was removed, the magnitude of the effect reduced to g= 0.15, indicating no 
superiority of CBT over control on self-reported outcome measures. 
 These findings provide further support to the notion that CBT is effective at reducing 
anxiety in children and adolescents with ASD when considering informant-reported or 
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clinician-rated outcomes. However, the effect sizes reported here are lower than those 
previously reported by Sukhodolsky et al. (2013), Ung et al. (2015) and Kreslins et al. (2015), 
with all previous meta-analyses in the area having included fewer studies.   
4.2.2 Research Question 2: How effective is Cognitive Behavioural Therapy in 
the treatment of core features of Autism Spectrum Disorders? 
Findings from the meta-analysis of studies focused on the treatment of core features 
of ASD were very similar to those reported for the treatment of co-occurring mental disorder. 
Twenty-four studies that investigated the effectiveness of CBT in the treatment of core 
features of ASD in children, adolescents and adults with ASD were included. CBT was again 
associated with an effect size that ranged from “small” to “medium” and this was again 
dependent on the type of outcome measure used. 
When using data from self-reported outcomes, the difference between CBT and 
control groups post-treatment failed to reach significance; the overall effect size was g= 0.25, 
and this was further reduced when a sensitivity analysis was conducted to remove studies 
deemed to be at a high risk of bias. In contrast, clinician- and informant-reported outcome 
measures indicated that CBT was superior to control conditions post- treatment. The overall 
effect size on informant- reported outcomes following sensitivity analysis to remove studies 
deemed to be at a high risk of bias was g= 0.52, a “medium” treatment effect. 
The overall effect size on clinician-rated outcomes was also “medium” (g= 0.65). However, 
following the exclusion of studies deemed to be at risk of bias to reduce heterogeneity, there 
was a reduction in effect size (g = .44) and CBT was no longer significantly superior. In a 
similar pattern, the initial findings from task-based measures were significantly in favour of 
CBT as an effective treatment, with a “small” effect size (g = .35), although this was no 
longer statistically significant when studies deemed to be a high risk of bias were removed. It 
should be noted that there were a very small number of studies within the analysis for 
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clinician-rated and task-based measures which is likely to have been influential and this 
hinders our interpretation of the findings. 
4.2.3 Research Question 3: Is the effectiveness of Cognitive Behavioural 
Therapy with individuals with Autism Spectrum Disorders moderated by 
age? 
Subgroup analysis was planned to investigate whether the effectiveness of CBT with 
individuals with ASD is influenced by age. However, this was severely limited by the small 
number of studies involving adult participants; it was not possible to conduct sub-group 
analysis by age for informant-report or task-based outcomes for this reason. 
 Subgroup analysis of studies investigating CBT targeting both core features of ASD 
and co-occurring mental disorder indicated no significant differences between age groups on 
self-reported outcomes. A subgroup analysis based on clinician-rated outcome measures for 
the treatment of mental disorder was also conducted. The findings indicated a significantly 
larger effect for child and adolescent studies than for adult studies; CBT was superior than 
control and was associated with a “large” effect size (g = .95) when used with children and 
adolescents, while CBT was not superior and was associated with a “small” effect size (g = -
.04) in adults. However, this analysis relied on small numbers of studies which hinders 
interpretation and prevents firm conclusions from being drawn. At present these findings 
should therefore be regarded as preliminary in nature. 
4.2.4 Research Question 4: Is individual Cognitive Behavioural Therapy more 
effective than group-based Cognitive Behavioural Therapy in individuals 
with Autism Spectrum Disorders? 
The planned subgroup analysis to investigate whether the effectiveness of CBT with 
individuals with ASD is moderated by CBT type was also restricted. For studies investigating 
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CBT for core features of ASD, subgroup analysis by CBT type was not possible for any 
outcome type due to the lack of studies investigating individual CBT.  
 In terms of studies investigating CBT for mental disorder, it was not possible to 
conduct subgroup analysis on task-based outcomes as only one study investigating the 
effectiveness of CBT for co-occurring symptoms of mental disorder included a task-based 
measure. Subgroup analysis of self-reported, informant-reported and clinician-rated outcome 
measures in studies investigating CBT targeting symptoms of mental disorder in individuals 
with ASD indicated no significant difference in effect between individual and group-based 
CBT. However, this analysis relied on small numbers of studies so, again, it would be unwise 
to draw firm conclusions in relation to Research Question 4. These findings should be 
regarded as preliminary in nature. 
4.3 Theoretical Implications 
 The current study provides some support for Gaus’s (2007) theoretical rationale for 
the utility of CBT in individuals with ASD. Gaus (2007) postulates that CBT may be 
particularly useful in this client group due to the complex nature of ASD and because CBT 
aims to target behavioural, cognitive and affective skills simultaneously. Individuals with 
ASD may experience information processing deficits, social skills deficits and difficulties in 
daily living, all of which are likely to contribute to the development or reinforcement of 
negative beliefs and affect. In addition, difficulties with social cognition and cognitive 
rigidity can also make it more difficult for individuals with ASD to make use of contextual 
information and to modify existing beliefs and affect. CBT may therefore provide a more 
holistic approach than other psychosocial interventions as its conceptual basis assumes 
reciprocity between an individual’s thoughts, feelings and behaviours in social situations 
(Beck, 2011) and interventions are thus multifaceted. Social skills training programmes that 
are not specific to ASD have reported increased effectiveness in interventions incorporating 
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CBT techniques, in contrast to those that focus on either social, cognitive or behavioural 
techniques independently (Bauminger, 2007). Whilst the current study has not compared the 
effectiveness of CBT to that of other interventions, it is the first study to demonstrate that 
CBT can be beneficial in the treatment of both core features of ASD and symptoms of co-
occurring mental disorder, supporting the theoretical rationale outlined above. 
 The present study may also provide support against the argument that CBT may not 
be suitable for use with individuals with ASD given the fact that ASD has been shown to be 
associated with difficulties identifying emotions and cognitions. Although the content of CBT 
interventions utilised in included studies was not directly investigated in the present research, 
all included studies incorporated both cognitive and behavioural components based on well-
established and theoretically driven principles and techniques. The fact that CBT was shown 
to be superior to control groups may therefore suggest that individuals with ASD were in fact 
able to utilise this model in order to make improvements noticeable by informants and 
clinicians. This is in line with recent evidence which suggests that individuals with ASD are 
able to accurately report their anxious and depressed cognitions (Ozsivadjian et al., 2014), in 
addition to performing comparably to typically developing individuals on tasks requiring 
discrimination among thoughts, feelings and behaviours and cognitive mediation (Lickel et 
al., 2012). 
 The fact that many of the included studies involved increased emphasis on teaching 
practical skills, particularly those targeting the treatment of core features of ASD, also raises 
important theoretical questions. As discussed in Chapter One, a key component of CBT 
interventions is the identification and modification of cognitive structures, i.e. thoughts, 
beliefs and schemas, to facilitate clinical improvement (Beck, 1976). It is therefore 
interesting to note that CBT was superior to control groups based on informant- and clinician-
rated outcomes in the current study, despite a de-emphasis on introspection and increased 
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emphasis on behavioural techniques across many of the included studies. It was beyond the 
scope of the current project to directly assess content of intervention; modifications and 
adaptations varied considerably across studies and it is therefore difficult to make conclusions 
in this area. However, it is fair to say that a lesser focus on cognitive aspects of CBT was 
noted across the included studies. More systematic and experimental investigation of 
intervention content would enable clearer discussion regarding whether the mechanism of 
action for clinical improvement is robust to more behaviourally focused treatment. This 
would be a useful addition to literature arguing that there is little evidence that specific 
cognitive interventions significantly increase the effectiveness of CBT (Longmore & Worrell, 
2007). Further exploration in this area would also be important in terms of increasing the 
efficacy of CBT with this client group. 
4.4 Clinical Implications 
 This is the first study to demonstrate that CBT can be beneficial in the treatment of 
both core features of ASD and symptoms of co-occurring mental disorder, making it a 
potentially unique and desirable intervention for use with this client group. However, the fact 
that CBT was not shown to be effective when based on self-report measures is an important 
finding which should be addressed. Substantial difference in treatment efficacy dependent on 
the outcome measure type has been reported, both in the present study and in three meta-
analytic studies focused on the treatment of anxiety in children and adolescents with ASD 
(Kreslins et al., 2015; Sukhodolsky et al., 2013; Ung et al., 2015). In the current study, self-
report measures were not associated with significant change following CBT treatment across 
all age groups, in addition to studies investigating the treatment of both core features of ASD 
and co-occurring mental disorder. As previously discussed, this may be due to a difficulty in 
reliably reporting symptoms due to developmental challenges associated with ASD (Kreslins 
et al., 2015; Sukhodolsky et al., 2013; Ung et al., 2015). The fact that this pattern is consistent 
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across the lifespan and across symptom type provides further support for this notion, 
highlighting the need for further research to develop valid and reliable measures for use with 
individuals with ASD. However, it is also important to consider the fact that the self-reported 
outcomes may in fact be accurate, i.e. CBT may not be an effective treatment for individuals 
with ASD. It is possible that informant- and clinician- reported outcomes are biased by an 
observer-expectancy effect, particularly as the level of blinding across studies was poor and 
data management was not usually independent. It is therefore important that future studies 
use masked assessors and improve blinding procedures in order to increase our understanding 
in this area. 
Related to the above, it is also important to acknowledge the fact that even when CBT 
was shown to be superior to control conditions, all effect sizes reported in the current study 
are “small” to “medium”. This is interesting, given the fact that CBT has been associated 
with much larger effects in other populations (Hofmann et al., 2012). It is likely that 
methodological issues across studies are playing a role here, although consideration should be 
given to the possibility that clinical adaptations currently being utilised in the treatment of 
individuals with ASD may not be appropriate or could be greatly improved. Thus, it is again 
argued that further systematic research into the content of CBT being utilised with 
individuals with ASD would be beneficial. NICE guidelines for the diagnosis and 
management of autism in children and adults (NICE, 2012a, 2013) state that the method of 
delivery of cognitive and behavioural interventions for individuals with ASD should include 
adaptations such as the use of a more concrete and structured approach, greater use of written 
and visual information, placing greater emphasis on behavioural rather than cognitive 
interventions and involving family members. Indeed, clinicians and researchers have begun 
to adapt or modify CBT in order to take into account the specific needs of children and adults 
with ASD to increase its accessibility and effectiveness (e.g. Moree & Davis, 2010).  
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However, these adaptations and modifications have not yet been reviewed systematically, or 
tested experimentally. Whilst the heterogeneity in content of treatment and the modification 
of CBT techniques for individuals with ASD was noted in the present study, it was beyond 
the scope of the current research to conduct a thorough review of this area. Such a review 
would enable an assessment of whether adaptations are in line with theoretical frameworks 
for conceptualising difficulties experienced by individuals with ASD (e.g. Gaus, 2007), in 
addition to providing clarity on the actual content and processes used, thus informing clinical 
practice. 
4.5 Strengths and Weaknesses 
 A notable strength of the current research is that, to the best of my knowledge, this is 
the first quantitative review investigating the effectiveness of CBT in individuals with ASD 
to include studies involving adult participants. Whilst it is acknowledged that the number of 
adult studies in this area is limited, and the research base is certainly less developed than in 
child and adolescent populations, the inclusion of such studies has enabled preliminary 
analysis of the effectiveness of CBT for ASD at a later life stage. This has extended findings 
of previous meta-analytic reviews which have focused specifically on children and 
adolescents (Kreslins et al., 2015; Sukhodolsky et al., 2013; Ung et al., 2015), in addition to 
highlighting a clear need for further research involving adult participants in this area. 
 To the best of my knowledge, this study is also the first to systematically evaluate 
studies investigating the effectiveness of CBT in individuals with ASD for both co-occurring 
symptoms of mental disorder and core features of ASD. As previously reported, the use of 
CBT in the treatment of core features of ASD is receiving an increasing amount of attention, 
both clinically and in the research field. This study has provided an important contribution by 
highlighting the comparable effectiveness of CBT targeting core features to CBT targeting 
co-occurring mental disorder within this client group. 
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 A final strength that should be acknowledged is the fact that the current research 
considered the effectiveness of CBT based on a variety of outcome report types. As will be 
discussed below this method was not without its complications, but it allowed comparison of 
combined effect sizes across different informants and likely contributed to a reduction in 
heterogeneity given the very wide variation in outcome measures used across report types. 
Furthermore, by including clinician-rated and task-based measures, the present research 
provided an additional angle from which to consider previously reported incongruence 
between self- and informant-reported measures. 
 Despite these strengths, alongside the promising results reported, the study should be 
interpreted in the context of its limitations. Whilst in the majority of analyses the level of 
heterogeneity reduced significantly following the removal of outliers, in some cases 
considerable heterogeneity in treatment effect sizes remained that could not be explained by 
the potential moderating factors explored. Planned subgroup analysis was restricted 
considerably by the limited number of studies within some groups, whilst other potentially 
moderating variables were not considered. For example, it may have been useful to consider 
the impact of the involvement of parents in CBT sessions or parallel parent sessions since 
many, but not all, of the child and adolescent studies included these features. It may also have 
been useful to consider the intensity of the intervention and the effect of this on CBT efficacy 
since there was a high level of variability in this area across studies. 
 A further limitation is that the present research did not address longer term 
effectiveness of CBT within this client group. Whilst a general limitation of the included 
studies was the limited length of follow-up, approximately half of the studies included in 
quantitative synthesis did follow up participants at least six weeks after the end of the 
intervention. It would have been useful for the current study to have conducted further 
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analysis using follow-up data in order to investigate whether the treatment effects observed 
were maintained over time. 
 Finally, the present research excluded studies which were not published in English 
which may have introduced a systematic bias and this may limit the conclusions drawn. 
4.6 Future Research 
 In addition to the aforementioned limitations, as with any meta-analysis the validity of 
the conclusions drawn is highly dependent on the quality of the studies included. As 
discussed in Section 3.4, the research base on CBT for individuals with ASD has 
considerable methodological limitations that caused some difficulty in the current review. In 
order to make recommendations regarding future meta-analytic research it is therefore 
primarily necessary to discuss such difficulties and to make recommendations regarding 
future trials in the area. 
 One key difficulty encountered was the heterogeneity in outcome measures used 
across studies. One possible reason for this is the lack of assessment tools specifically 
designed or adapted for individuals with ASD. Development and validation of measures for 
use with this client group, to assess both core features of ASD and co-occurring symptoms of 
mental disorder, would improve the specificity of findings in future trials. However, it is 
acknowledged that this is a time-consuming and ongoing process and it is argued that in the 
interim more consistent usage of pre-existing outcome measures across studies would also be 
beneficial. More recent studies targeting social skills in individuals with CBT have taken this 
approach, with several research groups using the Social Responsiveness Scale as a primary 
outcome measure (Constantino & Gruber, 2005), which has improved comparability across 
studies. 
 The fact that the majority of included studies did not specify a primary outcome 
measure was also problematic. This complicated the quantitative synthesis process, 
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particularly in studies in which a high number of outcome measures were utilised and/ or in 
studies using different measures to assess a range of constructs. Whilst a system was devised 
in order to provide consistency in the selection of which measure/s to include in the analysis 
(see Section 2.5.3.1), some element of subjectivity inevitably remained, threatening the 
validity of the results. Furthermore, the lack of specified primary outcome measures meant 
that it was not possible to fairly calculate a combined effect size across all studies and 
analysis was instead segregated across report types. It would therefore be particularly 
beneficial for researchers conducting future trials to identify primary outcome measures a 
priori. 
 Another difficulty across many studies was the fact that outcome measures were 
predominantly self- or informant-rated. Due to the nature of the intervention, it was not 
possible to blind or mask raters, leaving trials vulnerable to performance and detection bias. 
This appears to be something which is improving, with more recently published studies being 
more likely to include clinician-rated measures, although even on these occasions clinicians 
were not always adequately blinded to treatment group. In order to make more valid 
conclusions regarding meaningful changes following treatment, future studies should include 
measures rated by independent clinicians blinded to treatment group. Improved 
randomisation, allocation concealment procedures and independent management of data 
would also be beneficial. 
 In addition to the aforementioned difficulties relating to outcome measures, a number 
of other methodological limitations of included studies were identified during quality 
appraisal. Small sample size is a persistent problem across studies in this area, with a high 
number of trials being more accurately described as pilot or feasibility studies. This makes it 
difficult to draw firm conclusions from the research to date. As discussed in Chapter 1, the 
spectrum of features of ASD means that it is not surprising that heterogeneity exists within 
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the literature. Larger-scale studies would enable the examination of subgroups based on 
clinical characteristics. It is clear that further larger-scale and robust clinical trials are needed 
in the area in order to increase generalisability and to enhance our understanding of the use of 
CBT with individuals with ASD. 
 Furthermore, many studies did not report sufficient information regarding participant 
engagement and fidelity. Information regarding therapist competence and description of 
interventions was also poor in many cases. It would perhaps be advantageous for researchers 
to make their intervention protocols available publicly, in order to increase transparency and 
to enable further investigation of the content and adaptation of CBT across studies. 
 In summary, the difficulties encountered during the current study have led to the 
following recommendations which should be considered by groups conducting future clinical 
trials of CBT with individuals with ASD: 
• Small-scale studies should be clearly described as feasibility or pilot trials. Larger-
scale definitive trials are essential for the development of the current knowledge base 
in this area 
• Methods and interventions should be described fully, in line with CONSORT 
recommendations. Standardised reporting and a more uniform approach to study 
design would help to minimise heterogeneity across studies 
• Allocation concealment, randomisation and blinding procedures should be considered 
a priority and should be described fully 
• Where possible, more consistent usage of pre-existing outcome measures across 
studies would be beneficial in order to increase comparability across trials 
• Researchers should specify a primary outcome measure a priori 
• Participant engagement and fidelity should be clearly reported 
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 It is suggested that the implementation of such recommendations in future clinical 
trials would subsequently improve the validity of future meta-analytic studies in the area. 
Further meta-analytic research incorporating higher quality and larger-scale trials could 
potentially strengthen the findings of the current research, whilst enabling a more thorough 
investigation of potentially moderating factors.  
4.7 Conclusion 
 The primary aim of the current research was to systematically appraise the evidence 
for using CBT in the treatment of either core features of ASD or co-occurring mental disorder 
in individuals with ASD across the lifespan. Fifty eligible studies involving children, 
adolescents and adults with ASD were located, 48 of which were included in quantitative 
synthesis. Following the exclusion of outliers and studies deemed to be at a high risk of bias, 
results indicated that CBT has a “small” to “medium” treatment effect in the treatment of 
both core features of ASD or co-occurring mental disorder in individuals with ASD, when 
based on informant- and clinician-rated outcomes. In contrast, CBT was not found to be 
superior to control when self-reported outcome measures were utilised. Preliminary evidence 
indicated that CBT may be more effective for the treatment of children and adolescents with 
ASD than adults whilst individual and group CBT appeared to be equally effective. However, 
subgroup analysis was severely limited by a lack of studies, threatening the validity of the 
findings, and these conclusions should therefore remain tentative until further research is 
conducted. Future larger-scale clinical trials are needed to further explore the effectiveness of 
CBT in this client group, with well characterised samples, clearly defined primary outcome 
measures and adequate randomisation, allocation concealment and blinding. 
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Abstract	
The	aims	of	this	study	were	to	undertake	a	meta-analytic	and	systematic	appraisal	of	the	
literature	investigating	the	effectiveness	of	cognitive	behavioural	therapy	(CBT)	when	used	with	
individuals	who	have	autistic	spectrum	disorders	(ASDs)	for	either	a)	affective	disorders,	or	b)	the	
symptoms	of	ASDs.			Following	a	systematic	search,	48	studies	were	included.		CBT,	used	for	affective	
disorders,	was	associated	with	a	non-significant	small	effect	size,	g	=	.24,	for	self-report	measures,	a	
significant	medium	effect	size,	g	=	.66,	for	informant-report	measures,	and	a	significant	medium	
effect	size,	g	=	.73,	for	clinician-report	measures.		CBT,	used	as	a	treatment	for	symptoms	of	ASDs,	
was	associated	with	a	small	non-significant	effect	size,	g	=	.25,	for	self-report	measures,	a	significant	
small	effect	size,	g	=	.48,	for	informant-report	measures,	a	significant	medium	effect	size,	g	=	.65,	for	
clinician-report	measures,	and	a	significant	small	effect	size,	g	=	.35,	for	task-based	measures.		
Sensitivity	analyses	reduced	effect	size	magnitude,	with	the	exception	of	that	based	on	informant-
report	measures	for	the	symptoms	of	ASDs,	which	increased,	g	=	.52.			Definitive	trials	are	needed	to	
demonstrate	that	CBT	is	an	empirically	validated	treatment	for	use	with	people	who	have	ASDs.	
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Effectiveness	of	cognitive	behaviour	therapy	with	people	who	have	autistic	spectrum	disorders:		A	
systematic	review	and	meta-analysis	
Autism	spectrum	disorders	(ASDs)	are	a	range	of	neurodevelopmental	disorders	
characterised	by	difficulties	with	social	communication	and	interaction	across	contexts,	as	well	as	
restricted	and	repetitive	patterns	of	behaviour,	interests	and	activities.			The	phenotype	incorporates	
a	range	of	symptoms	across	multiple	domains,	including	cognitive,	behavioural,	affective	and	
sensory	symptoms	(Volkmar,	Paul,	Klin,	&	Cohen,	2005;	Wiggins	et	al.,	2015).			Sleeping	and	eating	
difficulties,	synaesthesia,	as	well	as	affective	dysregulation,	and	difficulties	with	initiation,	planning	
and	organisation	are	often	present	(Baron-Cohen,	2008;	Wiggins	et	al.,	2015).			The	prevalence	
amongst	4	year	olds	has	been	estimated	to	be	approximately	13.4	per	1000	(Christensen	et	al.,	
2016),	while	the	adult	prevalence	has	been	estimated	to	be	9.8	per	10000	(Brugha	et	al.,	2011).					
There	has	been	a	marked	increase	in	psychosocial	interventions	that	aim	to	treat	the	
symptoms	or	features	of	ASDs.			In	the	United	Kingdom,	the	National	Institute	for	Health	and	Care	
Excellence	(2012a)	recommended	that	people	with	ASDs	should	be	offered	age-appropriate	
psychosocial	interventions	for	comorbid	mental	health	problems	and	the	core	symptoms	of	ASDs.		
There	are	a	large	number	of	interventions	claiming	to	treat	symptoms	of	ASDs,	even	though	the	
evidence	base	is	poor	(Matson,	Adams,	Williams,	&	Rieske,	2013).		However,	there	is	evidence	to	
support	the	use	of	applied	behaviour	analysis	in	the	treatment	of	symptoms	of	ASDs,	and	the	
authors	of	a	Cochrane	review	concluded	that	early	and	intensive	behavioural	interventions	can	lead	
to	improvements	in	adaptive,	and	communicative	behaviour,	as	well	as	social	skills	(Reichow,	
Barton,	Boyd,	&	Hume,	2012).		Nevertheless,	there	are	few	studies	examining	the	effectiveness	of	
these	types	of	interventions	with	adults,	as	opposed	to	children,	with	ASDs	(Wright,	Brooks,	
D'Astous,	&	Grandin,	2013).			
Alongside	this,	psychiatric	comorbidity	amongst	people	with	ASDs	is	elevated	(Green,	
Gilchrist,	Burton,	&	Cox,	2000;	Kim,	Szatmari,	Bryson,	Streiner,	&	Wilson,	2000;	Lugnegård,	
Hallerbäck,	&	Gillberg,	2011;	Rescorla,	1986;	Russell	&	Sofronoff,	2005),	prompting	many	to	consider	
how	to	adapt	and	deliver	psychological	therapies	for	children,	adolescents	and	adults	with	ASDs.			
Several	meta-analytic	or	narrative	reviews	involving	studies	that	recruited	samples	of	children	and	
adolescents	have	been	completed	in	this	area	examining	the	effectiveness	of	cognitive	behavioural	
therapy	(CBT)	for	anxiety	disorders	or	social	skills	training	(Ho,	Stephenson,	&	Carter,	2014,	2015;	
Kreslins,	Robertson,	&	Melville,	2015;	Spain	&	Blainey,	2015;	Sukhodolsky,	Bloch,	Panza,	&	Reichow,	
2013;	Ung,	Selles,	Small,	&	Storch,	2015).			While	all	of	the	aforementioned	studies	have	concluded	
that	CBT	and	associated	interventions	for	anxiety	amongst	children	with	ASDs	appear	to	be	
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promising,	none	have	considered	CBT	across	the	lifespan,	which	is	clearly	relevant	because	
individuals	with	ASDs	experience	atypical	development.		Further	none	of	the	previously	completed	
meta-analyses	have:	(a)	considered	CBT,	as	opposed	to	applied	behavioural	analysis,	when	used	as	a	
treatment	for	the	actual	symptoms	or	features	of	ASDs,	rather	than	the	treatment	of	anxiety	
disorders,	(b)	included	studies	involving	adult	participants,	and	(c)	included	other	affective	disorders,	
such	as	depression,	alongside	anxiety	disorders.		In	order	to	address	these	weaknesses,	we	
completed	a	comprehensive	meta-analysis	and	systematic	review	of	the	literature	which	aimed	to	
investigate	the	effectiveness	of	cognitive	behavioural	therapy	across	the	lifespan	for	either	(a)	
affective	disorders	more	broadly,	or	(b)	the	symptoms	and	features	associated	with	ASDs.		A	
supplementary	aim	was	to	investigate	whether	there	are	differences	in	outcome	for	children,	
adolescents	and	adults.			
Method	
Relevant	studies	were	identified	by	systematic	searches	of	the	following	electronic	
databases:	PsycINFO;	MEDLINE;	CINAHL	Plus,	Web	of	Science,	as	well	as	Google	Scholar.		The	
Cochrane	Library	was	searched	to	identify	any	existing	systematic	reviews.	The	key	search	terms	and	
how	they	were	combined	are	found	in	Table	1.			Terms	were	searched	using	English	and	American	
terminology,	spelling,	and	truncation	to	ensure	that	all	variant	word	endings	were	identified.		
Alongside	this,	the	ancestry	method	was	used	to	identify	any	further	papers	that	may	have	met	
eligibility	criteria.		The	grey	or	fugitive	literature	was	also	searched	in	an	attempt	to	minimise	
publication	bias.		An	initial	search	was	completed	via	http://www.opengrey.eu	which	includes	
research	reports,	dissertations	and	conference	papers.		Dissertation	Abstracts	–	International	and	
the	Comprehensive	Dissertation	Index	were	also	searched,	as	well	as	trial	registers.				The	final	
search	for	studies	was	completed	on	29	January	2016.		The	review	was	registered	with	PROSPERO,	
an	international	database	of	systematic	reviews	in	health	and	social	care,	in	order	to	provide	
transparency	to	the	review	process	and	to	avoid	duplication	of	research	effort	(Registration	Number:	
CRD42015017766).		
Insert	Table	1	about	here.	
Initially,	titles	and	abstracts	were	screened	for	eligibility,	and	studies	were	included	if	all	of	
the	following	criteria	were	met:	(a)	participants	had	a	diagnosis	of	Autism	Spectrum	Disorder	(or	
autistic	disorder,	Asperger	disorder,	childhood	disintegrative	disorder	or	pervasive	developmental	
disorder	not	specified	prior	to	the	publication	of	DSM-V),	and	diagnosis	was	made	by	a	qualified	
clinician	and/or	using	a	standardised	diagnostic	assessment;	(b)	studies	used	a	control	or	
comparison	group	design,	e.g.	waiting	list	or	treatment	as	usual	(TAU),	with	or	without	
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randomisation;	(c)	a	clinician-led	CBT	intervention,	either	individual	or	group-based,	incorporating	
both	cognitive	and	behavioural	components	was	used.	Interventions	in	which	CBT	theory	and	
principles	were	utilised	to	teach	or	improve	behavioural	patterns,	e.g.	social	skills,	were	included,	
provided	that	this	was	explicitly	stated;	(d)	use	of	at	least	one	validated	and	standardised	outcome	
measure	of	either	core	features	of	ASDs,	i.e.	difficulties	in	social	interaction,	impaired	social	
communication	or	restricted	or	repetitive	patterns	of	behaviour	and	interests,	or	co-occurring	
symptoms	of	mental	disorder,	e.g.	anxiety,	depression,;	and	(e)	written	in	English.		
Studies	that	aimed	to	treat	affective	disorders	or	symptoms	of	ASDs	were	analysed	
separately	for	two	reasons:	(a)	the	“target”	of	the	intervention	was	separate	in	these	studies,	with	
one	group	focusing	on	trying	to	treat	symptoms	of	affective	disorders,	while	the	other	attempted	to	
reduce	difficulties	or	symptoms	associated	with	having	an	ASD,	and	(b)	CBT	for	either	incorporated	
psychoeducation,	skills	teaching,	skills	practice,	behavioural	experiments,	and	cognitive	
restructuring.		However,	the	description	of	the	interventions	across	studies	was	at	times	sparse,	and	
it	was	at	times	difficult	to	ascertain	the	degree	to	which	cognitive	restructuring	was	used	within	
some	of	the	interventions.		As	a	consequence,	it	was	clear	that	the	intervention	incorporated	both	
cognitive	and	behavioural	components	for	some	studies,	while	for	others,	this	was	less	clear,	
although	in	all	instances,	the	interventions	were	described	as	using	methods	drawn	from	cognitive	
behavioural	therapy.				However,	it	is	important	to	bear	in	mind	that	CBT	incorporates	both	cognitive	
and	behavioural	components,	although	for	some	disorders	there	is	a	clear	focus	on	behavioural	
interventions	(e.g.	exposure	and	response	prevention)	when	delivering	CBT.		As	mentioned	in	the	
paragraph	below,	we	excluded	any	studies	that	solely	made	use	of	behavioural	methods	alone.		
Studies	were	excluded	if	any	of	the	following	criteria	were	met:	(a)	the	methodology	used	
was	a	single	case,	case	series,	qualitative,	meta-analysis	or	review	articles;	(b)	the	design	of	the	study	
was	such	that	the	effect	of	the	CBT	intervention	could	not	be	isolated	from	other	treatment	
methods,	e.g.	psychotropic	medication;	(c),	the	primary	intervention	was	applied	behavioural	
analysis	or	behaviour	modification,	or	behavioural	activation	as	a	stand-alone	treatment;	and	(d)	the	
dataset	had	been	used	within	a	previously	included	study	to	avoid	double	counting	of	data	(Senn,	
2009).			No	limits	were	applied	to	the	date	of	publication,	age	of	participants	or	whether	the	study	
has	been	published	in	a	peer	review	journal.			
Studies	that	were	non-randomised	were	not	excluded.		While	this	represents	an	inherent	
weakness	by	increasing	the	risk	of	bias,	the	decision	was	made	to	include	non-randomised	studies	at	
this	stage	considering	the	likelihood	that	few	definitive	(Phase	III)	trials	within	this	area	have	been	
completed.			
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Following	the	removal	of	duplicate	studies,	the	systematic	search	of	the	electronic	
databases	returned	2332	potentially	eligible	studies.		Following	an	initial	screen	of	the	titles	and	
abstracts,	2263	were	excluded.			In	addition	to	the	remaining	69	studies,	a	further	102	were	
identified	using	the	ancestry	method,	and	two	were	located	from	searching	the	grey	literature.		The	
resulting	total	number	of	papers	retrieved	were	173,	six	of	which	were	protocols.	The	authors	of	
protocols	were	contacted	directly	to	try	to	source	outcome	data.;	two	of	these	research	groups	
provided	data,	while	the	remaining	four	did	not	respond	and	were	excluded.		A	further	107	papers	
were	excluded	because	they	did	not	include	a	comparison	or	control	group,	five	were	excluded	
because	they	had	made	use	of	a	pre-existing	dataset	that	had	been	previously	included,	four	were	
excluded	because	they	did	not	include	cognitive-behavioural	components	within	the	intervention,	
one	was	excluded	due	to	a	lack	of	validated	or	standardised	outcome	measures,	one	was	excluded	
because	the	effects	of	CBT	could	not	be	isolated	and	one	was	excluded	because	we	were	unable	to	
trace	the	paper.	
The	remaining	50	studies	met	the	eligibility	criteria,	although	two	studies	were	excluded	at	
this	stage	because	the	published	data	were	insufficient	and	we	could	not	calculate	effect	sizes;	the	
authors	did	not	respond	to	our	request	for	further	data	(DeRosier,	Swick,	Davis,	McMillen,	&	
Matthews,	2011;	Provencal,	2003).		Forty-eight	studies,	involving	2099	participants	(1081	CBT,	1018	
control)	were	therefore	included	in	the	quantitative	synthesis.	Figure	1	depicts	a	PRISMA	flow	
diagram	(Moher,	Liberati,	Tetzlaff,	&	Altman,	2009),	outlining	the	identification,	screening	and	
inclusion	or	exclusion	of	articles	throughout	the	process.	Reasons	for	article	rejection	are	clearly	
indicated.	The	eligibility	criteria	were	applied	by	two	authors	(LW	&	PL)	independently,	and	inter-
rater	reliability	was	excellent,	96.5%,	k	=	.92,	95%	CI	[.85,	.98].	
Insert	Figure	1	about	here.		
	 The	standardised	mean	difference	(SMD)	was	calculated	to	estimate	the	difference	between	
the	treatment	and	control	conditions.			Cohen’s	d	was	transformed	into	Hedge’s	g	(Hedges,	1981)	
using	correction	factor	J	to	correct	for	possible	positive	bias	due	to	small	sample	sizes.	The	
magnitude	of	Hedge’s	g	was	interpreted	using	Cohen’s	convention	as	small	(0.2),	medium	(0.5),	and	
large	(0.8).	The	variance	and	standard	error	of	g	for	each	study	was	calculated.		As	outcome	
measures	may	take	the	form	of	self-,	clinician-	or	informant-reports,	and	there	is	evidence	to	suggest	
that	people	with	ASD	may	have	difficulties	with	judging	their	own	social	or	communicative	
behaviour,	(Baron-Cohen,	Jolliffe,	Mortimore,	&	Robertson,	1997)	effect	sizes	were	calculated	
individually	for	each	type	of	outcome	measure	where	possible	(i.e.	outcome	measures	were	grouped	
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as	either	self-report,	informant-report,	clinician-report,	or	task-based,	where	participants	were	
invited	to	complete	a	task,	such	as	an	emotion	recognition	task	using	faces).			
	 The	analysis	was	undertaken	using	RevMan	Version	5.3.		A	random	effects	model	was	used	
for	the	following	reasons:	(a)	heterogeneity	was	anticipated	as	data	came	from	a	variety	of	sources	
and	we	could	not	assume	a	common	effect	size;	and	(b)	inferences	made	from	random	effects	
models	are	unconditional	and	can	be	applied	to	a	population	of	studies	larger	than	the	sample.		
	 Heterogeneity	was	thought	to	be	associated	with	whether	CBT	was	delivered	as	a	group	or	
individually,	the	age	range	of	participants,	and	symptom	severity.			This	was	explored	using	the	I2	
statistic,	which	describes	the	percentage	of	variation	across	studies	due	to	heterogeneity,	rather	
than	chance	(Higgins	&	Thompson,	2002).	The	I2	statistic	has	been	chosen	rather	than	Cochran’s	Q	
since	it	enables	quantification	of	the	effect	of	heterogeneity,	providing	a	measure	of	the	degree	of	
inconsistency	in	results	(Higgins	&	Thompson,	2002),	and	it	does	not	inherently	depend	on	the	
number	of	studies	included	in	the	meta-analysis	(Higgins,	Thompson,	Deeks,	&	Altman,	2003).	The	
degree	and	impact	of	heterogeneity	was	assessed	using	the	categorisation	of	low	(25%),	medium	
(50%)	and	high	(75%),	in	addition	to	a	quality	assessment	of	the	methodology	(Higgins	et	al.,	2003).		
A	sensitivity	analysis	was	also	undertaken.		Outliers	were	removed	and	the	weighted	mean	effect	
size	was	recalculated.		Publication	bias	was	assessed	graphically	using	funnel	plots,	plotting	summary	
effect	size	against	standard	error	(Light	&	Pillemer,	1984);	a	skewed	and	asymmetrical	plot	may	
indicate	a	publication	bias	(Iyengar	&	Greenhouse,	2009).		Fail-safe	N	(Rosenthal,	1991)	was	used	to	
assess	the	impact	of	bias	by	calculating	an	estimate	of	the	number	of	new	studies	averaging	a	null	
result	that	would	be	required	to	bring	the	overall	treatment	effect	to	non-significance.		A	figure	
exceeding	5n+	10	would	indicate	that	the	results	could	be	considered	robust	to	the	effects	of	
publication	bias	(Rosenthal,	1991).		
	 Quality	appraisal	of	included	studies	was	undertaken	by	two	authors	(LW	&	PL)	
independently	using	the	National	Institute	for	Health	and	Care	Excellence	Quality	Appraisal	Checklist	
for	Quantitative	Intervention	Studies	(National	Institute	for	Health	and	Care	Excellence,	2012b),	
bearing	in	mind	that	the	use	of	such	scales	has	been	criticised	in	the	Preferred	Reporting	Items	for	
Systematic	Reviews	and	Meta-Analyses	(PRISMA)	guidance	(Liberati	et	al.,	2009).	There	was	
‘moderate’	agreement	between	the	two	authors	for	internal	validity,	72.0%;	k	=	.48;	95%	CI	[.26,	
.71],	and	‘good’	agreement	for	external	validity,	84.0%;	k	=	.66;	95%	CI	[.45,	.86).		
Results		
Quality	Appraisal		
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The	key	characteristics	of	the	50	included	studies	are	found	in	Appendix	A,	while	the	
summary	quality	appraisal	ratings	for	each	study	are	found	in	Appendix	B.		A	persistent	problem	
across	all	studies	was	small	sample	size,	contributing	to	reduced	power.		Freitag	et	al.	(2015)	
included	the	highest	number	of	participants	(101	CBT,	108	control),	whilst	eight	of	the	studies	
included	in	the	quantitative	synthesis	involved	less	than	ten	participants	per	group.	Several	of	these	
studies	were	defined	by	the	authors	as	pilot	or	feasibility	trials.	However,	a	number	of	studies	that	
were	not	called	pilot	or	feasibility	trials,	were	in	fact	lower	in	quality	and	had	smaller	sample	sizes	
than	many	clearly	defined	pilot	or	feasibility	trials.		Quality	appraisal	and	risk	of	bias	were	therefore	
considered	on	a	study	by	study	basis	and	sensitivity	analysis	was	conducted	by	removing	studies	
deemed	to	be	at	high	risk	of	bias,	rather	than	those	labelled	as	pilot	or	feasibility	trials.	
Other	common	problems	included	the	lack	of	reporting	on	participant	engagement	within	
intervention	sessions,	poor	reporting	on	missing	data,	and	minimal	information	on	fidelity	checks.	
Very	few	studies	reported	adequate	allocation	concealment	and	ten	of	the	studies	included	in	meta-
analysis	were	non-randomised,	contributing	to	a	high	risk	of	allocation	bias.	Due	to	the	nature	of	the	
interventions	involved,	it	is	not	possible	for	investigators	to	blind	participants	(and	often	informants)	
to	intervention	allocation.	However,	blinding	of	outcome	assessors	was	possible	but	was	not	
conducted	in	the	majority	of	studies,	contributing	to	detection	bias.	
A	final	common	difficulty	across	studies	was	failure	to	specify	a	primary	outcome	measure.		
This	complicated	the	meta-analysis,	particularly	in	studies	where	a	high	number	of	outcome	
measures	were	utilised	or	different	measures	were	used	to	assess	a	range	of	constructs.	The	lack	of	
measures	validated	for	use	with	individuals	with	ASD	was	noted,	although	this	is	clearly	a	wider	issue	
that	needs	attention.		
Cognitive	Behavioural	Therapy	for	Affective	disorders.		Twenty-four	of	the	included	studies	
aimed	to	examine	the	effectiveness	of	CBT	for	affective	disorders,	with	the	bulk	attempting	to	treat	
anxiety	disorders,	with	others	targeting	depression	or	emotion	regulation	difficulties.		Seventeen	of	
these	studies	involved	children	and	adolescents,	whilst	four	included	adult	participants.	Three	
studies	included	both	adolescent	and	adult	participants	and	were	therefore	assigned	to	a	‘Mixed	
Age’	subgroup	for	analysis	(McGillivray	&	Evert,	2014;	Pahnke,	Lundgren,	Hursti,	&	Hirvikoski,	2014;	
Russell	et	al.,	2013).	Fifteen	of	the	24	studies	examined	group-based	CBT,	whilst	eight	reported	on	
individual	CBT.	The	remaining	study	involved	21	group	sessions,	as	well	as	three	individual	sessions	
(Langdon	et	al.,	2016;	Langdon	et	al.,	2013).		Since	this	study	was	predominantly	group-based,	the	
decision	was	made	to	include	it	in	the	‘group-based’	subgroup	when	analysing	mode	of	CBT	delivery.			
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The	majority	of	studies	targeted	anxiety	(15	of	the	24	studies).	As	this	was	such	a	large	
group,	a	subgroup	analysis	was	conducted	to	assess	potential	variations	of	treatment	effects	across	
age	groups	within	this	subset	of	studies.	This	included	studies	investigating	the	treatment	of	anxiety	
disorders	that	had	been	included	in	earlier	meta-analytic	work	(Sukhodolsky	et	al.,	2013;	Ung	et	al.,	
2015),	but	also	included	additional	studies;	two	studies	targeted	symptoms	of	obsessive	compulsive	
disorder	(Russell	et	al.,	2013;	Russell,	Mataix-Cols,	Anson,	&	Murphy,	2009)	were	also	included	
within	this	subset,	as	was	a	study	investigating	depression,	anxiety	and	rumination	(Spek,	van	Ham,	
&	Nyklíček,	2013)	and	a	study	investigating	depression,	anxiety	and	stress		(McGillivray	&	Evert,	
2014).	In	the	latter	two	studies,	only	outcomes	pertaining	specifically	to	anxiety	were	used	to	reduce	
heterogeneity	within	the	quantitative	synthesis	as	much	as	possible.	In	total,	19	studies	were	
included	within	the	anxiety	subset.	Of	the	remaining	five	studies,	one	targeted	anger	(Sofronoff,	
Attwood,	Hinton,	&	Levin,	2007),	one	targeted	general	emotional	regulation	skills	(Scarpa	&	Reyes,	
2011),	one	targeted	insomnia	(Cortesi,	Giannotti,	Sebastiani,	Panunzi,	&	Valente,	2012),	one	
targeted	self-esteem,	quality	of	life	and	sense	of	coherence	(Hesselmark,	Plenty,	&	Bejerot,	2014)	
and	one	targeted	stress	and	emotional	distress	(Pahnke	et	al.,	2014).	
Fourteen	studies	were	defined	as	randomised	controlled	trials,	seven	of	which	compared	a	
CBT	intervention	with	a	waitlist	control	group,	and	three	compared	CBT	to	treatment	as	usual.	Three	
randomised	controlled	trials	compared	CBT	to	a	non-CBT	group-based	treatment:	either	a	social	
recreational	program	(Hesselmark	et	al.,	2014;	Sung	et	al.,	2011)	or	an	anxiety	management	group	
(Russell	et	al.,	2013).	The	final	randomised	controlled	trial	(Cortesi	et	al.,	2012)	compared	a	CBT	
group	to	a	group	which	received	a	placebo	drug.	This	study	also	included	a	condition	in	which	
participants	received	melatonin	and	a	condition	in	which	participants	received	both	melatonin	and	
CBT.	Participants	from	these	intervention	arms	were	not	included	as	the	use	of	a	drug-based	
comparison	group	was	not	utilised	in	any	other	included	study.		
Three	of	the	24	studies	investigating	CBT	for	the	treatment	of	affective	disorders	were	quasi-
experimental	or	non-randomised	(Clarke,	2012;	McGillivray	&	Evert,	2014;	van	Steensel,	Dirksen,	&	
Bögels,	2014),	whilst	seven	were	called	pilot	studies.		Three	of	the	seven	pilot	studies	within	this	
group	were	randomised,	whilst	four	were	not,	and	six	compared	a	CBT	intervention	to	a	waitlist	
control	group,	whilst	one	compared	CBT	to	treatment	as	usual.	
	 As	anticipated,	there	was	extensive	variation	in	the	outcome	measures	used	across	studies.	
Many	studies	included	outcome	measures	from	various	sources,	with	the	most	common	report	type	
being	self-report	within	studies	targeting	co-occurring	symptoms	of	affective	disorder,	followed	
closely	by	informant-report	(usually	parent)	outcomes	and	clinician-rated	outcomes.	Only	one	study	
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within	this	group	used	a	task-based	outcome	measure	(Cortesi	et	al.,	2012).		There	was	also	
considerable	variation	in	the	intensity	and	content	of	intervention.	The	number	of	sessions	ranged	
from	four	to	50,	whilst	the	length	of	each	session	ranged	from	40	to	180	minutes.	The	majority	of	
studies	used	a	structured	protocol	(22	out	of	24),	with	21	of	the	studies	utilised	“traditional”	CBT	
methods,	with	common	components	including	role	play,	exposure	and	teaching/	rehearsal	of	
emotional	regulation	skills.	Common	adaptations	to	CBT	included	an	increased	emphasis	on	
behavioural	rather	than	cognitive	components,	the	use	of	social	stories	and	vignettes	and	increased	
involvement	of	family	members.	One	of	the	studies	(Hepburn,	Blakeley-Smith,	Wolff,	&	Reaven,	
2015)	piloted	a	videoconferencing	CBT	intervention	designed	for	delivery	in	a	small,	multi-family	
group	format,	whilst	another	study	(Spek	et	al.,	2013)	used	a	modified	version	of	Mindfulness	Based	
Therapy	with	cognitive	elements	omitted.	Another	used	a	modified	Acceptance	and	Commitment	
Therapy	protocol	and	participants	in	the	CBT	group	engaged	in	daily	mindfulness	exercises	in	
addition	to	structured	intervention	sessions.	
Cognitive	Behavioural	Therapy	for	ASD.			There	were	24	included	studies	that	examined	the	
effectiveness	of	CBT	for	symptoms	or	features	of	ASD.		One	study	investigated	both	the	effect	of	CBT	
on	social	skills	and	anxiety	(White	et	al.,	2013)	and	the	outcomes	pertaining	to	social	skills	were	
included	in	the	meta-analysis.		Another	intervention	study	focused	upon	both	social	communication	
and	anxiety,	but	the	findings	were	reported	in	two	separate	papers	(Fujii	et	al.,	2013;	Wood,	Fujii,	
Renno,	&	Van	Dyke,	2014);	the	decision	was	made	to	exclude	Fujii	et	al.	(2013)	as	inclusion	would	
have	led	to	the	double	counting	of	data.			Provencal	(2003)		and	DeRosier	et	al.	(2011)	were	excluded	
as	attempts	to	obtain	data	required	to	calculate	effect	sizes	were	unsuccessful.	
The	majority	of	studies	targeted	social	skills	(18	of	the	24	studies	included	in	quantitative	
synthesis),	while	of	the	remaining	six	studies,	four	targeted	Theory	of	Mind	(Begeer	et	al.,	2011;	
Begeer	et	al.,	2015;	Ozonoff	&	Miller,	1995;	Solomon,	Goodlin-Jones,	&	Anders,	2004),	one	targeted	
affectionate	communication	(Andrews,	Attwood,	&	Sofronoff,	2013)	and	one	targeted	the	
perception	of	facial	emotions	(Baghdadli	et	al.,	2013).	A	number	of	studies	targeted	both	social	skills	
and	aspects	of	social	cognition.	In	these	circumstances,	the	primary	outcome	measure	was	included,	
but	there	was	extensive	variation	in	outcome	measures	across	studies.		In	situations	in	which	the	
primary	outcome	measure	was	not	specified,	only	outcome	measures	pertaining	to	social	skills	were	
included	to	avoid	comparisons	of	different	constructs	across	report	types.		The	most	common	type	
of	outcome	measure	was	informant-report,	followed	by	self-report.		In	contrast	to	studies	
investigating	the	effectiveness	of	CBT	for	affective	disorders,	seven	studies	within	this	group	utilised	
a	task-based	measures,	for	example	Theory	of	Mind	tasks.		
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Fourteen	of	the	studies	were	randomised	controlled	trials,	one	of	which	is	the	only	Phase	III	
trial	in	this	area	to	date	(Freitag	et	al.,	2015).	This	study	compared	CBT	to	treatment	as	usual,	whilst	
thirteen	of	the	RCT’s	compared	a	CBT	intervention	with	a	waitlist	control	group.	The	final		RCT	
(Soorya	et	al.,	2015)	compared	CBT	to	a	facilitated	play	active	control	group.		Three	of	the	remaining	
ten	studies	were	quasi-experimental	or	non-randomised,	and	seven	were	labelled	pilot	studies.		
These	studies	were	included	in	initial	analysis	but	the	quasi-experimental	studies	involved	a	variety	
of	control	groups:	Ozonoff	&	Miller	(1995)	compared	CBT	to	no	treatment,	Laugeson	et	al.	(2012)	
used	a	waitlist	control	group	and	Laugeson	et	al.	(2014;	Laugeson	&	Park,	2014)	reported	the	use	of	
an	active	control	group	based	on	a	non-CBT	social	skills	curriculum	("Superskills",	Coucouvanis,	
2004).	Three	pilot	studies	used	a	waitlist	control	group,	two	compared	CBT	to	treatment	as	usual	
and	one	compared	CBT	to	“no	intervention”	(Koning,	Magill-Evans,	Volden,	&	Dick,	2013).	The	
remaining	study	reported	the	use	of	an	active	control	group	with	sessions	consisting	predominantly	
of	leisure	activities	(Baghdadli	et	al.,	2013).	Six	of	the	seven	pilot	studies	within	this	group	were	
randomised,	whilst	the	remaining	study	was	quasi-experimental	(Turner-Brown,	Perry,	Dichter,	
Bodfish,	&	Penn,	2008).	
There	was	considerable	variation	in	the	intensity	and	content	of	intervention.	The	number	of	
sessions	ranged	from	five	(Andrews	et	al.,	2013)	to	70,	with	Laugeson	et	al.	(2014)	reporting	on	an	
intervention	in	which	children	received	30	minute	sessions	five	days	per	week	over	a	period	of	14	
weeks.	The	length	of	each	session	ranged	from	30	minutes	to	whole	day	sessions.	The	majority	of	
studies	investigating	the	effectiveness	of	CBT	for	core	features	of	ASD	used	a	structured	protocol	(22	
out	of	24).		In	terms	of	treatment	content,	studies	within	this	group	less	commonly	reported	
“traditional”	CBT	methods.	Some	studies	did	not	directly	refer	to	cognitive	behavioural	therapy	per	
se,	but	they	explicitly	mentioned	the	inclusion	of	both	cognitive	and	behavioural	techniques	in	the	
intervention,	and	therefore	met	inclusion	criteria	for	the	current	study.	Content	commonly	included	
direct	social	skills	teaching	and	role	play,	emotional	identification	work	and	problem-solving	
exercises	or	discussions.	Common	adaptations	included	increased	use	of	social	stories	and	vignettes,	
increased	use	of	role	play	and	the	involvement	of	family	members	in	intervention	sessions	and	
homework	activities.	
Effectiveness	of	CBT	for	reducing	symptoms	of	affective	disorders	
Self-report	outcome	measures.		Seventeen	studies,	including	645	participants	(329	CBT,	316	
control),	included	self-reported	outcome	measures.	One	study	utilised	a	relevant	self-reported	
outcome	measure	but	it	was	not	possible	to	include	this	in	the	analysis	as	an	attempt	to	obtain	the	
data	necessary	to	calculate	the	effect	size	was	unsuccessful	(Storch	et	al.,	2013).	The	outcome	
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measures	used	varied	considerably	across	studies.		A	random-effects	meta-analysis	of	these	trials	
indicated	a	small	but	non-significant	effect	favouring	CBT	over	waiting-list,	treatment	as	usual	or	
active	control	as	reported	by	participants,	g	=	.24;	95%	CI	[-.05,	.53],	z	=	.11,	p	=	.11,	(Figure	2).	The	
analysis	revealed	a	significant	amount	of	heterogeneity,	with	I2	indicating	that	69%	of	the	variability	
in	estimated	treatment	effect	was	due	to	heterogeneity	rather	than	chance,	p	<	.001.	
	 As	one	study,	had	a	SMD	(g	=	2.64)	considerably	higher	than	the	other	included	studies,	g	
ranged	from	-.39	to	.85,	a	sensitivity	analysis	was	conducted	and	this	outlier	was	removed	(Chalfant,	
Rapee,	&	Carroll,	2007).	Exclusion	of	this	study	resulted	in	no	significant	treatment	effect,	g	=	.10;	
95%	CI	[-.06,	.27],	z	=	1.21,	p	=	.23,	and	I2	reduced	markedly	to	4%,	p	=	.41,	indicating	the	
considerable	impact	that	the	inclusion	of	this	study	had	on	the	pooled	SMD.		A	further	sensitivity	
analysis	to	remove	studies	deemed	to	be	at	a	high	risk	of	bias	(Clarke,	2012;	Hesselmark	et	al.,	2014;	
McGillivray	&	Evert,	2014;	Reaven	et	al.,	2009;	Russell	et	al.,	2009)	resulted	in	a	very	similar	effect,	g	
=	.09;	95%	CI	[-.12,	.30],	z	=	.84,	p	=	.40.	
Informant-report	outcome	measures.		Sixteen	studies,	including	620	participants	(325	CBT,	
295	control),	made	use	of	informant-reported	outcome	measures.	One	study	utilised	a	relevant	
informant-reported	outcome	measure	but	was	excluded	because	we	did	not	obtain	the	data	
necessary	to	calculate	the	effect	size	(Pahnke	et	al.,	2014).	The	outcome	measures	used	varied	
considerably	across	studies.	The	meta-analysis	of	these	trials	indicated	a	significant	medium	effect	
favouring	CBT	over	waiting-list,	treatment	as	usual	or	active	control	as	reported	by	informants,	g	=	
.66;	95%	CI	[.29,	1.03],	z	=	3.49,	p	<	.001,	(Figure	3).	The	analysis	indicated	a	significant	amount	of	
heterogeneity,	with	I2	indicating	that	78%	of	the	variability	in	estimated	treatment	effect	was	due	to	
heterogeneity	rather	than	chance,	p	<	.001.	
	 Again,	Chalfant	et	al.	(2007)	had	a	SMD,	g	=	4.27,	considerably	higher	than	the	other	
included	studies,	g	ranged	from	-.39	to	1.21,	and	a	sensitivity	analysis	was	therefore	conducted	to	
remove	this	outlier.	Exclusion	of	this	study	resulted	in	a	lower	treatment	effect,	g	=	.47;	95%	CI	[.25,	
.69],	z	=	4.17,	p	<	.001,	although	it	remained	statistically	significant.	I2	reduced	to	38%,	p	=	.07,	again	
indicating	the	impact	that	the	inclusion	of	this	study	had	on	the	pooled	SMD.	A	further	sensitivity	
analysis	to	remove	studies	deemed	to	be	at	a	high	risk	of	bias	(Clarke,	2012;	Hepburn	et	al.,	2015;	
Reaven	et	al.,	2009;	Scarpa	&	Reyes,	2011)	resulted	in	a	very	similar	effect,	g	=	.45;	95%	CI,	.18	to	
.72,	z	=	3.24,	p	=	.001.	
	 Clinician-rated	outcome	measures.		Thirteen	studies,	including	514	participants	(262	CBT,	
252	control),	made	use	of	clinician-rated	outcome	measures,	but	there	was	substantial	variation	in	
the	type	of	choice	of	measure.	Two	of	these	studies	presented	dichotomous	data	(Chalfant	et	al.,	
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2007;	van	Steensel	et	al.,	2014).	In	order	to	include	these	studies	in	a	random-effects	meta-analysis,	
the	odds	ratio	was	calculated	and	re-expressed	as	a	SMD	(Chinn,	2000).		A	random-effects	meta-
analysis	using	the	Generic	Inverse	Variance	method	was	conducted	as	estimates	of	effect	were	
calculated	for	the	two	aforementioned	studies.	The	analysis	indicated	a	significant	medium	effect	
favouring	CBT	over	waiting-list,	treatment	as	usual	or	active	control	as	rated	by	clinicians,	g	=	.73;	
95%	CI	[.38,	1.08],	z	=	4.05,	p	<	.001,	(Figure	4).	The	analysis	again	indicated	a	significant	amount	of	
heterogeneity,	with	I2	indicating	that	69%	of	the	variability	in	estimated	treatment	effect	was	due	to	
heterogeneity	rather	than	chance,	p	<	.001.	
	 Two	studies	(Chalfant	et	al.,	2007;	Wood	et	al.,	2009)	had	a	SMD,	g	=	2.51	and	g	=	2.47	
respectively,	considerably	higher	than	the	other	included	studies,	g	ranged	from	-.31	to	1.38,	and	a	
sensitivity	analysis	was	conducted	to	remove	these	outliers.	Exclusion	of	these	studies	resulted	in	a	
lower	treatment	effect,	g	=	.52;	95%	CI	[.27,	.77],	z	=	4.06,	p	<	.001,	although	it	remained	statistically	
significant.	I2	reduced	to	36%,	p	=	.11,	again	indicating	the	impact	that	the	inclusion	of	these	studies	
had	on	the	pooled	SMD.	A	further	sensitivity	analysis	to	remove	studies	deemed	to	be	at	a	high	risk	
of	bias	(Russell	et	al.,	2009;	van	Steensel	et	al.,	2014)	resulted	in	a	very	similar	effect,	g	=	.59;	95%	CI	
[.33,	.85],	z	=	4.48,	p	=	<.001.	
Task-based	outcome	measures.		As	only	one	study	made	use	of	this	type	of	outcome	
measure,	if	was	not	possible	to	calculate	the	pooled	SMD.		
Effectiveness	of	CBT	for	symptoms	associated	with	autism	
Self-report	outcome	measures.		Nine	studies	(370	participants;	192	CBT,	178	control),	
investigated	the	effectiveness	of	CBT	in	treating	symptoms	associated	with	ASD	and	included	
appropriate	self-reported	outcome	measures.	As	indicated	in	Figure	5,	a	random-effects	meta-
analysis	of	these	trials	indicated	a	small,	but	non-significant	effect	favouring	CBT	over	waiting-list,	
treatment	as	usual	or	active	control,	as	reported	by	participants,	g	=	.25;	95%	CI,	[-.03,	.53],	z	=	1.77,	
p	=	.08.	Heterogeneity	was	not	significant,	although	I2	indicated	that	40%	of	the	variability	in	
estimated	treatment	effect	was	due	to	heterogeneity	rather	than	chance,	p	=	.10.	A	sensitivity	
analysis	to	remove	studies	deemed	to	be	at	a	high	risk	of	bias	(Gantman,	Kapp,	Orenski,	&	Laugeson,	
2012;	Laugeson	et	al.,	2012;	Turner-Brown	et	al.,	2008)	resulted	in	no	significant	treatment	effect,	g	
=	.10;	95%	CI	[-.24,	.45],	z	=	0.58,	p	=	.56.		
Informant-report	outcome	measures.		Eighteen	studies	(950	participants;	480	CBT,	470	
control)	were	included	in	this	analysis	revealing	a	significant	small	effect	favouring	CBT	over	waiting-
list,	treatment	as	usual	or	active	control	as	reported	by	informants,	g	=	.48;	95%	CI	[.30,	.65],	z	=	
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5.39,	p	<	.001.	Heterogeneity	was	not	significant,	although	I2	indicated	that	36%	of	the	variability	in	
estimated	treatment	effect	was	due	to	heterogeneity	rather	than	chance,	p	=	.06.		A	sensitivity	
analysis	to	remove	studies	deemed	to	be	at	a	high	risk	of	bias	(Gantman	et	al.,	2012;	Ichikawa	et	al.,	
2013;	Koning	et	al.,	2013;	Laugeson	et	al.,	2012)	resulted	in	a	slightly	larger	medium	treatment	
effect,	g	=	0.52;	95%	CI	[0.34,	0.70],	z	=	5.63,	p	<	.001,	with	a	small	reduction	in	heterogeneity,	I2	=	
33%,	p	=	.12.	
Clinician-rated	outcome	measures.		Six	studies,	including	153	participants	(79	CBT,	74	
control)	were	included.	One	of	these	studies	presented	the	outcome	as	dichotomous	data,	and	
therefore	the	odds	ratio	was	calculated	and	expressed	as	a	SMD	(Koenig	et	al.,	2010);	the	generic	
inverse	variance	method	the	estimate	of	effect	was	calculated.			The	analysis	indicated	a	significant	
“medium”	effect	favouring	CBT	over	waiting-list,	treatment	as	usual	or	active	control	as	rated	by	
clinicians,	g	=	.65;	95%	CI	[.10,	1.21],	z	=	2.30,	p	=	.02),	(Figure	7).	Heterogeneity	was	non-significant,	
although	I2	indicated	that	47%	of	the	variability	in	estimated	treatment	effect	was	due	to	
heterogeneity	rather	than	chance,	p	=	.10.	
One	study	had	a	SMD,	g	=	2.43	(Koenig	et	al.,	2010),	considerably	higher	than	the	other	
included	studies,	g	ranged	from	.08	to	1.51.		Removing	this	outlier	resulted	in	a	lower	treatment	
effect,	g	=	0.47;	95%	CI	[0.09,	0.85],	z	=	2.40,	p	=	.02,	although	it	remained	statistically	significant.	I2	
reduced	to	1%,	p	=	.40,	indicating	the	considerable	impact	that	the	inclusion	of	this	study	had	on	the	
pooled	SMD.	A	further	sensitivity	analysis	to	remove	studies	deemed	to	be	at	a	high	risk	of	bias	
(Ichikawa	et	al.,	2013;	Turner-Brown	et	al.,	2008;	Wood	et	al.,	2014)	resulted	in	a	very	similar	but	
lower	and	non-significant	treatment	effect,	g	=	0.44;	95%	CI	[-.01,	.89],	z	=	1.90,	p	=	.06).		It	is	highly	
likely	that	this	is	related	to	the	fact	that	the	exclusion	of	the	above	studies	left	only	two	studies	in	
the	analysis,	and	as	such,	this	analysis	should	be	interpreted	with	marked	caution.	
Task-based	outcome	measures.		Seven	studies,	incorporating	237	participants	(117	CBT,	120	
control),	were	included	in	this	analysis,	which	revealed	a	significant	small	effect	in	favour	of	CBT	over	
waiting-list,	treatment	as	usual	or	active	control	on	task-based	measures,	g	=	0.35;	95%	CI	[0.09,	
0.61],	z	=	2.67,	p	=	.008.	Heterogeneity	was	not	an	issue,	I2	=	0%,	p	=	.58.			Removing	studies	deemed	
to	be	at	a	high	risk	of	bias	(Baghdadli	et	al.,	2013;	Koning	et	al.,	2013;	Ozonoff	&	Miller,	1995;	
Solomon	et	al.,	2004)	resulted	in	a	very	similar	non-significant	effect	size,	g	=	0.30;	95%	CI	[-.12,	.72],	
z	=	1.42,	p	=	.16).		Again,	it	is	highly	likely	that	this	is	related	to	the	fact	that	the	exclusion	of	the	
above	studies	left	only	three	studies	in	the	analysis	should	therefore	be	interpreted	with	marked	
caution.	
The	effectiveness	of	CBT	across	differing	age	groups	
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Further	subgroup	analysis	using	self-report	outcome	measures	was	not	completed	because	
our	initial	analysis	indicated	that	CBT	was	not	superior	to	control	conditions	when	used	to	treat	
either	affective	disorders	of	symptoms	associated	with	autism.			While	there	were	16	studies	that	
made	use	of	informant-report	outcome	measures	when	treating	affective	disorders,	none	of	these	
included	adult	participants,	and	only	one	study	looking	at	the	treatment	of	symptoms	related	to	
autism	included	adult	participants.		As	such,	a	subgroup	analysis	based	on	informant-report	outcome	
measures	was	not	completed.		
Subgroup	analysis	using	clinician-rated	outcome	measures	across	different	age	groups	was	
possible,	but	only	for	studies	that	aimed	to	treat	affective	disorders.		There	was	substantial	
variability	that	appeared	due	to	genuine	subgroup	differences,	rather	than	sampling	error,	I2	=	
80.2%,	p	=	.006,	and	a	large	combined	effect	size	in	favour	of	CBT	for	studies	involving	children	and	
adolescents,	g	=	.95;	95%	CI	[.55,	1.35],	z	=	4.64,	p	<	.001,	but	not	for	studies	involving	adults,	g	=	-
.04;	95%	CI	[-.50,	.43],	z	=	0.15,	p	=	.88.			Exclusion	of	two	outliers	(Chalfant	et	al.,	2007;	Wood	et	al.,	
2009)	from	the	studies	involving	children	and	adolescents	resulted	in	a	lower	but	significant	effect	
size,	g	=	.67;	95%	CI	[.42,	.91],	z	=	5.28,	p	<	.001.		The	comparison	between	studies	involving	children,	
adolescents	and	adults	is	inherently	problematic	and	should	be	interpreted	cautiously	because	only	
two	studies	involving	adults	were	included	(Figure	9).			
Publication	Bias	
	 Visual	inspection	of	Funnel	plots	did	not	reveal	significant	asymmetry	for	self-reported	
outcome	measures	used	within	studies	that	aimed	to	treat	affective	disorders.		Fail-safe	N	was	not	
calculated	because	CBT	was	not	superior	to	control	conditions.			A	similar	analysis	could	not	be	
completed	for	studies	that	focused	on	symptoms	related	to	autism	because	there	were	less	than	
ten.				
Turning	to	informant-based	outcome	measures,	used	for	both	studies	that	focused	on	
affective	disorders	and	symptoms	associated	with	autism,	no	significant	asymmetry	was	found.			For	
studies	involving	affective	disorders,	281	new	studies	averaging	a	null	result	would	be	required	to	
bring	the	overall	treatment	effect	to	non-significance.			For	studies	targeting	symptoms	related	to	
autism,	287	new	studies	averaging	a	null	result	would	be	needed	to	again	bring	the	overall	
treatment	effect	to	non-significance.		These	figures	exceed	5n	+	10,	and	the	conclusion	that	these	
findings	are	robust	to	publication	bias	is	valid.			
Considering	clinician-rated	outcome	measures,	there	was	no	significant	asymmetry	for	
studies	that	treated	affective	disorders,	while	a	Funnel	plot	was	not	created	for	studies	that	treated	
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symptoms	of	autism	because	there	were	fewer	than	ten.		Fail-safe	N	revealed	that	227	new	studies	
averaging	a	null	result	would	be	needed	to	bring	the	treatment	effect	to	non-significance	calculated	
using	clinician-rated	outcome	measures	taken	from	studies	that	treated	affective	disorders.		The	
effect	calculated	using	clinician-rated	outcome	measures	taken	from	studies	treating	symptoms	
associated	with	autism	would	become	non-significant	if	only	18	papers	averaging	a	null	effect	were	
published	suggesting	that	this	finding	may	be	subject	to	publication	bias	and	influenced	by	the	fewer	
papers	in	this	area.			
Whilst	it	was	not	possible	to	examine	task-based	outcome	measures	for	studies	that	treated	
mental	disorder,	for	studies	that	focused	on	symptoms	related	to	autism,	because	the	number	of	
papers	was	less	than	ten,	a	Funnel	plot	could	not	be	created.		However,	Fail-safe	N	revealed	that	
only	5	new	studies	averaging	a	null	effect	size	would	bring	the	overall	treatment	effect	to	non-
significance.			This	means	that	publication	bias	may	feature,	and	the	conclusions	are	heavily	
influenced	by	there	being	relatively	few	papers.			
Discussion	
The	results	of	the	meta-analysis	indicated	that	cognitive	behavioural	therapy	(CBT)	is	
associated	with	a	small	to	medium	effect	size	when	used	to	treat	co-morbid	affective	disorders	with	
children,	adolescents,	or	adults	who	have	ASDs,	but	this	varied	according	to	whether	the	outcome	
data	was	taken	from	self-report,	informant-report,	clinician-report,	or	task-based	measures.			CBT	
was	associated	with	a	small	and	non-significant	effect	size,	g	=	.24,	when	the	analysis	was	completed	
using	self-report	measures,	and	associated	with	significant	heterogeneity;	when	studies	at	risk	of	
bias	were	excluded,	resulting	in	low	heterogeneity,	treatment	was	associated	with	a	small	non-
significant	effect	size,	g	=	.09.			CBT	was	superior	to	control	conditions	when	the	analysis	was	
completed	with	either	informant-	and	clinician-report	measures,	both	being	associated	with	a	
medium	effect	size,	but	there	was	significant	heterogeneity;	a	sensitivity	analyses	reduced	
heterogeneity,	and	revealed	that	CBT	remained	superior,	and	was	associated	with	a	medium	effect	
size	of,	g	=	.45,	and,	g	=	.59,	respectively.		
Turning	to	consider	CBT	for	symptoms	associated	with	ASDs,	the	findings	from	the	meta-
analysis	were	very	similar	to	that	found	for	CBT	when	used	to	treat	co-morbid	affective	disorders.		
CBT,	when	used	as	a	treatment	for	the	symptoms	of	ASDs,	rather	than	affective	disorders,	was	
associated	with	an	effect	size	that	ranged	from	small	to	medium,	again,	dependent	upon	the	type	of	
outcome	measure	used.			Using	data	from	self-report	measures,	CBT	was	associated	with	a	small	
non-significant	effect	size,	g	=	.25,	and	while	heterogeneity	was	not	significant,	excluding	studies	at	
risk	of	bias	to	reduce	heterogeneity	reduced	the	effect	size;	it	remained	small	and	non-significant,	g	
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=	.1.		There	was	evidence	that	CBT	was	significantly	beneficial	when	the	analysis	was	based	on	
informant-report	measures,	and	resulted	in	a	small	effect	size,	g	=	.48,	which	increased	to	medium	
following	our	sensitivity	analysis	to	account	for	heterogeneity,	g	=	.52.			Considering	clinician-report	
measures,	CBT	was	found	to	be	significantly	superior,	and	associated	with	a	medium	effect	size,	g	=	
.65.		Following	the	exclusion	of	studies	thought	to	be	at	risk	of	bias	to	reduce	heterogeneity,	CBT	
was	no	longer	superior,	and	associated	with	a	non-significant	medium	effect	size,	g	=	.44.			Task-
based	measures,	which	are	both	less	subjective	and	completed	by	the	participant,	were	also	
evaluated	to	determine	whether	CBT	is	an	effective	treatment	for	symptoms	of	ASDs.			The	initial	
findings	were	significantly	in	favour	of	CBT	as	an	effective	treatment,	and	associated	with	a	small	
effect	size,	g	=	.35,	but	the	exclusion	of	studies	thought	to	be	at	higher	risk	of	bias,	led	to	a	non-
significant	treatment	effect,	falling	in	the	small	range,	g	=	.3.		
	 Sub-group	analysis	based	on	the	age	of	the	participants	was	not	completed	for	self-report	
measures	as	there	was	no	evidence	that	CBT	was	superior	to	control	conditions,	nor	was	this	
possible	for	informant-based	measures,	as	few	studies	involving	adults	also	included	an	informant-
based	measure.			It	was	only	possible	to	undertake	a	sub-group	analysis	for	the	treatment	of	
affective	disorders	based	on	clinician-report	measures,	and	the	findings	indicated	that	CBT	was	
superior	and	associated	with	a	large	effect	size,	g	=	.95,	when	used	with	children	and	adolescents,	
while	following	our	sensitivity	analysis,	this	reduced	to	a	medium	effect	size,	g	=	.67.			These	effect	
sizes	are	lower	than	that	previously	reported	by	Sukhodolsky	et	al.	(2013)	and	Kreslins	et	al.	(2015),	
with	both	previous	meta-analyses	having	included	fewer	studies.		Turning	to	consider	adults,	the	
results	indicated	that	CBT	was	not	superior	to	control	conditions,	and	was	associated	with	a	small	
effect	size,	g	=	.04;	interpreting	this	result	is	problematic	because	it	is	only	based	on	two	published	
studies.		
	 Within	the	current	meta-analysis,	and	those	completed	previously	which	focused	on	the	
treatment	of	anxiety	amongst	children	and	adolescents	(Kreslins	et	al.,	2015;	Sukhodolsky	et	al.,	
2013;	Ung	et	al.,	2015),	there	are	substantial	differences	in	treatment	efficacy	dependent	upon	the	
type	of	outcome	measure	included	within	the	analysis.			Self-report	measures,	in	contrast	to	
informant-	and	clinician-report	measures,	are	not	reliably	associated	with	significant	change	
following	treatment.			Within	the	current	meta-analysis,	this	was	the	case	for	studies	involving	
children,	adolescents	or	adults	who	received	treatment	for	affective	disorders	more	broadly.		This	
was	also	the	case	for	studies	where	CBT	was	used	to	treat	the	symptoms	of	ASDs.		As	discussed	
previously	by	both	Sukhodolsky	et	al.	(2013)	and	Kreslins	et	al.	(2015)	it	may	be	the	case	that	
individuals	with	ASDs	have	difficulties	with	reporting	symptoms	because	of	associated	
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developmental	challenges	(e.g.	communication	problems)	faced	by	this	population	leading	to	
difficulties	with	reliably	reporting	symptoms.		Interestingly,	Kreslins	et	al.	(2015)	suggested	that	
children	with	ASDs	may	confuse	symptoms	of	anxiety	and	ASDs,	which	may	lead	to	difficulties	with	
completing	self-report	measures	of	anxiety.				However,	it	is	apparent	that	adults	with	ASDs	also	
have	these	difficulties,	as	while	there	are	few	trials	involving	adults,	those	that	have	been	completed	
had	similar	difficulties	with	the	use	of	self-report	measures.			Alongside	this,	trials	of	CBT	used	to	
treat	symptoms	of	ASDs,	rather	than	affective	disorders,	have	also	encountered	similar	difficulties	
with	self-report	measures.			It	is	perhaps	probable	that	individuals	with	ASDs	may	find	self-report	
measures	difficult	because	of	their	associated	developmental	problems	(e.g.	perspective-taking,	
communication	problems)	and	further	work	regarding	the	development	of	valid	and	reliable	
measures	for	use	with	this	population	is	needed.			However,	it	must	also	be	mentioned	that	perhaps	
CBT	does	not	bring	about	change	for	individuals	with	ASD,	and	the	results	using	both	informant-	and	
clinician-report	measures	have	been	subjected	to	an	observer-expectancy	effect,	considering	that	is	
very	difficult	to	mask	informants,	and	not	all	studies	made	use	of	masked	assessors,	introducing	
significant	bias.			While	this	may	not	explain	all	the	variability	within	the	data,	it	has	a	role	to	play,	
and	as	such,	it	is	vitally	important	that	future	trials	ensure	that	they	make	use	of	masked	assessors	
and	have	satisfactory	arrangements	for	independent	data	management.				
	 Related	to	these	difficulties,	there	were	a	variety	of	issues	associated	with	the	included	
studies,	highlighted	by	the	quality	appraisal,	which	need	to	be	considered	further.		First,	the	majority	
of	the	studies	included	involved	small	samples,	and	trials	labelled	as	feasibility	or	pilot	trials	often	
had	larger	sample	sizes	than	studies	that	were	not	identified	as	either	a	feasibility	or	pilot	trial.		Eight	
of	the	studies	included	in	this	meta-analysis	had	less	than	ten	participants	per	group.		This	is	
problematic,	as	there	are	no	large	scale	definitive	trials	in	this	area	making	use	of	robust	
methodologies.			As	such,	the	conclusions	reached	within	this	meta-analysis,	and	previous	meta-
analyses	are	potentially	limited.		This	does	not	mean	that	the	conclusions	are	entirely	invalid,	but	it	
does	allow	some	questions	to	be	raised	about	validity,	which	could	be	addressed	in	the	future	with	
the	completion	of	several	large	scale	definitive	trials	by	different	research	groups	around	the	world.		
Related	to	these	issues,	the	study	by	Chalfant	et	al.	(2007)	tended	to	have	a	relatively	higher	
standardised	mean	difference.		While	this	was	a	randomised	trial,	the	accessors	were	not	masked,	
and	in	fact	were	the	actual	therapists	who	carried	out	the	intervention.			Considering	the	lack	of	
blinding	and	independent	data	management	within	this	study,	there	is	an	inherent	increased	risk	of	
bias.		Several	other	studies	included	within	this	meta-analysis	also	had	a	relatively	higher	
standardised	mean	difference	(e.g.	Wood	et	al.,	2009),	and	the	majority	of	them	did	not	make	use	of	
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independent	data	management	and	analysis,	something	we	would	strongly	recommend	for	future	
trials	in	this	area.			
	 Second,	studies	often	did	not	report	sufficient	information	regarding	participant	
engagement	and	fidelity,	while	third,	there	were	issues	with	adequate	allocation	concealment	that	
must	be	addressed	within	future	studies.		Fourth,	it	is	important	to	note	that	ten	studies	were	not	
randomised,	and	few	reported	that	data	were	managed	and	analysed	independently.		Fifth,	and	
again	looking	forward	to	the	future,	researchers	in	this	area	need	to	specify	a	primary	outcome	
measure	within	their	trials,	and	further	work	to	develop	valid	and	reliable	measures	of	outcome	for	
use	with	participants	who	have	ASDs	is	needed.			Sixth,	it	would	be	advantageous	for	researchers	to	
describe	their	interventions	more	thoroughly	or	ensure	that	they	are	available	for	scrutiny,	perhaps	
within	public	databases.		Finally,	it	is	recommended	that	future	trials	make	use	of	and	adhere	to	the	
CONSORT	recommendations	for	reporting	randomised	control	trials	to	help	increase	the	quality	of	
the	evidence	that	is	available.		
	 There	are	a	number	of	strengths	associated	with	the	current	meta-analysis.		Considering	
strengths,	within	the	current	meta-analysis,	we	attempted	to	include	studies	that	aimed	to	treat	
affective	disorders	more	broadly,	rather	than	just	anxiety,	and	included	studies	that	were	designed	
to	evaluate	CBT	as	a	treatment	for	the	actual	symptoms	or	core	features	of	ASDs.		As	such,	our	work	
is	comprehensive,	capturing	studies	that	have	attempted	to	make	use	of	CBT	with	individuals	with	
ASDs	for	a	variety	of	problems	and	this	is	a	marked	strength	over	and	above	previously	completed	
meta-analytic	work.			Alongside	this,	we	have	included	studies	with	samples	of	children,	adolescents,	
and	adults,	or	mixed	samples,	while	at	the	same	time,	undertaking	a	subgroup	analysis	to	compare	
differences	between	children/adolescents	and	adults,	considering	the	developmental	differences	
between	these	populations	which	may	have	an	impact	upon	the	process	of	engaging	in	and	
completing	therapy.		We	have	also	made	use	of	an	appropriate	analytic	strategy,	and	made	use	of	
independent	reviewers	for	both	screening	and	the	quality	appraisal.			As	such,	the	current	meta-
analysis	is	the	most	comprehensive	to	date,	covering	CBT	used	to	treat	either	affective	disorders	or	
symptoms	of	autism.			
Turning	to	consider	weaknesses,	there	are	a	variety	of	problems	with	many	of	the	included	
studies	which	have	been	mentioned	in	the	preceding	paragraph,	and	these	problems	need	to	be	
considered	when	interpreting	the	results	of	this	meta-analysis.				While	this	does	not	necessarily	
invalidate	our	conclusions,	it	must	be	considered	when	interpreting	the	findings	and	considering	
future	research.		
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We	would	suggest	that	future	studies	in	this	area	adhere	to	following	recommendations,	(a)	
small-scale	studies	should	be	clearly	described	as	feasibility	or	pilot	trials,	(b)	methods	and	
interventions	should	be	described	fully,	in	line	with	CONSORT	recommendations.	Standardised	
reporting	and	a	more	uniform	approach	to	study	design	would	help	to	minimise	heterogeneity	
across	studies,	(c)	appropriate	allocation	concealment,	randomisation,	blinding	procedures	and	
independent	data	management	should	be	considered	a	priority	and	should	be	described	fully,	(d)	
where	possible,	consistent	usage	of	pre-existing	outcome	measures	across	studies	would	be	
beneficial	in	order	to	increase	comparability	across	trials,	(e)	researchers	should	specify	a	primary	
outcome	measure	a	priori,	and	(f)	participant	engagement	and	fidelity	should	be	clearly	reported.		
Looking	forward	to	the	future,	considering	the	marked	number	of	small	trials,	well-designed	
definitive	trials	from	different	research	groups	around	the	world	are	needed	in	order	to	
demonstrate	that	CBT	is	an	empirically	validated	treatment	use	with	people	who	have	ASDs.	To	
date,	there	has	only	been	a	single	definitive	trial	within	this	area	(Freitag	et	al.,	2015).		
Bearing	the	aforementioned	recommendations	for	future	studies	in	mind,	and	considering	
the	conclusions	from	both	the	current	and	previous	meta-analyses,	CBT	is	at	least	associated	with	a	
small	non-significant	effect	size,	and	at	best,	associated	with	a	medium	effect	size,	depending	on	
whether	you	ask	those	receiving	the	treatment,	those	supporting	the	treatment,	or	those	delivering	
the	treatment.		There	are	three	further	comments	we	would	like	to	add	to	help	in	the	design	of	
future	studies,	including	the	interventions.		First,	there	have	been	a	variety	of	modelling	and	pilot	
studies	across	different	countries,	but	very	few	researchers	have	developed	interventions	within	the	
spirit	of	co-production	with	people	with	autism	and	their	families.		Co-production	means	working	
together	with	those	who	will	receive	the	intervention	when	developing	and	running	a	clinical	trial	to	
ensure	that	those	who	are	likely	to	receive	the	intervention	have	also	genuinely	helped	design	the	
intervention.		While	some	studies	employed	this,	if	used	more	commonly,	such	a	strategy	would	
lead	to	improved	engagement	and	outcomes,	especially	from	the	point	of	view	of	children	and	
adults	with	autism.			
Second,	many	of	the	reviewed	studies	focused	on	delivering	group-based	interventions	for	a	
variety	of	different	problems.			While	delivering	interventions	in	a	group	may	be	more	cost	effective,	
this	may	not	be	associated	with	greater	effectiveness.		The	reason	for	this	is	that	co-morbidity	is	high	
amongst	people	with	autism,	and	within	a	group	there	may	be	participants	who	have	obsessive-
compulsive	disorder,	social	phobia,	generalised	anxiety	disorder,	depression,	or	many	other	
psychiatric	problems,	in	addition	to	the	difficulties	associated	with	autism	itself.				While	there	are	
marked	similarities,	cognitive	behavioural	therapy	for	depression	is	different	than	cognitive	
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behavioural	therapy	for	obsessive	compulsive	disorder,	and	delivering	interventions	within	a	group	
may	have	prevented	therapists	form	being	able	to	tailor	the	intervention	to	address	the	needs	of	
each	individual	within	the	group	adequately.			Related	to	this,	there	are	some	individuals	with	ASDs	
who	may	be	unable	or	unwilling	to	access	group-based	interventions.		As	such,	we	recommend	that	
researchers	begin	to	focus	more	heavily	on	formulation-driven	and	trans-diagnostic	interventions	
delivered	with	individuals,	rather	than	within	a	group,	bearing	in	mind	that	there	is	evidence	that	
individually	delivered	CBT	is	associated	with	stronger	effect	sizes	than	group-based	CBT	for	people	
with	intellectual	disabilities,	another	group	which	tends	to	have	marked	co-morbidity	(Vereenooghe	
&	Langdon,	2013).		
Finally,	there	has	been	little	attention	paid	to	the	accreditation	of	cognitive	behavioural	
therapists	within	the	literature.		While	behavioural	therapists	are	certified	through	the	Behaviour	
Analyst	Certification	Board®,	those	offering	cognitive	behavioural	therapy	are	not	certified	in	a	
similar	manner	in	many	jurisdictions.		In	some	countries,	such	as	the	United	Kingdom,	there	are	
organisations	which	accredit	cognitive	behaviour	therapists,	namely	the	British	Association	for	
Behavioural	and	Cognitive	Psychotherapies	(BABCP),	but	this	does	not	mean	that	therapists	have	
appropriate	clinical	expertise	and	experience	of	working	with	people	who	have	ASDs	in	order	to	
ensure	that	they	are	able	to	adapt	therapy.		Related	to	this,	while	CBT	should	be	adapted	to	meet	
the	needs	of	those	with	ASDs,	we	still	know	relatively	little	about	the	effectiveness	of	many	of	these	
adaptations,	as	they	have	not	been	investigated	using	experimental	designs	to	determine	whether	
they	lead	to	substantial	improvements	in	treatment	engagement	and	outcome.			While	future	
definitive	trials	are	certainly	needed	within	this	area,	alongside	this,	we	also	need	greater	
experimental	work	examining	the	effectiveness	of	various	adaptations	to	CBT	for	use	with	people	
who	have	ASDs.		
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Appendix B- Output summaries from initial database search 
1) PsycINFO 
 
 
Tuesday, December 09, 2014 8:53:10 AM 
# Query Limiters/Expanders Last Run Via Results 
S16 S15 NOT S6 
Limiters - English; 
Population 
Group: Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
1,443 
S15 S14 NOT S5 
Limiters - English; 
Population 
Group: Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
1,627 
S14 S13 NOT S4 
Limiters - English; 
Population 
Group: Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
1,633 
S13 S12 NOT S3 
Limiters - English; 
Population 
Group: Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
2,522 
S12 S11 NOT S2 
Limiters - English; 
Population 
Group: Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
2,768 
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Database - PsycINFO 
S11 S10 NOT S1 
Limiters - English; 
Population 
Group: Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
3,667 
S10 S9 
Limiters - English; 
Population 
Group: Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
4,089 
S9 S7 AND S8 Search modes - Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
5,025 
S8 
"cognitive 
behavio* therapy" 
OR "cognitive 
behavio* 
treatment" OR 
"cognitive 
behavio* 
intervention" OR 
"cognitive 
therapy" OR 
"cognitive 
treatment" OR 
"cognitive 
intervention" OR 
"behavio* 
therapy" OR 
"behavio* 
treatment" OR 
"behavio* 
intervention" OR 
"CBT" OR 
"psychotherap*" 
OR "problem 
solving" 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
302,494 
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S7 
"autism spectrum 
disorder" OR 
"ASD" OR 
"autis*" OR 
"asperger*" OR 
"kanner*" OR 
"pervasive 
developmental 
disorder" 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
51,537 
S6 ADHD 
Limiters - English 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
17,629 
S5 epilepsy 
Limiters - English 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
25,685 
S4 
education OR 
classroom* OR 
school* 
Limiters - English 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
1,082,816 
S3 applied behavio* analysis OR ABA 
Limiters - English 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
5,039 
S2 gene* 
Limiters - English 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - 
Advanced Search 
Database - PsycINFO 
710,799 
S1 drug* OR 
medication* OR 
Limiters - English 
Search modes - 
Interface - EBSCOhost 
Research Databases 369,765 
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vitamin* OR 
hormon* OR 
pharmacotherap* 
Boolean/Phrase Search Screen - 
Advanced Search 
Database - PsycINFO 
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2) MEDLINE 
 
 
Tuesday, December 09, 2014 10:42:48 AM 
# Query Limiters/Expanders Last Run Via Results 
S16 S15 NOT S6 
Limiters - 
English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
627 
S15 S14 NOT S5 
Limiters - 
English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
647 
S14 S13 NOT S4 
Limiters - 
English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
651 
S13 S12 NOT S3 
Limiters - 
English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
1,025 
S12 S11 NOT S2 Limiters - English 
Language; 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
1,069 
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Human 
Search modes - 
Boolean/Phrase 
Search 
Database - MEDLINE 
Complete 
S11 S10 NOT S1 
Limiters - 
English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
1,417 
S10 S9 
Limiters - 
English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
1,576 
S9 S7 AND S8 Search modes - Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
2,001 
S8 
"cognitive 
behavio* therapy" 
OR "cognitive 
behavio* 
treatment" OR 
"cognitive 
behavio* 
intervention" OR 
"cognitive 
therapy" OR 
"cognitive 
treatment" OR 
"cognitive 
intervention" OR 
"behavio* 
therapy" OR 
"behavio* 
treatment" OR 
"behavio* 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
152,190 
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intervention" OR 
"CBT" OR 
"psychotherap*" 
OR "problem 
solving" 
S7 
"autism spectrum 
disorder" OR 
"ASD" OR 
"autis*" OR 
"asperger*" OR 
"kanner*" OR 
"pervasive 
developmental 
disorder" 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
34,669 
S6 ADHD 
Limiters - 
English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
14,579 
S5 epilepsy 
Limiters - 
English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
86,943 
S4 
education OR 
classroom* OR 
school* 
Limiters - 
English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
2,825,199 
S3 applied behavio* analysis OR ABA 
Limiters - 
English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
7,969 
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S2 gene* 
Limiters - 
English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
4,775,943 
S1 
drug* OR 
medication* OR 
vitamin* OR 
hormon* OR 
pharmacotherap* 
Limiters - 
English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - MEDLINE 
Complete 
4,522,498 
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3) CINAHL Plus 
 
 
Tuesday, December 09, 2014 7:47:38 AM 
# Query Limiters/Expanders Last Run Via Results 
S16 S15 NOT S6 
Limiters - English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
225 
S15 S14 NOT S5 
Limiters - English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
230 
S14 S13 NOT S4 
Limiters - English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
231 
S13 S12 NOT S3 
Limiters - English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
297 
S12 S11 NOT S2 
Limiters - English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
318 
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S11 S10 NOT S1 
Limiters - English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
386 
S10 S9 
Limiters - English 
Language; 
Human 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
405 
S9 S7 AND S8 Search modes - Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
856 
S8 
"cognitive 
behavio* 
therapy" OR 
"cognitive 
behavio* 
treatment" OR 
"cognitive 
behavio* 
intervention" OR 
"cognitive 
therapy" OR 
"cognitive 
treatment" OR 
"cognitive 
intervention" OR 
"behavio* 
therapy" OR 
"behavio* 
treatment" OR 
"behavio* 
intervention" OR 
"CBT" OR 
"psychotherap*" 
OR "problem 
solving" 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
51,747 
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S7 
"autism spectrum 
disorder" OR 
"ASD" OR 
"autis*" OR 
"asperger*" OR 
"kanner*" OR 
"pervasive 
developmental 
disorder" 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
15,936 
S6 ADHD 
Limiters - English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
5,221 
S5 epilepsy 
Limiters - English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
11,244 
S4 
education OR 
classroom* OR 
school* 
Limiters - English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
490,337 
S3 applied behavio* analysis OR ABA 
Limiters - English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
422 
S2 gene* 
Limiters - English 
Language 
Search modes - 
Boolean/Phrase 
Interface - EBSCOhost 
Research Databases 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
303,362 
S1 drug* OR 
medication* OR 
Limiters - English 
Language 
Interface - EBSCOhost 
Research Databases 625,483 
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vitamin* OR 
hormon* OR 
pharmacotherap* 
Search modes - 
Boolean/Phrase 
Search Screen - Advanced 
Search 
Database - CINAHL Complete 
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4) Web of Science  
 
Web of Science: 09/12/14 17.30 
Search History:  
 
Set 
 
Results 
 
 
Edit 
Sets 
Combine 
Sets 
AND 
OR 
 
Delete 
Sets 
 
 
 
# 18 502 #17 NOT #7  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 17 598 #16 NOT #6  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 16 608 #15 NOT #5  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 15 613 #14 NOT #4  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 14 755 #13 NOT #3  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 13 830 #12 NOT #2  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 12 1,049 #11 NOT #1  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 11 1,158 #9 AND #8  
Refined by:LANGUAGES: ( ENGLISH )  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
 Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 10 1,247 #9 AND #8  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 9 119,057 TOPIC: ("cognitive behavio* therapy") OR TOPIC: 
("cognitive behavio* treatment") OR TOPIC: 
Edit  Select to 
combine 
Select to 
delete this 
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("cognitive behavio* intervention") OR TOPIC: 
("cognitive therapy") OR TOPIC: ("cognitive 
treatment") OR TOPIC: ("cognitive intervention") OR 
TOPIC: ("behavio* therapy") OR TOPIC: ("behavio* 
treatment") OR TOPIC: ("behavio* intervention") OR 
TOPIC: ("CBT") OR TOPIC: ("psychotherap*") OR 
TOPIC: ("problem solving")  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
sets.  set.  
 
# 8 44,534 TS=("autism spectrum disorder") OR TS=("ASD") OR 
TS=("autis*") OR TS=("asperger*") OR TS=("kanner*") 
OR TS=("pervasive developmental disorder")  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 7 7,940,807 TOPIC: (animal) OR TOPIC: (mice) OR TOPIC: 
(mouse) OR TOPIC: (rat*) OR TOPIC: (monkey*)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 6 19,522 TS=(ADHD)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 5 99,311 TS=(epilepsy)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 4 818,067 TOPIC: (education) OR TOPIC: (classroom*) OR 
TOPIC: (school*)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 3 70,733 TS=(applied behavio* analysis) OR TS=(ABA)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 2 6,461,473 TOPIC: (gene*)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 1 1,939,217 TOPIC: (drug*) OR TOPIC: (medication*) OR TOPIC: 
(vitamin*) OR TOPIC: (hormon*) OR TOPIC: 
(pharmacotherap*)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
    
AND 
OR 
 
 
 
  
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS   
 
 210 
Appendix C- Email sent to corresponding authors of included studies to request support in 
identifying unpublished or ongoing research 
 
 
 
 
Dear [author name] 
  
I am a Trainee Clinical Psychologist at the University of East Anglia, UK, and I am currently 
conducting my doctoral thesis on the use of Cognitive Behavioural Therapy in individuals 
with Autism Spectrum Disorder. I am being supervised by Dr Peter Langdon (University of 
Kent) and Dr Jo Hodgekins (University of East Anglia). I am planning to include your [year 
of study] trial in a meta-analysis that I am conducting on the effectiveness of CBT in 
individuals with ASD. 
  
I am keen to include any relevant 'grey' literature which I may not have been able to access 
via literature searches so I am asking all authors of included studies if they can think of any 
studies which are less accessible that I may have missed? If you know of any ongoing or 
unpublished trials investigating the effectiveness of CBT in individuals with ASD I'd be very 
grateful if you could let me know. There is no restriction on age range of participants and I 
am including studies investigating the use of CBT for either core features of ASD or co-
occurring symptoms of mental disorder. 
  
Thank you very much in advance for any help you can give. 
  
  
Lisa Weston 
Trainee Clinical Psychologist  
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS   
 
 211 
Appendix D- Data extraction form 
Code	items	with	missing	data	as	99.	Code	items	deemed	not	applicable	as	11.	
	
General	
1. Study	ID:	Assign	a	unique	identification	number	
________	
2. Reference:	Text;	Document	full	reference	in	APA	format	
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________	
3. Year	of	Publication:	Four	digits	
________	
4. Country	of	Origin:	Text	
________	
5. Type	of	Report:	Circle	
1. Journal	article	
2. Book	chapter	
3. Thesis	or	doctoral	dissertation	
4. Conference	paper	
5. Other	(+	specify)	__________________________________________________________	
	
Group	Descriptors	
6. CBT	Format:	Circle	
1. Individual	
2. Group-based	
7. Number	of	Control	Groups	
________	
8. Format	of	Control	Group/s:	If	more	than	one	control	group,	code	separately	in	additional	
columns	
1. Treatment	as	usual	
2. Waiting	list	
3. Attention	placebo	
	
9. Length	of	Each	Treatment	Session:	In	minutes	
________	
10. Number	of	Treatment	Sessions	Offered	
________	
11. Mean	Number	of	Treatment	Sessions	Attended	
________	
12. Total	Length	of	Treatment	Offered:	In	minutes	
________	
13. Mean	Total	Length	of	Treatment	Received:	In	minutes	
________	
14. Baseline	Group	Differences:	Circle	
1. Not	assessed	
2. Assessed,	Negligible	Differences	
3. Assessed,	Some	Difference,	Judged	Unimportant	
4. Assessed,	Some	Difference,	Judged	Important	(significant	differences	across	several	
variables/	significant	difference	on	a	major	variable,	e.g.	age)	
	
Sample	Descriptors	
Control	Group	 1	 2	 3	
Code	 	 	 	
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15. Total	Sample	Size	(at	baseline)	
________	
16. Sample	Size	of	Intervention	Group	(at	baseline)	
________	
17. Sample	Size	of	Control	Group	(at	baseline):	If	more	than	one	control	group,	code	separately	
in	additional	columns,	ensuring	that	the	columns	correspond	to	those	used	in	Item	7	
	
	
18. Mean	Age	of	Total	Sample:	An	
average	may	be	used	if	only	an	age	range	is	documented	
________	
19. Age	Range	of	Total	Sample	
________	
20. Mean	Age	of	Intervention	Group:	An	average	may	be	used	if	only	an	age	range	is	
documented	
________	
21. Age	Range	of	Intervention	Group	
________	
22. Mean	Age	of	Control	Group:	An	average	may	be	used	if	only	an	age	range	is	documented.	If	
more	than	one	control	group,	code	separately	in	additional	columns,	ensuring	that	the	
column	numbers	correspond	to	those	used	in	Items	7	and	14	
	
	
	
23. Age	Range	of	Control	Group:	If	more	than	one	control	group,	code	separately	in	additional	
columns,	ensuring	that	the	column	numbers	correspond	to	those	used	in	Items	7,	14	and	19	
	
	
	
Design	Descriptors	
24. Randomisation:	Circle	
1. Randomised	
2. Non-randomised	
25. CBT	Target:	Circle	
1. Core	ASD	feature/s	(+	specify)	_________________________________	
2. Co-occurring		mental	disorder	(+	specify)	_________________________________	
3. Both	core	ASD	feature/s	and	co-occurring	mental	disorder	(+	specify)	
_________________________________	
26. Relevant	Features/	Symptoms	Quantitatively	Measured;	:	Circle	all	that	apply	
1. Social	interaction	difficulties	
2. Social	communication	difficulties	
3. Restricted	or	repetitive	patterns	of	behaviour	and	interests	
4. Other	ASD	features	(+	specify)	_________________________________	
5. Anxiety	symptomatology	
6. Depressive	symptomatology	
7. Psychotic	symptomatology	
8. Other	symptoms	of	mental	disorder	(+	specify)	_________________________________	
27. Relevant	Outcome	Measures	Used;	Text	
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________	
Control	Group	 1	 2	 3	
Sample	Size	 	 	 	
Control	Group	 1	 2	 3	
Mean	Age	 	 	 	
Control	Group	 1	 2	 3	
Age	Range	 	 	 	
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28. Length	of	Follow	Up	
________	
	
	
Effect	Size	(ES)	Data	
If	more	than	one	relevant	outcome	variable	is	used,	code	effect	size	data	separately	for	each	
outcome	variable.	All	of	the	following	items	should	be	coded	for	each	individual	effect	size	using	
additional	columns	in	the	table	below	
29. Effect	Size	Type	
1. Immediately	post	intervention	
2. Follow	up	
30. Outcome	Descriptor:	Text;	Description	of	outcome	variable	
31. Outcome	Report	Type	
1. Self	Report	
2. Clinician	Report	
3. Informant	Report	
32. Intervention	Group	Mean	
33. Control	Group	Mean:	If	more	than	one	control	group,	code	separately	in	different	rows,	
ensuring	that	the	row	number	corresponds	to	the	column	numbers	used	in	Items	7,	14,	19	
and	20	
34. Intervention	Group	Standard	Deviation	
35. Control	Group	Standard	Deviation:	If	more	than	one	control	group,	code	separately	in	
different	rows,	ensuring	that	the	row	number	corresponds	to	the	column	numbers	used	in	
Items	7,	14,	19	and	20	
36. Direction	of	Effect	
1. Favours	treatment	
2. Favours	control	
3. Neither	
	
	 	ES	1	 ES	2	 ES	3	 ES	4	 ES	5	
ES	Type	 	 	 	 	 	
Outcome	
Descriptor	
	
	 	 	 	 	
Outcome	
Report	Type	
	 	 	 	 	
Intervention	
Group	Mean	
	 	 	 	 	
Control	Group	
Mean	(1)	
	 	 	 	 	
Control	Group	
Mean	(2)	
	 	 	 	 	
Control	Group	
Mean	(3)	
	 	 	 	 	
Intervention	
Group	SD	
	 	 	 	 	
Control	Group	
SD	(1)	
	 	 	 	 	
Control	Group	
SD	(2)	
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Appendix E- Details of individual requests for data 
In the event of missing or unclear information needed to calculate effect sizes, 
corresponding authors of included studies were contacted via email in an attempt to obtain or 
clarify the data. 
Email Template 
Dear [author name] 
  
I am a Trainee Clinical Psychologist at the University of East Anglia, UK, and I am currently 
conducting my doctoral thesis on the use of Cognitive Behavioural Therapy in individuals 
with Autism Spectrum Disorder. I am being supervised by Dr Peter Langdon (University of 
Kent) and Dr Jo Hodgekins (University of East Anglia). I would like to include your [year of 
study] trial ([title of study]) in a meta-analysis that I am conducting on the effectiveness of 
CBT in individuals with ASD. 
  
In order to include your study in the meta-analysis, I would require some additional 
information and I was wondering if you could help me with this please? I require [details of 
missing data]. I would be very grateful if you would be able to share this data to enable me to 
include your paper in my study. 
   
Thanks very much in advance for your help 
 
 Lisa Weston 
Trainee Clinical Psychologist 
Details of Correspondence (listed in order of date contacted) 
Study Author Contacted Data Received (Y/N) 
Reaven et al. (2012) Judy Reaven Y 
Langdon et al. (2016) Peter Langdon Y 
Sofronoff et al. (2007) Kate Sofronoff Y 
Storch et al. (2013) Eric Storch Y 
Chalfant et al. (2007) Anne Chalfant Y 
DeRosier et al. (2011) Melissa DeRosier N 
Laugeson et al. (2012) Elizabeth Laugeson Y 
Soorya et al. (2015) Latha Soorya Y 
Baghdadli et al. (2013) Amaria Baghdadli Y 
Pahnke et al. (2014) Tatja Hirvikoski Y 
Gantman et al. (2012) Elizabeth Laugeson Y 
Yoo et al. (2014) Elizabeth Laugeson Y 
Laugeson et al. (2014) Elizabeth Laugeson Y 
Provencal (2003) Sherri Provencal N 
Freitag et al. (2015) Christine Freitag Y 
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Appendix F- NICE Quality Appraisal Checklist for Quantitative Intervention Studies (NICE, 
2012) 
 
Checklist items are worded so that 1 of 5 responses is possible: 
 
 
In addition, the reviewer is requested to complete in detail the comments section of the 
quality appraisal form so that the grade awarded for each study aspect is as transparent as 
possible.  
Each study is then awarded an overall study quality grading for internal validity (IV) and a 
separate one for external validity (EV):  
++ All or most of the checklist criteria have been fulfilled, where they have not been fulfilled 
the conclusions are very unlikely to alter. 
+ Some of the checklist criteria have been fulfilled, where they have not been fulfilled, or not 
adequately described, the conclusions are unlikely to alter. 
− Few or no checklist criteria have been fulfilled and the conclusions are likely or very likely 
to alter. 
 
++ Indicates that for that particular aspect of study design, the study has been 
designed or conducted in such a way as to minimise the risk of bias. 
+ Indicates that either the answer to the checklist question is not clear from the 
way the study is reported, or that the study may not have addressed all 
potential sources of bias for that particular aspect of study design. 
− Should be reserved for those aspects of the study design in which significant 
sources of bias may persist. 
Not reported 
(NR) 
Should be reserved for those aspects in which the study under review fails to 
report how they have (or might have) been considered.  
Not 
applicable 
(NA) 
Should be reserved for those study design aspects that are not applicable given 
the study design under review (for example, allocation concealment would not 
be applicable for case control studies).  
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Checklist 
Study identification: (Include full citation details)  
Study design: 
Refer to the glossary of study designs and the algorithm for classifying 
experimental and observational study designs to best describe the paper's 
underpinning study design 
 
Guidance topic:  
Assessed by:  
Section 1: Population 
1.1 Is the source population or source area well described?  
Was the country (e.g. developed or non-developed, type of healthcare 
system), setting (primary schools, community centres etc.), location (urban, 
rural), population demographics etc. adequately described? 
++ 
+ 
− 
NR 
NA 
Comments: 
1.2 Is the eligible population or area representative of the source 
population or area? 
Was the recruitment of individuals, clusters or areas well defined (e.g. 
advertisement, birth register)? 
Was the eligible population representative of the source? Were important 
groups under-represented? 
++ 
+ 
− 
NR 
NA 
Comments: 
1.3 Do the selected participants or areas represent the eligible population 
or area? 
Was the method of selection of participants from the eligible population well 
described? 
What % of selected individuals or clusters agreed to participate? Were there 
any sources of bias? 
Were the inclusion or exclusion criteria explicit and appropriate? 
++ 
+ 
− 
NR 
NA 
Comments: 
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Section 2: Method of allocation to intervention (or comparison) 
2.1 Allocation to intervention (or comparison). How was selection bias 
minimised? 
Was allocation to exposure and comparison randomised? Was it truly random 
++ or pseudo-randomised + (e.g. consecutive admissions)? 
If not randomised, was significant confounding likely (−) or not (+)?  
If a cross-over, was order of intervention randomised? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.2 Were interventions (and comparisons) well described and 
appropriate? 
Were interventions and comparisons described in sufficient detail (i.e. enough 
for study to be replicated)? 
Was comparisons appropriate (e.g. usual practice rather than no 
intervention)? 
++ 
+ 
-− 
NR 
NA 
Comments: 
2.3 Was the allocation concealed? 
Could the person(s) determining allocation of participants or clusters to 
intervention or comparison groups have influenced the allocation?  
Adequate allocation concealment (++) would include centralised allocation or 
computerised allocation systems. 
++ 
+ 
− 
NR 
NA 
Comments: 
2.4 Were participants or investigators blind to exposure and 
comparison? 
Were participants and investigators – those delivering or assessing the 
intervention kept blind to intervention allocation? (Triple or double blinding 
score ++) 
If lack of blinding is likely to cause important bias, score −. 
++ 
+ 
− 
NR 
NA 
Comments: 
2.5 Was the exposure to the intervention and comparison adequate? 
Is reduced exposure to intervention or control related to the intervention (e.g. 
adverse effects leading to reduced compliance) or fidelity of implementation 
(e.g. reduced adherence to protocol)? 
++ 
+ 
− 
Comments: 
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Was lack of exposure sufficient to cause important bias? NR 
NA 
2.6 Was contamination acceptably low? 
Did any in the comparison group receive the intervention or vice versa?  
If so, was it sufficient to cause important bias? 
If a cross-over trial, was there a sufficient wash-out period between 
interventions? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.7 Were other interventions similar in both groups? 
Did either group receive additional interventions or have services provided in 
a different manner?  
Were the groups treated equally by researchers or other professionals?  
Was this sufficient to cause important bias? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.8 Were all participants accounted for at study conclusion? 
Were those lost-to-follow-up (i.e. dropped or lost pre-,during or post-
intervention) acceptably low (i.e. typically <20%)?  
Did the proportion dropped differ by group? For example, were drop-outs 
related to the adverse effects of the intervention? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.9 Did the setting reflect usual UK practice? 
Did the setting in which the intervention or comparison was delivered differ 
significantly from usual practice in the UK? For example, did participants 
receive intervention (or comparison) condition in a hospital rather than a 
community-based setting? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.10 Did the intervention or control comparison reflect usual UK 
practice? 
Did the intervention or comparison differ significantly from usual practice in 
the UK? For example, did participants receive intervention (or comparison) 
++ 
+ 
− 
Comments: 
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delivered by specialists rather than GPs? Were participants monitored more 
closely? 
NR 
NA 
Section 3: Outcomes 
3.1 Were outcome measures reliable? 
Were outcome measures subjective or objective (e.g. biochemically validated 
nicotine levels ++ vs self-reported smoking −)? 
How reliable were outcome measures (e.g. inter- or intra-rater reliability 
scores)? 
Was there any indication that measures had been validated (e.g. validated 
against a gold standard measure or assessed for content validity)? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.2 Were all outcome measurements complete? 
Were all or most study participants who met the defined study outcome 
definitions likely to have been identified? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.3 Were all important outcomes assessed? 
Were all important benefits and harms assessed?  
Was it possible to determine the overall balance of benefits and harms of the 
intervention versus comparison? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.4 Were outcomes relevant? 
Where surrogate outcome measures were used, did they measure what they 
set out to measure? (e.g. a study to assess impact on physical activity assesses 
gym membership – a potentially objective outcome measure – but is it a 
reliable predictor of physical activity?) 
++ 
+ 
NR 
NA 
Comments: 
3.5 Were there similar follow-up times in exposure and comparison 
groups? 
++ 
+ 
Comments: 
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If groups are followed for different lengths of time, then more events are 
likely to occur in the group followed-up for longer distorting the comparison.  
Analyses can be adjusted to allow for differences in length of follow-up (e.g. 
using person-years). 
NR 
NA 
3.6 Was follow-up time meaningful? 
Was follow-up long enough to assess long-term benefits or harms?  
Was it too long, e.g. participants lost to follow-up? 
++ 
+ 
− 
NR 
NA 
Comments: 
Section 4: Analyses 
4.1 Were exposure and comparison groups similar at baseline? If not, 
were these adjusted? 
Were there any differences between groups in important confounders at 
baseline?  
If so, were these adjusted for in the analyses (e.g. multivariate analyses or 
stratification). 
Were there likely to be any residual differences of relevance? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.2 Was intention to treat (ITT) analysis conducted? 
Were all participants (including those that dropped out or did not fully 
complete the intervention course) analysed in the groups (i.e. intervention or 
comparison) to which they were originally allocated? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.3 Was the study sufficiently powered to detect an intervention effect (if 
one exists)? 
A power of 0.8 (that is, it is likely to see an effect of a given size if one exists, 
80% of the time) is the conventionally accepted standard. 
Is a power calculation presented? If not, what is the expected effect size? Is 
++ 
+ 
− 
NR 
Comments: 
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the sample size adequate? NA 
4.4 Were the estimates of effect size given or calculable? 
Were effect estimates (e.g. relative risks, absolute risks) given or possible to 
calculate? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.5 Were the analytical methods appropriate? 
Were important differences in follow-up time and likely confounders adjusted 
for?  
If a cluster design, were analyses of sample size (and power), and effect size 
performed on clusters (and not individuals)? 
Were subgroup analyses pre-specified? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.6 Was the precision of intervention effects given or calculable? Were 
they meaningful? 
Were confidence intervals or p values for effect estimates given or possible to 
calculate?  
Were CI's wide or were they sufficiently precise to aid decision-making? If 
precision is lacking, is this because the study is under-powered? 
++ 
+ 
− 
NR 
NA 
Comments: 
Section 5: Summary 
5.1 Are the study results internally valid (i.e. unbiased)? 
How well did the study minimise sources of bias (i.e. adjusting for potential 
confounders)?  
Were there significant flaws in the study design? 
++ 
+ 
− 
Comments: 
5.2 Are the findings generalisable to the source population (i.e. externally 
valid)? 
Are there sufficient details given about the study to determine if the findings 
are generalisable to the source population? Consider: participants, 
interventions and comparisons, outcomes, resource and policy implications. 
++ 
+ 
− 
Comments: 
COGNITIVE BEHAVIOURAL THERAPY IN AUTISM SPECTRUM DISORDERS   
 
 222 
Appendix G- Kappa Calculations 
 
All Kappa calculations were completed using an online calculator: 
http://graphpad.com/quickcalcs/kappa1.cfm 
 
1) Kappa calculation for study inclusion 
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2) Kappa calculation for internal validity of included studies 
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3) Kappa calculation for external validity of included studies 
 
 
 
 
